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ABSTRACT
The transcripts of bovine papillomavirus type 4 (BPV4) were 
analysed through cDNA cloning and sequencing. Two cDNA’s of 
particular interest were analysed. cDNA 7E11 was found to 
represent the 1 kb major transcript of BPV4. Primer extension 
and S1 nuclease protection mapping showed that this 
transcript had a multiple initiation site within the E6 orf 
region, with the major start site at nt870. cDNA and RNA 
sequencing showed that the transcript was spliced from nt10l6 
to nt3376. The polyadenylated 3* terminus was at nt4034, 
defining the early polyadenylation site of BPV4.
Sequencing of cDNA’s and RNA revealed alterations to the 
published genomic sequence (Patel et al., 1987) which changed 
the genomic organisation of BPV4. cDNA 7E11 was shown to 
encode a fusion orf in which the E4 orf was linked to an 
upstream ATG codon. Thus, as in other papillomaviruses, the 
major transcript of BPV4 encodes one of the E4 proteins 
(Doorbar et al., 1986). Orf homology analysis revealed that
the BPV4 E4 orf is most like those of the carcinogenic HPV’s 
16, 18, 33 and 8. Since the E4 proteins are thought to be
involved in the subversion of normal keratinocyte 
differentiation, this may be a significant finding.
In addition, rare transcripts represented by cDNA Q were 
mapped by RNA sequencing and S1 nuclease protection. A 1kb 
transcript, which may be spliced, extends 5’ to nt2834 and 
minor 5’ termini at nt3063, nt3093 and nt3151 may have 
represented transcripts encoding the putative E2 repressor of 
BPV4.
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1.1. Papillomaviruses: general.
1.1.1. Properties of papillomaviruses.
Papillomaviruses, a genus of the family Papovaviridae, are 
the aetiological agents of papillomas, the limited epithelial 
and, in some cases, fibroepithelial proliferations of the 
skin or mucosa in mammals and birds commonly known as warts 
(Pfister, 1984; Giri & Danos, 1986).
Virions extracted from productive papillomas are symmetrical 
icosahedral units approximately 55 nanometers (nm) in 
diameter according to electron microscopic (e.m.) 
visualisation. They are composed of 72 capsomeres arranged 
around a double-stranded (ds) circular molecule of DNA of 
average size 8000 base pairs (bp) which exists in both the 
supercoiled and relaxed (nicked) form. Viral DNA in benign 
papillomas is episomal and exists at high copy numbers per 
cell. Acetylated cellular histone proteins have been found 
associated with bovine papillomaviruses types 1 and 2 (BPV1 
and BPV2) and with human papillomavirus type 1 (HPV1) DNA’s 
in a chromatin-like structure; these proteins comigrate with 
histones H2a, H2b, H3 and H4 in sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (Pfister, 1984).
1.1.2. Papillomavirus types: host and tissue specificity.
Papillomaviruses are kncwn to infect a wide range of mammals: 
humans, cattle, sheep, goats, deer, elk, horses, rabbits,
14
monkeys, pigs, opossums, elephants and Mastomvs natalensis. A 
papillomavirus affecting the harvest mouse, Micromvs minutus, 
has recently been discovered. One avian papillomavirus has 
been described (Pfister, 1984; Sundberg et al., 1987;
Moreno-Lopez et al., 1984).
More than forty different types, and several subtypes of
human papillomaviruses have been characterised so far (Table
1). A new type is defined if it has less than 50% DNA 
sequence homology with known papillomavirus types by liquid 
hybridisation analysis. Groups are defined which have less 
than 1% homology with other groups. This essentially
arbitrary distinction appears to hold good with respect to 
site and histopathology of the lesions induced by different
papillomaviruses (Pfister, 1984).
The more recently discovered HPV's have not yet been 
classified into groups, so it is more convenient to divide 
them into two general categories: those infecting skin and
those infecting mucosa (Table 1b).
Six distinct types of bovine papillomaviruses have been 
characterised (Table 2); these are divided into two
subgroups: A: fibropapillomaviruses, and B: true
epitheliotropic papillomaviruses (Jarrett, 1985).
Although two members of the former group can infect
heterologous hosts , e.g. BPV1 induces equine sarcoids and 
tumours in the hamster (Lancaster and Olson, 1982), 
papillomaviruses are truly host specific in that all known
intergeneric infections are non-productive. They are also
strikingly site specific. Infections even of heterologous
15
Table 1. Classification of HFV*s.
GROUP TYPE LESION
A HFV1 verruca plantaris
B HPV2 verruca vulgaris
HPV3 verruca plana
HPV10 verruca plana; E.V.
C HPV4 verruca vulgaris
D HPV5 E.V. & immunosuppressed patients; 
skin carcinoma
HPV8 E.V.; skin carcinoma
HFV9 E.V.
HFV12 E.V.
HPV14 E.V.
HPV15 E.V.'
HPV17 E.V.; skin carcinoma
E HFV6 condyloma acuminatum; ano-genital 
carcinoma
HFV11 condyloma acuminatum; laryngeal 
papilloma; CUT
HPV13 focal epithelial hyperplasia
E HPV7 ’’butchers* warts”
G HFV16 condyloma acuminatum; CIN; 
genital cancer
HFV18 Morbus-Bowen disease; genital 
cancer
from Pfister, 1984*
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Table 1b, The relationship between HFV type and lesion site.
HFV TYPE SITE OF LESION
HFV 1,2,3,4,7,10,31,33
HFV 3,5,8,9,10,12,14,15, 
17,19-29
SKIN
common cutaneous warts 
epidermodysplasia verruciformis
HFV 13
HFV 6,11,30 
HFV -16,18,33
MUCOSAL TISSUE 
buccal cavity 
larynx; genitals 
genitals (cervix, penis)
from Campo, 1987*
Table 2. Classification of bovine papillomaviruses.
SUBGROUP TYPE LESION
A BFV1 fibropapilloma of paragenital area
BFV2 fibropapilloma of skin
BFV5 fibropapilloma of teat
B BFV3 papilloma of skin
BFV4 papilloma of upper alimentary
tract
BPV6 papilloma of udder
from Jarrett, 19^5•
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sites within the same animal are usually non-permissive if at 
all successful (Jarrett et al., 1984). This specificity 
suggests a narrow-margined permissive system for 
papillomaviruses, an hypothesis supported by studies of their 
infective cycle .
1.1.3. Biology of papillomavirus infection.
The molecular biology of papillomaviruses may be more easily 
put in the context of their effects on the host by a 
description of the virus-productive infective cycle. 
Papillomavirus infection may be experimentally induced by 
inoculating scarified epithelium with virus (Jarrett, 1985). 
In at least BPV1, BPV2 and Shope papillomavirus, epithelial 
trauma is an absolute requirement for successful infection, 
as apparently is epithelial contact with mesenchyme (Kreider 
and Bartlett, 1981). Presumably this accounts for the low 
infectivity of some papillomaviruses (Pfister, 1984). 
Consequent of successful inoculation are the five stages of 
papillomavirus infection defined for the cottontail rabbit 
papillomavirus (CRPV) in the domestic rabbit by Kreider 
(1980; Table 3).
Stage 0 is the "latency period" during which no apparent 
changes occur on the macroscopic level: the length of this
varies between species, being from 3 to 18 months in man and 
from 3 to 8 weeks in rabbits. Molecular events taking place 
during this time are unknown; however it has been shown that 
cloned BPV1 DNA can reside in cultured cells without viral
18
Table 3. Stages in the progression of CRPV—induced tumours in the 
domestic rabbit.
STAGE EVENT BAYS POST- 
INFECTIQN
# PAPILLOMAS 
AFFECTED
0 Latency 0 1 100
I Papillomas appear ■P* 
! 
1 ro 100
II Exponential growth 36 - 60 100
Regression 60 - 90
%-I0
III Persistence Indefinite 20 - 30
IV Carcinoma 350 - 450 40 - 60
from Kreider and Bartlett, 1981
Table 4* Abattoir survey of alimentary papillomatosis in cattle.
CATTLE INC HENCE OF 
PAPILLOMAS,#
MORE THAN 3 
PAPILLOMAS,#
MORE THAN 1 
SITE,#
Normal 19 0.025 4
From high 
cancer farms
80 55 -
Cancerous
cattle
96 90 65
from Jarrett et al., 1980
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replication taking place (Meneguzzi et al., 1984), and latent 
papillomavirus infections are well documented. Of particular 
interest in this respect was a report by Maitland et al. 
(1987) in which HPV16 DNA was shown to exist in 41 % of
biopsies of normal oral epithelium. This followed reports by
the same group in which 33 % of normal cervical tissue 
biopsies were found to contain HPV16 DNA (Cox et al., 1986;
Meanwell et al., 1987); in both cases the DNA was in episomal
form. All these samples came from patients with no clinical 
history of HPV16 infection. Thus papillomavirus DNA may 
remain latent in infected cells for considerable periods 
before some undefined event(s) initiate its vegetative life 
cycle
It is assumed that transformation of one or more basal cells 
occurs at some time during the latent period, followed by 
proliferation of the epidermis resulting in the clinical 
appearance of papillomas at Stage 1.
Papillomas then enter a stage of exponential growth due to 
hyperproliferation of keratinocytes (Stage 2). In situ 
hybridisation of wart sections with tritiated papillomavirus 
cRNA probes suggested that extensive viral replication occurs 
in the stratum granulosum or keratohyalin layer, and may 
commence in the stratum spinosum (Orth et al., 1971); viral
capsid antigens only appear in the stratum granulosun where 
virions may be seen in the nucleus, and in the stratum 
corneum. where they form crystalline arrays embedded in 
keratin (Pfister, 1984). Productively infected keratinocytes 
at this stage contain large numbers of viral genomes, as many
20
as 100,000 genome equivalents per cell (Campo et al., 1985b). 
The mature papilloma consists of a number of tubular 
subunits, attached at their base and extending into tapered 
fronds with highly keratinised tips.
Mature papillomas either regress within a time period
dependent on species and type of virus, or persist. The
factor(s) which predispose a papilloma to regress are
unknown, but regressors are characterised by massive
infiltration of leukocytes into the basal and suprabasal 
layers, accompanied by a 50% reduction in tritiated thymidine 
uptake, which alone would effect the regression of the
tumour. Persisting papillomas are said to be in Stage 3
(Kreider, 1980).
Fibropapillomas have a similar aetiology in the epithelium, 
but their initial site of proliferation is in the subjacent 
fibroblasts; fibroblastic proliferation precedes that of the 
epithelium, which tends to be less markedly hyperplastic than 
in purely epitheliotropic virus infection (Jarrett, 1985).
It is apparent from these studies of benign papillomas and 
from their strict host- and tissue specificity that the sole 
permissive system for papillomaviruses is differentiating 
epithelium. This has been confirmed by attempts to produce 
virions in heterologous hosts and tissues and in vitro
(Butel, 1971; Pfister, 1984). Basal cells are the presumed
site of initial infection and transformation, but viral 
replication and synthesis of viral capsid proteins only occur 
in the stratum eranulosum , i.e. keratin-synthesising cells, 
and full differentiation is required for virion assembly.
21
Malignant progression (Stage 4) was first observed by Rous 
and Beard (1935) in the Shope papilloma-carcinoma complex of 
domestic rabbits. 40-60% of persisting papillomas undergo 
malignant conversion 12-15 months post infection, developing 
into invasive and highly metastatic carcinomas.Since then 
several more papillomaviruses have been implicated in 
carcinogenesis (Smith and Campo, 1985).
1.1.4. Papillomaviruses and cancer: the Shone
papilloma-carcinoma complex in domestic rabbits.
The Shope, or cottontail rabbit papillomavirus (CRPV) was 
discovered by Richard Shope in 1933 in his investigations of 
horn-like papillomas on cottontail rabbits (Shope and Hurst, 
1933). CRPV displays a relaxed host specificity, although 
intergeneric cross-infections are non-permissive. However, 
as further work demonstrated, neoplastic progression of 
Shope papillomas occurs in domestic rabbits , as outlined 
above. CRPV was thus one of the first mammalian oncogenic 
viruses discovered, and the Shope papilloma-carcinoma complex 
of domestic rabbits was the first model of oncogenesis by a 
papillomavirus (Kreider and Bartlett, 1981).
Study of the model established several features peculiar to 
the system:
1). In papillomas, the viral DNA exists in an episomal, 
monomeric form.
2). Cancers are normally non-permissive, but viral capsid
22
antigens can be detected in carcinoma sections by 
immunofluorescence methods.
3). In the transplantable carcinomas VX2 and VX7, derived 
from Shope papillomavirus-induced malignancies, the viral DNA 
is integrated into the host cell genome (Georges et al. 
1984). This may be the general case for CRPV-induced 
carcinomas and metastases, although it may not preclude the 
existence of episomal forms (Wettstein and Stevens, 1982).
4). Rous and Beard (1935) discovered that the application of 
tar to rabbits’ ears induced generalised hyperplasia and 
papillomatosis. Rous and Kidd (1937) found that subsequent 
intravenous injection of CRPV resulted in the development of 
carcinomas in the tarred areas. Application of tar to 
established Shope papillomas accelerated the onset and 
increased the frequency of malignant progression. These 
latter findings show the synergistic effects of two 
tumour-inducing agents, a phenomenon encountered also in 
other papillomavirus-carcinoma systems.
1.1.5. Human papillomavirus-associated cancer.
A rare genetic disorder in humans, characterised by a lesion 
of the cell-mediated immune system, is manifested by the 
disease Epidermodysplasia verruciformis (EV) in which the 
patient develops generalised papillomatosis caused by HPV’s 
of Group D (Pfister, 1984 . Table 1). Papillomas caused by 
HPV’s 5, 8 and 17 are known to progress to carcinomas in
about 30$ of EV sufferers, mainly in sunlight-exposed areas
of the skin (Orth et al., 1980). Pre-malignant, virus-
producing lesions have been observed progressing to Bowen’s 
carcinoma; although the cancers contain viral DNA, they are 
not virion productive (Jablonska et al., 1972); however, the 
presence of HPV17-specific transcripts in an EV skin 
carcinoma points to a possible role for the viral DNA in the 
oncogenic process (Yutsudo and Hakura, 1987). This situation 
appears to parallel the Shope papilloma-carcinoma system and 
may indicate a common mechanism of transformation. 
Immunosuppressed patients, e.g. renal allograft recipients, 
present a similar case to that of EV: an increased incidence
of warts and the association of these with carcinomas in 
areas exposed to sunlight . Frequency of malignant 
progression is related to duration of sunlight exposure in
both cases, implicating ultraviolet light in the role of
co-carcinogen (Boyle et al., 1984)). In a study of one
hundred and twenty renal allograft recipients of varying
graft duration, 48% were found to have warts, with 87% of
those with graft survival time of more than 5 years having
warts. Six of the latter patients with multiple warts also 
had skin or anogenital carcinomas; the skin cancers occurred 
in light-exposed sites. HPV16 DNA was found in the case of a 
vulvar carcinoma. The EV-like plaque lesions on one patient 
were found to contain HPV5 DNA (Rudlinger et al., 1987). The 
latter case is of great interest as it may be indicative of
latent infection by EV papillomaviruses of the general
population at a sub-clinical level. The large number of types 
of EV papillomaviruses in this rare and widely geographically
24
scattered condition would lead one to expect a more general 
incidence of infection.
Papillomavirus research has proliferated with the discovery 
that cervical intraepithelial neoplasia (CIN) and cervical 
cancer are associated with papillomavirus infection (Gissmann 
et al., 1984). HPV’s 16 and 18 are most frequently involved
in genital cancer; HPV’s 6 and 11 are also found, although 
they usually infect the external genitalia and HPV11 
additionally causes laryngeal papillomas. More recently, 
HPV's 31 (Lorincz et al., 1986) and 33 (Beaudenon et al. T
1986) have also been discovered in a small percentage of 
CIN’s.
HPV's 16 and 18 are usually found to be integrated into the 
host genome in cancers and metastases (Shirasawa et al.. 
1986; Georges et al., 1984; Pater and Pater, 1985); however, 
other cancer associated HPV’s are not e.g. HPV’s 6, and in 
some cases 16 (Gissmann, 1984) and EV associated HPV’s 5, 8
and 17 (Ostrow et al., 1982; Yutsudo et al, 1985).
No co-carcinogen has yet been associated with oncogenesis in 
genital HPV's, although women who smoke have an increased 
risk of cervical cancer. Sexual promiscuity also leads to a 
higher incidence of genital cancer (Gissmann, 1984)
Four common statements are emergent from the above examples 
in association with oncogenic papillomaviruses:
1). Cancers can be shown to progress from benign, 
papillomavirus-induced lesions;
2). Genetic predisposition and/or environmental 
co-carcinogens are involved in malignant progression.
25
3). Cancers are non-permissive for viral production.
4). Viral DNA persists in the malignant cells and in some 
cancers it is integrated into the host cell genome.
1.1.6. BPV1 in transformed fibroblasts as a model for
papillomavirus-associated oncogenesis.
As has already been mentioned, the study of papillomaviruses 
has until recently been retarded by the lack of a permissive 
in vitro system. However, the advent of new molecular
biological techniques has enabled considerable advances to be 
made in the field , such that the biochemical activities of 
some of the early proteins are now kncwn, as is the nature 
of some of their transcriptional control.
No permissive in vitro system has yet been found for
papillomaviruses, but three non-permissive systems have 
yielded much information:
1. cells directly transformed by papillomaviruses and/or 
their DNA, in particular BPV1 in mouse fibroblast cell lines 
NIH 3T3 and C127 (Dvoretsky et al., 1980);
2. cell lines explanted from HPV- and CRPV-infected 
carcinomas;
3. production and expression of molecularly cloned 
papillomavirus DNA and their subgenomic fragments in E. coli, 
and transfection of these DNA’s into fibroblasts.
The fact that BPV1 infects fibroblasts in its natural host 
makes it an obvious candidate for _in vitro mouse fibroblast 
transformation. BPV1 virions and DNA have been shown also to
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be capable of non-productively transforming primary cell 
cultures of bovine origin (Pfister, 1984 ), but since mouse
NIH3T3 and C127 cells form a well-characterised and
universally utilised molecular biological system, it is from 
these that most of the current information on BPV1 has been 
obtained.
Mouse fibroblasts transfected in vitro by BPV1 DNA form foci, 
grow in soft agar and are tumourigenic in nude mice, i.e. 
they conform to the phenotypic criteria of transformation. As 
such, they provide a system in which to study not only 
transformation activity but also such functions as regulation 
of transcription, translation and replication of the viral 
genome. These characterisations have progressed through the
use of complementation studies on the partially deleted 
genome, and the directing of transcription of subgenomic
fragments and cDNA clones by heterologous promoters. The use 
of well-characterised assays, e.g. the chloramphenicol acetyl 
transferase (CAT) assay, and inhibition assays of 
transcription and translation, has defined trans- and 
cis-acting sequences and their functions.
BPV1, because of the ease with which it transforms 
fibroblasts, and because it has been studied for longer than 
most papillomaviruses, is the best characterised 
papillomavirus in this system, and has become the reference 
point for other papillomavirus research. It must, however, be 
borne in mind that its specificity for fibroblasts sets BPV1 
apart from most papillomaviruses including all the human 
ones, in spite of their homology; also, studies on in vitro
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cell cultures cannot precisely reflect the in vivo mammalian 
system.
This limitation is most apparent in view of the fact that 
BPV1 is not oncogenic in its natural site of infection. Cells 
explanted from BPV1-induced fibropapillomas do not exhibit 
the transformed phenotype in culture; however, hamsters 
injected with BPV1 DNA develop fibrosarcomas from which 
transformed cells may be recovered (Pfister, 1984). 
Oncogenesis in heterologous host cells has been investigated 
in vitro by a number of workers: of particular interest are
those experiments carried out on untransformed primary cells. 
Amtmann and Sauer (1982a) demonstrated the induction of 
replication and transcription of quiescent BPV1 DNA in mouse 
embryo fibroblasts using the tumour promoters 
12-0-tetradecanoyl phorbol-13-acetate (TPA) and 12-0-retinoyl 
phorbol-13-acetate (RPA). The cells subsequently attained a 
transformed phenotype.
Transgenic mice in which tandem repeats of a transforming 
fragment of the BPV1 genome were integrated into the host 
chromosomes developed epithelial proliferations over the 
entire skin surface; the tumours were mitotically active but 
not metastatic, nor were tumour cells transformed in 
phenotype (Lacy et al., 1986). This model may represent an
early stage in carcinogenesis, or merely a non-productive 
infection in an heterologous host.
Latency of transformation has also been shown using 
molecularly cloned BPV1 DNA in immortalised C127 mouse
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fibroblasts, in which a single application of TPA was 
sufficient to induce transformation (Meneguzzi et al., 1984). 
These types of experiments may reflect the apparent two-stage 
progression to malignancy seen in vivo in other
papillomaviruses. Other groups, however, report the 
transformation of both primary and inmortalised cells by 
papillomavirus DNA alone. nSingle-hitn transformation of NIH 
3T3 fibroblasts by molecularly cloned BPV's at a rate of 
200-300 transformants per ug of DNA was demonstrated by Campo 
and Spandidos (19S3)- Cloned HPV16 DNA was also capable of 
transforming NIH 3T3 cells, but the transformation efficiency 
of this supposedly highly oncogenic papillomavirus was 
surprisingly low at only 27 transformants per ug (Yasumoto et 
al.f 1986). Recently Matlashewski and co-workers (1987)
demonstrated the cooperation of the activated ras oncogene
with HPV16 sequences in the transformation of baby rat kidney 
primary cells. The HPV16 DNA was under the control of Moloney 
murine leukaemia virus regulatory sequences. Integrated HPV16 
DNA alone did not effect reproducible transformation of these 
cells. Cloned HPV16 DNA under control of the Moloney murine 
tumour virus promoter with a neomycin resistance selection 
marker transformed human foreskin keratinocytes to an 
immortal, tumourigenic phenotype under selection conditions 
(Pirisi et al., 1987). This finding would appear to have a
closer relationship to the natural system, which occurs in 
human genital epithelial cells.
These experiments and others, in spite of the superficial 
differences in their findings, may eventually lead to a
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unified theory of papillomavirus-mediated oncogenesis. One 
such theory is that papillomavirus infection may expand a 
target for oncogenic events, and have no other role in
progression of the cell in question to malignancy (M. S.
Campo, personal communication). Before this question may be 
addressed, however, a comprehensive characterisation of
papillomavirus functions is required. The steps which have 
been taken towards such an understanding will now be
reviewed.
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1.2. The molecular biology of the papillomaviruses.
1.2.1 Genome organisation of the papillomaviruses.
So far, no in vitro permissive system has been found for any 
of the papillomaviruses, even in human keratinocytes capable 
of partial differentiation in culture (Butel, 1971; Laporta 
and Taichman, 1982; Burnett and Gallimore, 1983; Pirisi et 
al.T 1987)). Hence the examination of their genetic structure 
has been directed along two routes: (i) analysis of
transcripts both _in vivo and in cultured cells transformed 
by molecularly cloned papillomavirus DNA; (ii) DNA sequence 
analysis. The elucidation of the sequences of several 
papillomaviruses represents a considerable advance in 
papillomavirus research as current knowledge of the functions 
of DNA sequences may be extended to them and point to 
pertinent aspects for further investigation.
The genomic organisations of HPV1, HPV16, CRPV and BPV1 are 
presented as typical examples of papillomaviruses (Fig. 1) 
These data intimate another set of statements peculiar to the 
papillomaviruses:
1. All open reading frames (orf's) of significant size are 
confined to one strand of the DNA duplex. This is supported 
by the finding that transcription is unidirectional (Amtmann 
and Sauer, 1982b).
2. All three reading frames are utilised, and several orf’s 
overlap or are contained within another orf.
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3. The genome can be functionally divided into three 
sections:
(i) that containing orf’s coding for the two viral capsid 
proteins (Engel et al, 1983), termed the Late region by 
analogy to the L-region of polyomavirus and SV40 (Tooze, 
1980);
(ii) the "transforming region", so named because a fragment 
comprising 69% of the BPV1 genome, containing these orf’s, 
was found sufficient to transform mouse fibroblasts jLn vitro 
(Lcwy et al., 1980): this is termed the Early region. The 3’ 
ends of the early and late regions are signified by one or 
two polyadenylation signals, AATAAA;
(iii) a non-coding region of approximately 1 kb which recent 
work has shown to direct most of the complex transcriptional 
control of papillomaviruses.
4. Considerable homologies exist in some orf’s of different 
viruses at the amino acid level (Giri and Danos, 1986): the 
L1 capsid gene is particularly well conserved, as is the E1 
orf; however
5.the L2 capsid gene is widely divergent, except at its 3* 
end, indicating a possible tissue recognition function; 
similarly the non-conservation of the E4, E5, E6 and E7 orf’s 
is suggestive of adaptations to divergent intracellular 
conditions in different tissue types.
Such hints at gene function demanded more detailed 
examination, with the result that a large body of data has 
been collected on the molecular biology of papillomaviruses 
in _in vitro culture systems.
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Figure 1.
The format used in this diagram to represent papillomavirus genome 
organisation is maintained in all other such diagrams in this thesis, 
USTA is represented by an unbroken horizontal line. Boxes represent 
orf’s in the three translational frames. Vertical broken lines 
indicate the position of the first ATG codon in each orf. E = early; 
L = late.
Polyadenylation signals are shown in this figure by vertical arrows. 
Restriction sites are also included.
Numbers refer to nucleotide positions on the BFV4 genome.
Figure 1 • Genomic organisations of BF\M, CRPV, HFV1 and HF\T16j
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Broker and Botchan. 1986.
1.2.2. The state of papillomavirus DNA and its transcription 
in vivo and in vitro.
1.2.2.(i) BPV1 DNA in fibropapillomas and transformed cells.
BPV1 DNA replicates in bovine fibroblasts and keratinocytes 
in vivo and in mouse C127 fibroblasts _in vitro independently 
of the host cell genome. It is maintained as a circular
episome which in BPV1-transformed C127 cells (ID13) exists at
a copy number of about 150 per cell (Law et al., 1981).
Initial experiments aimed at functional analysis tested the 
transforming activity of various subgenomic fragments cloned 
into plasmids and showed that a cloned fragment of BPV1 DNA 
representing 69 % of the genome (Fig. 2) was capable of
transforming C127 cells (Lcwy et al., 1980). Plasmids
containing the fragment remained episomal in the transformed 
cells. Sequence analysis later established that the eight 
early orf’s were encoded in this fragment (Chen et al. f
1982), and this led to the designation ’’early" or 
"transforming" region for these orf’s.
1.2.2.(i)(a). The transcriptional organisation of BPV1 in 
fibropapillomas.
Northern blot analyses of BPV1-specific transcripts in bovine 
fibropapillomas using single-stranded BPV1 DNA probes showed 
that transcription occurred only on one strand. Eight size
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classes of RNA were found in the polyadenylated fraction, of 
8.0 0; 6 .7 0; 4.05; 3.8 0; 3 -7 0; 1.7 0; 1.15 and 1.05 kb
respectively. It was also shown that the 8.0; 6.7; 3.8 and
1.7 kb species contained sequences hybridising to the late 
region of BPV1 and that the 3* termini of these transcripts 
were near the late polyadenylation signal. The 8.0 kb species 
hybridised to fragments from all regions of the genome. The
other RNA’s hybridised to the early region only and
terminated exclusively at the early polyadenylation site. In 
view of the large number of RNA splicing signals scattered 
throughout the BPV1 genome, it was considered that the larger 
transcripts were probably nuclear precursors (Engel et al. T
1983).
The analysis of a cDNA library produced from BPV1 
fibropapilloma mRNA is presented in Figure 2 (Baker and 
Howley, 1987). It is immediately apparent from this map that 
a complex splicing pattern is directed by viral sequences, in 
sane cases joining parts of different orf’s to create new 
orf’s. Another characteristic of papillomaviruses 
demonstrated by this analysis is the low abundance of their
transcripts: in spite of high viral genome copy numbers in
papilloma cells, viral transcripts accounted for only 1.3 %
of polyadenylated RNA in this analysis (Baker and Hcwley, 
1987).
All the cDNA classes isolated had 5’ ends around nt7250 in 
the non coding region, except for class F. The most abundant 
BPV1 transcript in fibropapillomas was represented by cDNA’s 
of class C (Fig. 2). Sequence analysis showed that a fusion
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Figure 2. Genomic and transcriptional organisation of BFV1.
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orf was created by the splice, with the leader exon from the 
non-coding region contributing an ATG plus one other codon, 
joined onto a truncated E4 orf. The E5 orf was also encoded 
by this cDNA.
Class D cDNA’s specified a splice junction between the same 
leader and the 3’ 78 codons of the E2 orf. The 3’ terminus of 
both classes of cDNA was at the early polyadenylation site.
A late transcript, represented by cDNA’s of class E, was 
formed by the splicing of the leader exon described above to 
a short exon containing sequences transcribed from the within 
the E2 orf; this was in turn spliced onto the L1 orf. Two 
major orf’s were encoded by this cDNA: analysis of sequences
flanking the ATG codons of each orf according to rules 
defined by Kozak (1986) showed that an ATG lying within the 
L1 orf was in the most favourable configuration for 
translation initiation. However, another fusion orf beginning 
with the two codons from the leader exon continued through 
the middle exon and terminated in a short open reading frame 
in the L1 exon, but not in the L1 reading frame. This orf
specified a putative 72 amino acid protein. Although the
translation initiator sequence is a weak one, the elaborate 
splicing pattern seen in this cDNA would seem to argue in 
favour of some function for the fusion protein; otherwise it 
may serve as an unusually large leader for the L1 orf.
The 5’ terminus of the class F cDNA, encoding the L2 orf, was 
not close to any known promoter and was considered to be a
truncated copy of the transcript it represents.
The two other cDNA classes defined in this analysis,
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represented transcripts derived from the early region, both 
having 3’ termini at the early polyadenylation site, nt4203. 
Class A cDNA’s were colinear with the BPV1 genome, whereas 
those of class B were spliced from the beginning of the E1 
orf to the splice acceptor in the middle of both the E2 and 
E4 orf’s.
1.2.2.(i)(b). Transcriptional promoters of BPV1.
The cDNA’s described above did not account for all the size 
classes of BPV1 RNA reported by Engel et al. (1983).
Furthermore, all but one showed transcriptional initiation 
from one small area of the genome, whereas sequence analysis 
located several other potential promoters (Chen et al.T 
1982). Therefore, further transcriptional analysis was
carried out on polyadenylated RNA from fibropapillomas using 
S1-nuclease protection and primer extension (Baker and
Howley, 1987). These experiments showed that the majority of 
mRNA's were transcribed from a variety of sites between 
nt7214 and nt7254, implying that transcriptional initiation 
from this promoter is not precisely directed in vivo.
However, when polyadenylated RNA from the fibromatous part 
only of the fibropapillomas was used in this analysis, no 
transcripts could be found which had initiated from this 
promoter. Since the expression of late viral products is
confined to the outer differentiated layers of epithelial 
cells (Amtmann and Sauer, 1982b; Pfister, 1984), this
promoter was termed the major late promoter, P^ . Two tandem
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copies of a sequence 73 % homologous to the SV40 late 
promoter sequence, GGTACCTAACC, were found upstream of the 
"late” transcription initiation sites. This promoter is 
important in SV40 for the specification and efficient 
utilisation of the major late RNA start site (Brady et al.,
1984). Since many of the transcripts initiating at this site 
in BPV1 are confined to "early" region sequences, the 
re-definition of this region as the transforming region might 
be more appropriate.
Mapping of transcriptional start sites directed by other 
putative promoters was also presented in this report (Baker 
and Howley, 1987). An additional start site was found at 
nt7l85. Initiation mapped to a single nucleotide and a TATA 
homology was found overlapping the late polyadenylation 
signal 25 nucleotides upstream, but transcripts initiating 
here were far less abundant than those starting in P^ , 
particularly in RNA from the fibromatous part of the tumour. 
This minor late promoter was designated
Transcriptional initiation sites were also mapped at nt89, 
and a cluster between nt7934 and nt7939. TATA consensus 
sequences were found about 30 nucleotides upstream of these 
two sites and were termed Pgg and Prespectively.
Two other start sites were found within the transforming 
region. In one, the main cluster of termini was seen between 
nt3072 and nt3080, with minor signals scattered as far 
upstream as nt3012. The other start site was mapped to nt2443 
(Ahola et al., 1987). The promoters for these start sites
were designated P^qqq and P2443’ respectively. No TATA box
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sequences could be found for *3080* but a TATA homolo6y 
exists at nt2414 which could direct ?2443 transcription. 
Mapping of transcripts initiated at P2443 showed that, while 
some were colinear with the genome, 90 % were spliced from 
nt2505 to nt3225. The 3’ termini of transcripts directed by 
all promoters except was at the transforming region 
polyadenylation site.
1.2.2.(i)(c). Differential utilisation of BPV1 promoters in 
fibroblasts and epithelial cells of bovine 
f ibropapillomas.
Quantitative analyses of transcription from the various 
promoters of BPV1 carried out separately on RNA isolated from 
the fibromatous and epithelial parts of a bovine 
fibropapilloma revealed differences between levels of 
promoter utilisation in the two types of cell (Baker and 
Howley, 1987).
Apart from the non-utilisation of P^  in bovine fibroma cells, 
it was also found that the level of transcription from Pgg 
and PyQ2|Q *n these cells was approximately ten times that in 
the epithelial part of the tumour. Transcription from ^2443 
was reduced in epithelial cells to approximately 30 % of the 
level quantified in fibromatous tissue. Transcripts initiated 
at P2443 anc* P3080 were the most abundant viral transcripts 
found in fibroma cells, while in the epithelial portion of 
the tumour, P^-directed transcripts were 10- to 100-fold more 
abundant than those initiated at any other viral promoter.
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These data have important implications for the fibroblast 
model for papillomavirus functions. It appears that 
transcription from is activated only in epithelial cells 
and must therefore be dependent upon the interaction, either 
direct or indirect, of keratinocyte-specific factors with 
viral promoters. The transcription of the capsid encoding 
orf’s L1 and L2 is also dependent on failure to respond to 
the early transcription termination signal. Since the 
majority of classes of P^-directed transcripts terminate 
here, transcription of L1 and L2 may be due to the 
attenuation of some termination mechanism operating at this 
site. This could be effected through titration of the 
termination factor(s) due to rapid increase in viral copy 
number in the suprabasal layers of the epithelium, or by the 
expression of a cellular factor specific to keratinocytes. 
Failure to express late transcripts, and the increased level 
of transcription from the other promoters, may be a feature 
of an early, fibroblastic phase of the life cycle of BPV1, 
and in vitro studies in fibroblasts have to be judged within 
these parameters. In particular, progression to malignancy is 
a feature of persistent, long-term papillomatosis in the 
Shope system (Kreider and Bartlett, 1981) and therefore less 
likely to be associated with an early event in the viral life 
cycle. Transformation of cells _in vitro may not necessarily 
be brought about by the same mechanisms operating In vivo.
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1.2.2.(i)(d). Transcriptional organisation of BPV1 in
transformed C127 cells.
BPV1-specific transcripts in ID13 cells (Law et al., 1981)
are a subset of those found in fibropapillomas and represent 
0.02 % of polyadenylated RNA, according to analysis of a cDNA 
library (Yang et al., 1985a). The primary difference
accounting for these discrepancies is the absence of 
transcripts initiated at the transcriptional start sites. 
Mapping of BPV1 mRNA's in ID13 cells has been done by cDNA 
analysis (Yang et al., 1985a), electron microscopy of DNA:RNA 
hybrids, S1-nuclease protection analysis and primer extension 
(Stenlund et al., 1985; Ahola et al., 1987; Baker and Hcwley, 
1987). Results of these analyses are in good agreement and 
are therefore represented by the cDNA map in the lower part 
of Figure 2.
Again, differential splicing of viral transcripts results in 
junctions between parts of different orf's with potential to 
code for new orf’s. 90 % of BPV1 transcripts in ID13 cells 
were found to be transcribed from a region around P2443’ 
their 5’ ends were highly heterogeneous, with the major start 
sites occurring between nt2436 and nt2447, and minor signals 
mapping around nt2410 (Ahola et al., 1987). 90 % of these
were of the spliced species described under the previous 
heading (Baker and Howley, 1987), and represented by class V 
cDNA’s (Fig. 2), and the remainder were unspliced. The only 
orf of significant size in these transcripts was the E5 orf, 
which contained an internal AUG codon following a leader of
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nearly 800 nucleotides. The colinear transcripts of P2443 
also encode the E5 orf, but also the full-length E2 orf. 
Transcripts directed by the Pg^ promoter were represented by 
approximately 4 % of cDNA’s, comprising classes I and II.
Class I cDNA’s encoded an E6/E7 fusion orf while those of 
class II contained an E6/E4 fusion; these fusions were 
created by differential splicing from the same splice donor 
in the middle of the E6 orf. cDNA’s encoding the full-length 
E6 orf (class III) were found in very low abundance in this 
analysis, as were those encoding the E7 orf. The apparent 
start sites represented by these molecules did not conform to
mapped coordinates (Baker and Hcwley, 1987; Ahola et al.T
1987), so these were probably truncated cDNA’s.
Quantitative analysis of BPV1 transcripts in ID13 cells
showed that levels of viral promoter utilisation in these 
cells were equivalent to those in the fibromatous part of 
fibropapillomas (Baker and Howley, 1987). No capsid protein 
encoding transcripts have been found in ID13 cells, although 
P7185 was ^ounc* be active at a very low level (Baker and 
Howley, 1987), and transcription from P^  could only be 
detected after treatment of the cells with cycloheximide 
(Kleiner et al., 19 86). According to cDNA analysis,
transcripts initiated at P^  have the potential to direct the 
synthesis of a variety of proteins from different orf’s, each 
presumably essential to the propagation and possibly
persistence of the virus in epithelial cells. Non-utilisation 
of this promoter may be responsible for the transformed 
phenotype of ID13 cells, perhaps due to overexpression of
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transcripts suppressed in keratinocytes. The untransformed 
nature of fibroblasts in fibropapillomas, however, indicates 
that some feature of C127 cells or their culture system must 
act synergistically with the virus in the induction of the 
transformed phenotype.
The absence of P^-directed transcripts in ID13 cells presents 
an opportunity to investigate the functions of their 
translation products by supertransfection of the appropriate 
cDNA under control of constitutive promoters. cDNA’s, or 
subgenomic fragments containing specific orf's, may be used 
in this way in two experimental approaches aimed at 
characterisation of papillomaviruses:
1). as functional assays for the encoded proteins, and in 
complementation experiments with deletion mutants;
2). in the analysis of interactions between viral proteins 
and cis-acting regulatory regions.
In addition, sub-genomic fragments and cDNA’s may be used in 
prokaryotic vectors for the production in bacteria of viral 
peptides against which antisera may be raised, providing a 
means of isolating the protein in question from cells, or of 
localising it in cells and tumour sections by in situ 
fluorescence attachment.
1.2.2.(ii). Transcriptional organisation of CRPV in 
papillomas and the VX2 carcinoma.
As an animal model for papillomavirus-associated oncogenesis, 
the Shope complex in domestic rabbits presents an apparently
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ideal system. However, the molecular biological 
characterisation of CRPV has lagged behind that of BPV1, in 
spite of the availability of the VX2 carcinoma, transplanted 
between generations of domestic rabbits for over 30 years 
(1.1.4.).
As has already been mentioned, CRPV DNA, although episomal in 
benign papillomas, exists entirely in integrated form in VX2 
carcinoma cells. Most of the 10-20 copies of the genome in 
malignant cells are arranged in a head-to-tail tandem 
configuration; the viral integration coordinate is unknown 
(Georges et al., 1984).
Transcriptional analysis of CRPV in both the benign and 
malignant contexts was carried out by R-loop analysis 
(Georges et al., 1984) and nuclease protection assays
(Nasseri and Wettstein, 1984; Danos et al.. 1985; Wettstein
et al., 1987). The results of these experiments are
summarised in Figure 3.
Northern blot hybridisation analysis defined 5 transcript 
size classes in virion-productive papillomas of cottontail 
rabbits. As in transcripts of BPV1, all CRPV transcripts 
terminated at either the early or the late polyadenylation 
site. Transcription was shown to be unidirectional. Two 
transcripts hybridising to the late region of CRPV, of 4.8 
and 2.6 kb, and a message containing sequences from the E2/E4 
region, of 0.9 kb, were not found in the non-productive VX2 
carcinoma or domestic rabbit papillomas induced by CRPV
(Nasseri and Wettstein, 1984). The late region exons of the
4.8 and 2.6 kb messages were found to be spliced to distal 5’
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Figure 3. Transcriptional organisation of CRPV in papillomas
and carcinomas.
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exons; like their P^-directed counterparts in BPV1, their 
transcription initiated at the 5f end of the non coding
region, and the leader exon was spliced from within this
region to another exon within the transforming 
region.The second exons of these transcripts have not yet
been mapped, but are thought to be in the E6-E7 region
(Wettstein et al., 1987). In the 2.6 kb species, the second
exon was spliced onto an L1-encoding terminal exon, while the 
main body of the 4.8 kb mRNA may consist of multiple exons
transcribed from the E2/E4, L1 and L2 orf’s (Nasseri and
Wettstein, 1984).
Transcripts of 2.0 and 1.3 kb were found in all CRPV-induced 
papillomas and carcinomas. In papillomas, the 2.0 kb message 
was more abundant than the 1.3 kb, whereas in the VX2 
carcinoma, the 1.3 kb transcript predominated. In addition, a 
minor 1.25 kb species was found in VX2 RNA.
Detailed S1-nuclease mapping showed that the 2.0 kb 
transcript consisted of two exons: a leader transcribed from
the beginning of the E6 orf and spliced from a position 
downstream of the E7 orf to an exon transcribed from within 
the E2/E4 region, terminating at the first polyadenylation 
site of the transforming region (Danos et al., 1985;
Wettstein et al., 1987). Two transcriptional start sites were 
found at nt95 and ntl65; these sites were 35 nucleotides 
downstream of two TATA boxes and straddled the first A7G 
codon of the E6 orf, the major start site being downstream. 
The E6 orf of CRPV is unusually large by comparison with 
other papillomaviruses (Giri et al., 1985), so it may be that
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the truncated form encoded by the major 2.0 kb leader exon 
represents the "consensus" E6. The significance of the larger 
exon has not been established; there is no difference in its 
transcription level between benign and malignant tumours.
The 1.3 kb transcript, expressed at an elevated level in the 
VX2 carcinoma, has two transcriptional start sites. The major 
start site was mapped to nt908, at the 3’ end of E6, and 
utilised in all CRPV-induced lesions. A minor start site at 
nt958, also at the 3’ end of E6, was defined only in the VX2 
carcinoma, and accounts for the 1.25 kb RNA species (Danos et 
al., 1985). The leader exon of both species was shown to be
spliced onto the E2/E4 exon utilising the same splicing 
signals as the 2.0 kb transcript (Wettstein et al.T 1987). 
The significance of the differential start site is unknown, 
as the first AUG codon of both transcripts is the same, 
within the E7 orf.
In addition, a rare transcript containing an exon coding for 
the full-length E2 orf was found. In RNA extracted from a 
Shope carcinoma, this exon terminated at either of the two 
early polyadenylation sites. However, in polyadenylated RNA 
from a cottontail rabbit papilloma, this exon was shown to 
extend 3’ to the early polyadenylation signals in a 
sub-population of molecules. It was also shown by neutral 
agarose gel analysis of mung bean nuclease protection assays 
that this exon was spliced to approximately 1.25 kb of 
upstream sequences, and may therefore be another 2.6 kb 
transcript.
The current transcriptional map of CRPV in the Shope
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papilloma carcinoma system thus demonstrates, as in the case 
of BPV1, the "switching-off" of a viral transcriptional 
promoter in an heterologous cell system, accompanied by 
failure to transcribe past the early polyadenylation signals 
and an alteration in the steady-state levels and positional 
accuracy of transcriptional initiation from another promoter. 
Most notable is the fact that only three CRPV-specific 
transcripts are found in domestic rabbit papillomas and 
carcinomas, at least two of which have as their first orf the 
E6 or E7 orf*s. This may implicate the translation products 
of these orf's in the oncogenic process and/or maintenance of 
the malignant state, particularly in the VX2 carcinoma in 
which these sequences have presumably been transcribed for 
over thirty years. The above studies, although detailed and 
to an extent repetitious, do not represent a functional 
study, which could only be effectively instituted using 
cDNA's to express translational products of the transcripts 
in question.
1.2.2.(iii) HPV's in papillomas and carcinoma cell lines.
The bovine model for papillomavirus infection has allowed 
rapid progress in the characterisation of BPV1 In vivo. 
Ethical restraint has retarded such studies in the case of 
HPV’s, but the establishment of several cell lines from 
genital cancers containing HPV DNA has provided potential for 
the investigation of papillomavirus-associated oncogenesis. 
Like BPV1, HPV DNA in benign papillomas and condylomata
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exists as a multicopy episome, but in most cancers and 
cancer-derived cell lines at least some of the viral DNA is 
integrated into host chromosomes.
1.2.2.(iii)(a) Transcription of HPV's 1. 6b and 11 in benign 
tumours.
Viral transcription in plantar warts containing HPV1, in a 
vulvar condyloma containing HPV11 and in an anal condyloma 
containing HPV 6b was studied by R-loop analysis, the results 
of which are reproduced in Figure 4 (Chow et al., 1987a,b). 
Although precise details of transcriptional start sites and 
splice junctions cannot be mapped by electron microscopy of 
R-loops, these exhaustive analyses provide a more 
comprehensive examination of papillomavirus transcripts and 
define an emerging pattern of transcription in benign 
epithelial tumours. Furthermore, they enabled the selection 
of subgenomic fragments from which antisense probes specific 
for each class of transcript could be synthesised. These 
probes were used to localise transcripts in the various 
differential layers of condylomata by in situ hybridisation. 
The transcriptional organisation of HPV's 1, 6b and 11 was 
found to be in many ways similar to the overall map of BPV1 
transcription in fibropapillomas. The 3’ ends of all 
transcripts occurred near either the early or late 
polyadenylation signal, and transcription was shown to be 
unidirectional. Nearly all R-loops demonstrated splicing. 
Transcription appeared to be initiated from three main
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Figure 4. Transcriptional organisation of HTVs 1t 6b and 11
in benign tumours.
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promoters: in HPV1, these occurred in the non coding region,
at the beginning of the E6 orf and within the E? orf; in 
HPV’s 6b and 11, they were located in the non coding region, 
in the overlapping region of the E7 and E1 orf’s and within 
the E1 orf. Many transcripts had small, distal leader exons 
transcribed from these promoters spliced onto the main 
exon(s). The single exception was a transcript spanning the 
late region which initiated at a point immediately 5 ’ to the 
L2 orf, similarly to cDNA’s of class F from BPV1 transcripts. 
The large majority of R-loops represented a single mRNA 
species, class (a), containing sequences transcribed from the 
E2/E4 region spliced to a distal upstream leader of about 120
nucleotides, transcribed from the E7/E1 region. A cDNA
library synthesised from RNA from a condyloma containing 
HPV11 yielded cDNA’s representing only this transcript. 
Sequence analysis revealed a fusion orf consisting of four 
codons following an ATG from the 5’ end of E1, joined to 85 
codons form the E4 orf; the E5a and E5b orf's were also
encoded by these cDNA’s. A high degree of amino acid sequence 
conservation was observed between the fusion orf and a 
predicted corresponding fusion orf in HPV6b (Nasseri et al., 
1987). Antisense probes from the E4-E5 region of HPV6b
displayed a broad area of hybridisation to condyloma 
sections, particularly in the middle and outer differentiated 
layers (Chow et al., 1987a).
HPV1 RNA’s of class (b) and HPV6b and 11 RNA’s of class (e) 
bear similarity to class III cDNA’s of ID13 cells (Fig. 2; 
Yang et al.,1985a); again, it could not be determined whether
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these rare species were partially spliced intermediates of an 
analogue of ID13 class I transcripts, although no R-loops 
representing E6/E7 splices were found (Chow et al., 1987a). 
Transcripts of HPV1 classes (d-f) and HPV6b and 11 class (m) 
were similar to BPV1 class E. A 320 nucleotide stretch 
transcribed from the E2/E4 region was spliced 3’ to an L1 
exon, and 5 ’ either to short leaders from the non coding 
region (HPV1) and the E7/E1 overlap (HPV’s 1, 6b and 11), or 
to a longer exon containing the E6 and EJ orf's (HPV1). This 
apparent conservation of splicing adds more weight to the 
argument for a function encoded by the fusion orf in the BPV1 
class E cDNA [1.2.2.(i)(a)3. Similar leader exons were found 
in transcripts terminating at the early polyadenylation site. 
Antisense probes from the E6 and E7 orf’s localised higher 
concentrations of transcripts containing these sequences to 
the more differentiated strata of condyloma sections, and L1 
and L2 probes only gave signals in the superficial layers, 
showing that they are late transcripts in the temporal as 
well as notional sense.
Downstream exons of the transforming region transcripts of 
HPV’s 6b and 11 contained both the full-length E2 orf and a 
truncated E2 beginning within the overlapping region of the 
E4 orf. All contained both E5 orf’s; a rare transcript was 
internally spliced in the E2/E4 overlapping region. By 
contrast, all the corresponding HPV1 transcripts found in 
plantar wart RNA encoded only the 3f-E2/E4 region in their 3' 
exons, and terminated before the first AUG codon of the 
single E5 orf.
53
Colinear transcripts and those containing long uninterrupted 
exons were extremely rare in these analyses and thought to be 
nuclear intermediates of mature transcripts. As was the case 
with BPV1, transcription from the E1 region was rarely seen, 
and an antj.sense DNA probe from this region did not show a 
detectable level of hybridisation to the cytoplasm of 
condyloma cells, although nuclear signals were obtained (Chow 
et al., 1987a,b). These could represent unspliced precursors
of other mRNA’s or undegraded by-products of splicing, or 
precursors of highly labile E1 messages.
Apart from the differences noted above, transcription of 
HPV’s in benign tumours parallels, at least superficially, 
that of BPV1 in fibropapillomas. This might be expected in 
view of their very similar genomic organisations. The most 
notable difference between the transcript maps of the HPV’s 
themselves was that the E5 orf of HPV1 was not transcribed in 
any of the early transcripts, whereas all the early mRNA’s of 
the cancer-causing HPV’s 6b and 11 contained the respective 
E5a and E5b orf’s. Whether the E5 orf confers carcinogenic 
potential is therefore an important topic for functional
analysis, although HPV.1 DNA has been shown to transform mouse 
cells in culture (Watts et al., 1984).
In situ hybridisation analysis, although it identified the L1 
and L2-encoding transcripts as truly late messages, only 
demonstrated a general increase in the levels of other
transcripts towards the superficial layers of the benign 
tumour, which may only reflect the amplification of the viral 
template rather than any regulatory activity. Again, the
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conclusion is that true functional dissection can only be 
achieved through manipulation of papillomavirus-specific 
cDNA's.
1.2.2.(iii)(b). Transcription of integrated HPV16 DNA in 
carcinoma cell lines.
(1). The state of HPV16 DNA in cervical carcinomas and their 
derived cell lines.
HPV16 DNA transforms both NIH3T3 fibroblasts (Yasumoto et 
al., 1986) and human foreskin keratinocytes (Pirisi et al. f
1987); it is found in 62 % of cervical carcinomas and shows a 
prevalence in cervical dysplasias proportional to the 
severity of the lesions (Shirasawa et al., 1986). In all
cases, the viral DNA is integrated into the host chromosomes, 
invariably with rearrangements and deletions of the viral 
genome. The presence of integrated HPV16 in precancerous 
lesions (Shirasawa et al., 1986; Schneider-Manourv et al. T 
1987), together with the almost universal presence of HPV DNA 
in cervical carcinomas (95 %, using hybridisation probes of 
known type: Gissmann et al., 1987), are strong evidence for a 
causal link between papillomaviruses and cancer.
Two carcinoma cell lines containing HPV16 DNA have been 
characterised: the CaSki and SiHa cell lines. CaSki cells
contain approximately 600 copies per cell of the viral 
genome, predominantly as head-to-tail tandem repeats of the 
intact genome, and one from which the non coding region has 
been deleted. By contrast, the SiHa cell line contains only a
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single copy of the HPV16 genome, which has a 215 bp deletion 
of the E2 orf. The integration site coincides with the ends 
of this deletion, creating fusion orf’s with human DNA 
sequences. These run into the E2/E4 region from the 
left-flanking human sequences, and out of the 5’ part of the 
E2 orf into the right-flanking sequences (Baker et al., 1987) 
The integration of viral DNA in cell lines and carcinomas 
does not preclude the existence of the episome, which has 
been found in some tumour samples (Smotkin and Wettstein, 
1986); however, virions are never produced by these cancers, 
and the absence of episomal papillomavirus DNA in most 
cervical cancers (Gissmann et al., 1987) indicates that it
has no function in the malignant state.
(2). Transcription of HPV16 in SiHa and CaSki cells. 
Hybridisation of strand-specific subgenomic probes to RNA 
extracted from SiHa cells showed that transcription of the 
HPV16 genome in these cells was unidirectional and confined 
to the region of the E6, E7 and E1 orf’s, although the 
transcript sizes of 4.6 and 4.1 kb indicated that 3’ flanking 
cellular sequences were also transcribed and presumably 
spliced onto the viral sequences.
The CaSki cell line contained four size classes of HPV RNA: 
a 3-6 kb band hybridising to probes from the E6, E1 and E2 
orf’s; 1.5 and 1.0 kb bands encoding E6, E7 and E2 sequences 
and a 0.65 kb species hybridising to E2 sequences. No late 
region transcription was detectable in either case (Baker et 
al., 1987).
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Exon mapping of HPV16 transcripts in CaSki cells was carried 
out by Smotkin and Wettstein (1986; Fig.5). Their 
identification of major transcripts of 4.5 and 1.5 kb, and a 
minor species of 2 .3 kb, was at variance with the later 
report (Baker et al., 1987), although the same methods were
used.
5* exons were mapped to the E6-E7 region of HPV16; these 
transcripts had a common initiation site at nt97, just 
downstream of the first ATG of the E6 orf. A minor exon 
contained both the E6 and E7 orf’s, and two other transcripts 
were found to initiate in this region. A major transcript 
initiating in this region was spliced from nt232 internally 
within the E6 orf to nt407. Another minor transcript 
contained a splice junction between nt257 and nt522, just 
upstream of the E7 orf. Two 3* ends were mapped downstream of 
these splice junctions, at nt884 and nt940, both 31 to the E7 
orf.
These transcripts were shown by non-denaturing gel analysis 
of S1-nuclease protection assays to be spliced to exons 
mapping to the E2/E4 region. The 5' ends of these exons were 
mapped to a minor site upstream of the E2 orf and a major 
site within the overlapping region. The 3' end of both was 
identical and occurred within the E2 orf, downstream of the 
E4 orf. Since no polyadenylation signal was found near this 
position, and the maximum estimated size of the full 
transcripts was short of those established by Northern 
analysis, it was assumed that this corresponded to a 
viral/host DNA junction and that transcription proceeded
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Figure 5. Transcriptional organisation of HFV18 INA in CaSki cells.
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along human sequences until a termination signal was reached. 
In a separate analysis of RNA from a tumour containing 
episomal as well as integrated HPV16 DNA, these 3' exons 
terminated at the early polyadenylation site.
These analyses showed the extent of disablement of HPV16 in 
malignant tumours. Similarities in the splicing arrangements 
to those found in BPV1 and other HPV transcript maps 
indicates that the CaSki transcripts are a subset of those in 
benign tissues; it also appears that they are only derived 
from viral DNA at an integration junction. This precludes the 
transcription of the 3 ’ end of the transforming region, 
containing the E5 orf and the 3' end of the E2 orf, and of 
the late region, although the latter is not transcribed even 
from episomal HPV16 DNA in cervical carcinoma cells. Only one 
promoter is active, directing transcription from just within 
the E6 orf. An unusual internal splice is seen in sequences 
coding for the E6 orf, and the transcription of only E6 , E7 
and E2/EM sequences may indicate an involvement of these in 
the progression to and/or maintenance of the malignant state, 
particularly in view of the finding that integrated HPV16 
sequences are found in precancerous dysplasias.
1.2.2.(iii)(c). Transcription of HPV18 DNA in carcinoma cell 
lines.
Three established cervical carcinoma-derived cell lines were 
found to contain integrated HPV18 DNA: HeLa, C4-1 and SW756. 
The viral integration pattern is similar to that of HPV16 in
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SiHa cells, although several copies of the HPV18 genome exist 
at different integration sites in these cell lines. 
Integration is again within the E2 orf, and the 3 ' end of the 
transforming region and part of the late region are deleted 
in HeLa and C4-1 cells, indicating that these parts of the 
viral genome at least are no longer required in cancerous 
cells (Schwarz et al., 1985).
Polyadenylated RNA from HeLa, C4-1 and SW756 cells hybridised 
only to probes from the E6-E7-E1 region of HPV18, even in RNA 
species of up to 6.5 kb. Analysis of a cDNA library 
synthesised from these RNA fractions revealed a transcription 
pattern very similar to that of HPV16 in CaSki cells (Fig. 6 ; 
Schneider-Gadicke and Schwarz, 1986). Primer extension 
analysis showed that transcription initiated around a 
position 30 nucleotides downstream of a TATA box, and near to 
the first ATG codon of the E6 orf, which is in the optimal 
translation initiation context ACCAIGG according to Kozak 
rules (Kozak, 1986).
Three classes of cDNA were isolated (Fig. 6), distinguished 
by their differential splicing patterns. cDNA’s of class 1 
consisted of a 5’ exon spanning the whole of the E6 and E7 
orf’s, spliced from the fifth codon of the E1 orf to cellular 
sequences downstream of the integration site. In cDNA’s of 
class 2, the E1 splice site was also utilised but in 
addition, internal sequences from the E6 orf were spliced 
out. This created a novel orf resulting from the in-frame 
fusion of the 5* part of E6 , including its translation 
initiator, with the 3* end of another orf within E6 but in a
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different reading frame, 180 nucleotides downstream. The new 
orf, designated E6#, encoded 57 amino acids in a sequence 
distantly homologous to those of epidermal growth factors. 
Class 3 cDNA’s also contained the E6* orf, but were not 
spliced within E1 and terminated at an Eco R1 restriction 
endonuclease site; this termination was presumably due to a 
cloning artifact.
Analysis of viral/human fusion sequences in the cDNA’s showed 
an E1-human fusion orf of only 24 codons, and the maximum 
size of any cellular orf was 87 codons. As with viral-human 
sequences analysed in a genomic library of SiHa cells (Baker 
et al., 1987), no homologies were found between the human
sequences represented in the cDNA’s and any known human gene. 
However, E6- and E6*-specific DNA probes hybridised to a 
variety of RNA’s in HeLa, C4-1 and SW756 cells, predominantly 
the 1.5 kb size class of which the majority were of the E6* 
type in HeLa cells, but also to larger transcripts up to 6.5 
kb in size. Thus transcription from the E6 proximal promoter 
may continue well into cellular sequences in these cell
lines, and the expression of endogenous genes by the viral 
promoter cannot yet be ruled out.
As with the VX2 carcinoma, it appears that viral integration
and the malignant phenotype are associated with the
transcription and presumably expression of sequences derived 
from the E6 and E7 orf’s of the resident viral DNA.
Co-transcribed viral sequences have an unknown significance 
at this stage.
The conservation of transcriptional organisation of different
61
papillomas in cancers affecting different species suggests 
either that it is a feature of the conserved viral 
integration site, or that the E6 and E7 orf’s and their 
spliced derivatives have some association with progression to 
and/or maintenance of the malignant phenotype. The latter 
interpretation is supported by the findings that the E6# orf 
has some homology to epidermal growth factors; if it 
functions as such, ’’viral transformation” may occur by clonal 
expansion of a target cell for a subsequent oncogenic event, 
due to the activity of the E6* product.
In ID13 cells, similar E6- and E7-containing transcripts are 
transcribed at an increased level from the BPV1 genome
[1.2.2.(i)(b)], and the transcriptional organisation of HPV16 
in cervical carcinoma cells containing both integrated and 
episomal viral DNA is the same as in CaSki cells. This
transcriptional pattern may be governed by cellular factors 
expressed only in the transformed state, and may be part of a 
cascade of transforming events. On the other hand, the 
persistence of the viral genome may be merely incidental,
having played an early role in oncogenesis such as the 
expansion of a cellular target as mentioned above.
Whatever the case, the isolation of cDNA’s of the transcripts 
presents exciting potential for the functional analysis of 
HPV18 in transformed cells.
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1.2.3* Transcriptional control in papillomaviruses: cis- and 
trans-acting factors.
1.2.3.(i) A transcriptional enhancer element in the late 
region of BPV1.
The first report of enhancer activity in BPV1 was by Campo 
et al. (1983; Fig. 2): a subgenomic fragment 3’ to the early
region and 2 .5 kb away from the nearest downstream promoter 
was found to enhance the expression of the vector-linked 
herpes simplex virus thymidine kinase gene in an orientation 
independent manner. Detailed mapping located the enhancer to 
a 40 bp fragment, nt4394 to nt4433, and showed that it 
consisted of two essential domains separated by an octamer 
(Weiher and Botchan, 1984). These domains contained consensus 
sequences for enhancer activity. The enhancer exhibited three 
fold greater activity in bovine cells than in mouse 
fibroblasts (Spandidos and Wilkie, 1983), indicating that 
cell-specific factors were involved in its activation. The 
effect of this enhancer In vivo is unknown. BPV1 mutants 
carrying deletions of the 3 ' enhancer element do not show 
impaired transformation efficiency in mouse C127 cells 
(Howley et al., 1985). It is possible, therefore, that it
drives transcription from P^  and the putative upstream 
promoter of transcriptional initiation at nt4096 in response 
to a keratinocyte-specific factor.
63
1.2.3.(ii). A viral trans-acting transcriptional enhancer.
A factor which activated transcription from the non coding 
region (ncr) of BPV1 was mapped to the E2 orf (Spalholz et 
al., 1985; Yang et al., 1985b). Termination mutants were
engineered into a cDNA encoding the E2, E3, E4 and E5 orf’s
and expressed under control of the SV40 early promoter.
Enhancer activation in the ncr was detected by the
simultaneous transfection into CV1 cells of this construct 
and a derivative of the pAIOCAT vector in which the BPV1 ncr 
was cloned upstream of the enhancer-deleted SV40 early
promoter, driving the transcription of the chloramphenicol 
acetyl transferase (CAT) gene. When a construct containing 
the intact E2 orf was transfected, CAT activity in the cells 
was restored to levels expressed by the intact SV40 early 
enhancer/promoter. This enhancer activation was also seen in 
C127 cells with the E2 orf expressed by a suitable promoter. 
Similar experiments using the HPV16 E2 orf and ncr
demonstrated the same trans-activation function (Phelps and 
Howley, 1987). Quantitation of CAT gene transcription by 
primer extension also demonstrated that enhancer activation 
operated at the level of transcription in both cases 
(Spalholz et al., 1985; Phelps and Hcwley, 1987).
1.2.3.(iii). E2-responsive elements in the ncr of BPV1.
It was clear from the above experiments that the 
translational product(s) of the E2 orf of papillomaviruses
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acted on the viral ncr to enhance transcription. Experiments 
were therefore carried out on the BPV1 system to dissect this 
function. Transcriptional regulatory elements acting in cis 
were defined by two separate experimental approaches.
One approach was to study the effect of progressive deletions 
from either end of the ncr on its responsiveness to E2
trans-activationT using the CAT assay as above (Spalholz et
al.T 1987). Two E2-responsive elements (E2RE's) were found. 
The first of these was an orientation-independent element 
located in a fragment spanning nt76l1 - nt7806, which was 
termed E2RE^  (Fig. 7). Further deletion of this fragment from 
nt7806 to nt7768 decreased its E2-activated enhancer activity 
to approximately 50 % of the original level, and a further 
deletion of only 7 nucleotides abolished enhancer activity 
altogether. Deletions from the other end of the element to 
nt7656 also reduced CAT expression to basal levels in this 
assay, showing that two separate but dependent sequences were 
required for enhancer activity. Sequence analysis of E2RE^  
revealed a repeated motif, ACCN^GGT, which occurred in two 
paired arrangements, each located around the deletion sites 
which impaired enhancer activity. Deletion from nt7806 to
nt7768 removed one of these motifs, showing a requirement for
two intact pairs of motifs for full E2RE^  activity. Deletion 
of a pair of motifs at either end of the element eliminated 
enhancer activity.
The second E2-responsive element, E2RE£, was mapped to a 
region between nt7200 and nt7386 (Fig. 7). Although deletion 
of this element did not affect the overall enhancer activity
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Figure 7. Non coding region of the BIV1 genome.
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of the ncr, in isolation from E2RE^  it sustained 
transcriptional enhancement in this assay at 20 % of the 
maximum level. This may indicate that it does not act on the 
SV40 promoter when distanced from it by the ncr. ACCN^GGT 
motifs were also found in E2RE2 , and deletion of one was 
shown to reduce its enhancer activity.
The responsiveness of the ncr’s of HPV’s to their own or
heterologous E2 orf products has also been examined (Chew et
al., 1987a; Phelps and Howley, 1987). Trans-activation by E2
orf’s was demonstrated not only in their own ncr’s but in
ncr’s of other papillomaviruses also. The ncr’s of HPV’s 1,
6 , 7, 11, 16 and 18 and CRPV all responded to the E2
trans-acting factors of HPV's 1 and 11, and BPV1. In a 
reciprocal experiment, it was shown that HPV16 E2
trans-activated the BPV1 ncr E2RE's (Phelps and Howley, 1987) 
No E2RE activation was observed when the BPV1 ncr was 
transfected in the pAIOCAT vector into HeLa, CaSki or SiHa 
cells. E2RE activation was observed in these cells, however, 
when the BPV1 E2 orf was co-transfected under a constitutive 
promoter, showing that it was the absence of an E2
trans-activatorT rather than a cellular repressor, which
prevent activation of the BPV1 ncr. It was therefore assumed
that the ncr’s of the integrated HPV genomes in these cells 
must also be inactive.
The cross-reactivities displayed by E2 orf’s of different 
papillomaviruses may result from the conservation of amino 
acid sequence seen in this orf, particularly towards the 3 ’ 
and 5’ ends (Giri and Danos, 1986). This also imparts some
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significance to the ACCN^GGT motif, also conserved in the 
ncr’s of papillomaviruses.
This significnace was defined in another experimental 
approach aimed at locating the site of E2 enhancer 
activation. The 3 * three-quarters of the E2 orf of BPV1, 
including the first ATG, was expressed in bacteria in a 
prokaryotic expression vector. The purified fusion 
polypeptide was used to raise an antiserum in rabbits, which 
was used to immunoprecipitate radiolabelled subgenomic 
fragments bound to the E2 protein (Androphy et al., 1987).
DNA fragments thus precipitated were analysed for molecular
weight and thereby identified. Fragments from the ncr bound 
to the fusion polypeptide; these contained sequences from 
what were later defined as the E2RE's. The finding of the 
repeated ACCN^GGT motif prompted the use of a double-stranded 
oligonucleotide containing the sequence ACCGTCTTOGGT in 
competition assays with the labelled subgenomic fragments. 
The unlabelled oligonucleotide competed with the labelled
fragments for binding to the E2 fusion protein. In addition, 
the use of higher concentrations of protein identified a
subgenomic fragment, nt2904 - nt3259, which also bound to the 
E2 product. This fragment contained a similar E2RE motif.
It can be concluded from these experiments that the enhancer 
activation function encoded by the E2 orf is associated with 
the binding of a protein product of the orf to conserved
motifs near the main promoters of the viral genome. Enhancer 
activation takes place through an increase in transcription; 
the mechanism of activation is unknown. The requirement for
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two separate pairs of binding motifs may indicate cooperative 
binding of an E2 dimer or multimer. Experiments have not been 
carried out to ascertain the nunber of binding sites on the 
E2 protein. Palindromic symmetry of the motif means that 
there are up to 8 binding sites in E2RE^; the deletion of one 
or two of these resulted in drastically reduced enhancer 
activity, favouring the cooperative model.
The presence of a sequence in E2RE^  which resembles the 
polyomavirus a enhancer (Herbomel et al., 1984), also invokes 
the interaction of cellular factors with this element. The 
position of this sequence between the two interdependent 
pairs of E2-binding motifs suggests that binding of the E2 
trans-activator might alter the tertiary structure of the 
element in a way which allows the interaction of such a 
cellular factor. E2 enhancer activation may also be mediated 
by interactions of the E2 protein itself with cellular 
factors. The fact that the E4-overlapping region of E2 is not 
conserved between papillomaviruses infers a possible 
cell-specific function such as this.
1.2.3.(iv). The E2-encoded transcriptional repressor.
Treatment of ID13 cells with cycloheximide led to a 10 fold 
increase in levels of viral transcripts after only one hour 
(Kleiner et al., 1986). BPV1 mutants containing a stop codon
immediately upstream of the second ATG of the E2 orf 
responded in similar fashion in cycloheximide-treated C127 
cells, and this was thought to negate the role of the E2 orf
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in this phenomenon. The translation inhibitor had no effect, 
however, on papillomavirus transcription in HeLa, C4-1 or 
SiHa cells. These data indicated that viral transcription in 
ID13 cells is under the control of a labile protein repressor 
not found in the cell lines.
Genetic analysis established several phenotypic classes of E2 
mutants in BPV1, suggesting that more than one function was 
encoded by the orf (Rabson et al., 1986). Furthermore, the
utilisation of the two early region transcriptional start
sites, ?2443 and P3080 in > anc* different splice 
acceptors sites in the E2 orf in all papillomaviruses so far 
characterised, would lead to the expression of both the 
full-length E2 orf and a truncated version. In BPV1, the 
second ATG of E2, at nt3091, is both downstream of P^o80 ancl 
in an optimal context for translation according to Kozak 
rules. The common 3’ end of both putative polypeptides is not 
transcribed in any of the cell lines used in the translation 
inhibition experiments (Kleiner et al., 1986).
A BPV1 cDNA containing nt845 - nt4203 of the genomic 
sequence was cloned into a plasmid under control of the SV40 
early enhancer/promoter and cotransfected into the E2 
activator-BPV1 ncr CAT assay system described previously 
(Spalholz et al., 1987). E2 enhancer activation was reduced
15 fold in this experiment. When this cDNA was expressed in 
C127 cells in a cotransfect ion with BPV1 DNA, the 
transformation efficiency of BPV1 was decreased 5 to 10 fold 
in a non-cytotoxic manner (Lambert et al., 1987).
This cDNA contained the full-length orf’s E1-E5 and E8. The
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insertion of translation termination signals in all of these 
orf’s demonstrated that only the 3' part of the E2 orf was 
required to be intact to retain the repressor function. 
Primer extension analysis localised transcriptional 
initiation to P q^qq *n ce^^s transfected only with the cDNA 
construct. Deletion of the promoter in the same construct 
rendered it unable to repress transcription. A trans-acting 
factor was therefore responsible for the observed repressor 
activity.
On the evidence presented by these results, the protein 
encoded by the 3’ region of the E2 orf was termed the E2 
transcriptional repressor (E2TR).
1.2.3*(v). Control of BPV1 transcription bv E2 proteins.
The E2RE.J was shown by primer extension analysis to act on 
P7940 and ^89 (Spalholz et al., 1987). Transcripts initiating 
at these positions encode the E6 , E7 and possibly E1 orf's 
(Stenlund et al., 1985) and the E6/E7 and E6/E4 fusion orf’s
(Yang et al., 1985a), and hence variations in enhancer 
activation will have a pleiotropic effect on viral functions. 
Indeed, this has been demonstrated in BPV1 mutants with 
deletions of the E2 orf, which have reduced transforming 
efficiency and viral copy number in C127 cells (Sarver et 
al., 1984; Rabson et al., 1986), and by the low level of
transcription of papillomavirus DNA integrated into host 
chromosomes within the E2 orf (Smotkin and Wettstein, 1986; 
Baker et al., 1987).
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The E2 trans-activator effects enhancer activation through 
binding to discrete sequences upstream of the promoters 
involved. Thus it may influence transcription from P^ qqq* 
since it binds to a sub genomic fragment from this region, 
enhancing expression of E2TR. E2TR is thought to act through 
the E2RE’s; if so, it may have a critical regulatory function 
in the expression of the papillomavirus early region, 
including its own expression.
Preliminary results reported by Lambert and co-workers (1987) 
suggested that E2TR exhibits the same DNA binding specificity 
as the full-length E2 protein. Repression of transcription 
may therefore be due to competition for the E2-binding sites 
by the shared domain of the full-length E2 activator and 
E2TR. This would also suggest that the 5* domain of the E2 
enhancer activator, which is absent in E2TR, mediates the 
activator function. Transcriptional activation could also be 
modulated through oligomerisation of activator and repressor 
molecules, reducing the cooperative effect of several 
activators binding together.
The phenomenon of transcriptional regulation by antagonists 
encoded by the same orf is also seen in the adenovirus E1a 
gene, in which differential splicing of transcripts leads to 
the expression of a transcriptional activator 46 amino acids 
larger than a transcriptional repressor translated from the 
same orf (Lillie et al., 1986). The mechanism of regulation 
is not in this case through direct binding to cis elements, 
but a functional domain of 49 amino acids specific to the 
larger protein has been shown to indirectly activate the
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E1a-inducible promoter (Lillie et al., 1987). The dissection 
of protein into functional "cassettes” was demonstrated by 
the synthetic fusion of a domain of the yeast GAL4 
trans-activator gene with the DNA-binding domain of the 
E.coli lexA gene. The hybrid orf translation product 
activated transcription from a promoter near an E. coli lexA 
operator sequence cloned in yeast (Brent and Ptashne, 1985). 
The activation of the early promoters in BPV1 is analogous to 
the activation of promoters by early gene products seen in 
other viruses, e.g. the SV40 late promoter by the large T 
antigen (Brady and Khoury, 1985); the activation of 
expression of the E2 and E3 genes of adenovirus by the E1a 
transactivator (Imperiale et al., 1983); and the induction of 
herpes simplex virus delayed early genes by immediate early 
gene products (O’Hare and Hayward, 1984). This analogy is 
reinforced by the presence of three SP1 binding site core 
sequences between E2RE1 and the two promoters upon which it 
acts (Fig. 7; Baker and Howley, 1987).
The E2 trans-activator may therefore be an immediate early 
protein of papillomaviruses which activates viral early 
functions including its own modulator, E2TR. The abolition of 
this transcriptional control of viral DNA in carcinomas may 
be a factor involved in oncogenesis.
1.2.4. Control of BPV1 replication in C127 cells.
Replication of the extrachromosomal BPV1 genome in mouse 
fibroblasts is complex and involves factors preventing
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integration and maintaining copy number at a steady level. On 
transfection of BPV1 DNA, either uncloned or contained in a 
plasmid vector, transient replication of the episome occurs 
at a higher rate than that of cellular chromosomes. Following 
this, viral replication at mitosis maintains a copy nunber of 
approximately 150 viral genomes per cell (Lusky and Botchan,
1986). How such regulation is acheived is a difficult problem 
to address; also, the replication characteristics of BPV1 in 
vitro do not reflect the amplification of papillomavirus DNA 
seen in differentiating keratinocytes. A nunber of factors 
have been characterised.
1.2.4.(i) Plasmid maintenance and viral replication: cis- 
and trans-acting factors.
Two regions of the BPV1 genome were found to be cis-essential 
for the maintenance and replication of the episome (Lusky and 
Botchan, 1984; 1986). These regions , termed plasmid
maintenance sequences 1 and 2 (PMS1 and PMS2) supported the 
extrachromosomal replication of plasmids into which they were 
cloned, in the presence of the BPV1 genome which supplied a 
trans-acting factor. PMS2 was situated between nt1515 and 
ntl655 in the E1 orf; PMS1 was found to consist of a region 
homologous to PMS2 between nt71l6 and nt7234, and an 
orientation-independent transcriptional enhancer between 
nt6706 and nt6793 (Fig. 2). Electron microscopy of Cairns 
replication intermediates in subgenomic fragments localised 
the origin of replication of BPV1 to the PMS1 region (Waldeck
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et al., 1984).
The gene encoding the trans-acting factor involved in plasmid 
maintenance and replication was located by analysis of 
deletion mutants of BPV1. It was found that all viable 
mutants in the E1 orf failed to replicate in C127 cells and 
integrated into the cellular genome, and that these mutants 
had lesions of the 3* end of the E1 orf. It was therefore 
concluded that the 31 end of E1 encoded factor(s) responsible 
for plasmid maintenance and replication which acted in trans 
through the PMS’s (Lusky and Botchan, 1986).
1.2.4.(ii) Factors affecting maintenance of copy number.
A nunber of molecularly cloned deletion mutants were examined 
which affected the copy number of BPV1 in stably transformed 
C127 cells. Low copy number mutants which were deleted in 
either E6 or E7, after transfection initially transformed 
C127 cells and transiently replicated to approximately 150 
copies per cell. This was followed by a gradual decline in 
copy number down to 1 to 5 copies per cell, accompanied by 
reversion of the transformed phenotype (Berg et al., 
1986a,b). Both these classes of mutants could be fully 
complemented by the simultaneous transfection of a BPV1 class 
I cDNA (Fig. 2; Yang et al., 1985a) cloned into an expression 
vector, i.e. by expression of the E6/E7 fusion orf. However, 
although supertransfection of the cDNA construct into 
established cell lines containing the low copy number mutants 
resulted in the restoration of the transformed phenotype, the
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resident viral DNA was only slightly amplified, to 16 to 32 
copies per cell. Supertransfection of these cell lines with
wild type BPV1 DNA had the same effect; in this case, the
incoming DNA was not amplified as might have been expected of 
the intact genome.
From these experiments it was inferred that the E6/E7 gene
had a role in maintaining viral genome copy numbers acheived
by transient replication of the incoming DNA, either by a 
direct interaction or by activating the transcription of 
gene(s) involved in maintenance of copy number (Berg et al.T 
1986a). Studies of BPV1 replication imply that copy number is 
established in cultured cells by a precisely directed and 
ordered series of events in two replication phases:
amplification followed by maintenance. Since transcription of 
the E6/E7 fusion orf is itself controlled by the E2 
regulatory system (1.2.3.), if the E6/E7 protein is a 
transcriptional enhancer then the apparent two-stage
replication phenomenon is a further indication that the 
papillomavirus life cycle is governed by a temporal cascade 
of viral transcription.
1.2.4.(iii). A trans-acting repressor of replication is 
encoded bv the E1 orf.
Failure of supertransfected wild type BPV1 DNA to replicate
at all in low copy number cell lines prompted a further
investigation of replication control (Berg .et al*> 1986b).
Transcription of the low copy number mutants was extremely
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low and therefore could not account for a trans-acting 
repressor of replication. Therefore the repression factor had 
to be endogenous to the incoming DNA, or a cellular factor 
induced by the resident viral DNA.
Transient replication assays of plasmid-cloned BPV1 were 
carried out on a range of E1~ mutants. Replicated DNA was 
distinguished from unreplicated by transfecting methylated 
plasmids: unreplicated DNA was then sensitive to Dpn 1
restriction endonuclease digestion, whereas replicated, 
unmethylated DNA was not cut by this enzyme. Co-transfected 
mutants were distinguished by using different cloning sites 
in the plasmid vector, or different sizes of plasmid. Certain 
BPV1 mutants were lethal to C127 cells. These 
trans-complementable mutants contained frameshifts and 
deletions covering the 5T end of the E1 orf up to the splice 
donor site at nt1234, and probably therefore represented a 
transcriptional exon.
It was found that these mutants could replicate in C127 cell 
lines with resident E6~ or E6/E7~ low copy number mutants; 
if, however, they were transfected into these cells 
simultaneously with wild type BPV1 DNA, no replication of the 
incoming plasmids occurred. Transient replication assays of 
the E1 mutants alone in C127 cells were complicated by the 
lethality of the mutant, but they were considered in this 
report to have wild type replication characteristics, 
indicating that their endogenous replication factors were 
unaffected.
Finally, transient replication of wild type BPV1 DNA
77
supertransfected into ID13 cells was analysed. The incoming 
DNA exhibited transient replication but was maintained at 
only 30 copies per cell, while the resident viral DNA 
remained at the wild type level (Lusky and Botchan, 1984). 
From these data it was proposed that the 5f part of the E1 
orf encodes a trans-acting negative regulator of replication. 
This was supported by the finding that this region of the 
BPV1 genome could act in trans to repress runaway replication 
of the SV40 origin by SV40 T antigen activity (Roberts and 
Weintraub, 1986).
1.2.4.(iv). A model for BPV1 replication in C127 cells.
The following model was proposed by Berg and co-workers 
(1986b):
Replication of BPV1 in C127 cells can be divided into two 
phases. In the first phase, the expression of a replication 
factor encoded by the 3* end of E1 (Lusky and Botchan, 1986), 
by the incoming plasmid, induces replication to a high copy 
number. This amplification phase is ended by the expression 
of a negative regulatory factor, encoded by the 5’ end of the 
E1 orf, termed the replication modulator. The concerted 
action of both factors results in the maintenance of copy 
number; this is new the maintenance phase. Unpublished 
evidence that expression of the E1 genes was directed by the 
PMS1 enhancer/promoter, and that this enhancer was activated 
by products of the E6 and E$/E7 orf’s, was cited in this 
report. As viral transcription of the low copy number mutants
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was low, these mutants may produce only very low levels of 
the replication protein and modulator.
In supertransfections of ID13 cells with wild type BPV1 DNA, 
it might be expected that the incoming plasmid would not 
undergo transient replication because maintenance conditions 
already prevail in the cell. Instead, a short amplification 
phase occurs followed by maintenance of the incoming plasmid 
at the new, lower than wild type level. The resident viral 
DNA, however, remains at the same copy number. The transient 
replication of the incoming DNA may be caused by an excess 
pool of replication factors expressed by the resident viral 
DNA, until maintenance levels of replication protein and 
modulator are expressed by the new plasmid. Low copy number 
cell lines would have too small a pool of replication factors 
to effect transient replication of incoming wild type BPV1 
DNA, and in this case the new DNA enters directly into 
maintenance phase without amplifying. Mutants lacking the 
negative replication factor would escape immediate entry into 
maintenance phase in this situation and would amplify due to 
production of their own replication factor.
This model has an obvious inconsistency in that it does not 
explain why the resident DNA in the supertransfection 
experiments did not undergo transient replication along with 
the incoming plasmid. The experiments of Roberts and 
Weintraub (1986) demonstrated that the activity of the E1 
modulator protein was dependent on the linkage in cis of the 
BPV1 PMS1 and its proximal enhancer to the SV40 origin of 
replication.
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It was therefore suggested that the repressor bound to the 
BPV1 sequences and in this way limited replication of each 
plasmid to once per cell cycle, implying that each episome 
was somehow "marked" after replication and did not re-enter 
the replicating pool. However, densitometric labelling of 
newly synthesised DNA in ID13 cells demonstrated that BPV1 
episomes replicated in a random and non-selective manner 
throughout S-phase (Gilbert and Cohen, 1987), rendering this 
hypothesis impracticable. The modulatory effect of the E1 
repressor may therefore have more to do with rate than 
selectivity of replication.
Whatever the mechanism of replication control, it is linked 
to very fine transcriptional modulation and may be effected 
by very low levels of replication factors. The fact that 
E1-encoding transcripts of papillomaviruses have yet to be 
fully characterised may reflect their low abundance or may 
indicate that they have very short half lives.
The E1 replication protein is also essential for plasmid 
maintenance. If malignant progression of papillomas is 
related to the integration of the viral genome, then a defect 
in expression of this factor may be one of the oncogenic 
events.
How these analyses of replication control relate to the in 
vivo situation is not known. Cultured fibroblasts probably 
reflect an early stage in the life cycle of BPV1 and as such 
are not a model for the apparently uncontrolled replication 
of BPV1 which occurs in the more differentiated cells of 
papillomas. Again, the interplay of cellular factors must be
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invoked: it may be that differentiation-specific cellular
factors somehow switch off the replication modulator. High 
levels of replication are also associated with the activation 
of the promoter. Since this is close to PMS1 and the 
replication origin, it seems that this region of the genome 
is activated in differentiating keratinocytes.
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1.2.5. The transforming functions of BPV1.
Problems encountered in the dissection of the transforming 
functions of papillomaviruses are compounded by two factors: 
the considerable overlap of open reading frames makes 
deletion analysis complicated, and the abolition of one 
function may affect the expression of other orf’s encoding 
true transforming proteins.
The transformation functions of BPV1 are currently thought to 
reside in the E6 and E5 orf’s.
1.2.5.(i) The E6 orf.
Since the E6-encoding transcripts are among the major mRNA 
species in carcinomas containing papillomavirus DNA, this orf 
is an obvious candidate for a transformation assay. BPV1 
deletion mutants lacking the E6, E7, E8 and most of the E1
orf’s transformed C127 cells with an efficiency only 6 to 8 
percent of wild type (Sarver et al., 1984). In a converse
experiment, a class III cDNA (Fig. 2; Yang et al., 1985a)
containing the full-length E6 orf, was cloned into an 
expression vector under the control of SV40 transcriptional 
regulatory elements, and transformed C127 cells with an 
efficiency 3 % of wild type. The E7 and E6/E7 orf’s when
cloned into the same vector did not transform cells. Clearly 
the E6 orf, although it effected transformation in isolation 
from other viral sequences, required some cooperative 
function mediated by other viral factors to show wild type
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activity. Cotransfection of the E6 construct with plasmids 
expressing a class VI cDNA demonstrated this cooperative 
effect. Class VI cDNA’s themselves had intrinsic transforming 
efficiencies of up to 50 % of wild type; this efficiency 
increased to approach that of wild type in the cotransfection 
experiments (Yang et al., 1985a).
Experiments on the transforming activity of HPV16 DNA in baby 
rat kidney primary cells also demonstrated a cooperative 
effect (Matlashewski et al., 1987). Transformation by HPV16 
DNA alone was infrequent, and only seen in conditions 
selective for transfected cells. Cotransfection of the 
activated Ha-ras oncogene, however, resulted in reproducible 
transformation in the absence of selection. Deletion analysis 
of HPV16 defined a region spanning the 3’ end of E6 to a 
point within E7 which was absolutely required for 
transformation in this assay.
Antiserum to a BPV1 E6-R-galactosidase fusion protein 
produced in bacteria was used to isolate a 15.5 kiloDalton 
(kD) protein from C127 cells expressing the E6 orf under 
control of the Moloney murine sarcoma virus (MMSV) promoter. 
The E6 protein was located in the nuclear and non-nuclear 
membrane fractions of these cells (Androphy et al., 1985).
The amino acid sequence predicted for this protein contains 
four repetitions of the motif Cys-X-X-Cys, conserved in other 
papillomaviruses and evidently part of a 33 amino acid domain 
which has undergone evolutionary duplication (Giri and Danos,
1986). This arrangement is characteristic of viral nucleic 
acid binding proteins, including the SV40 and polyomavirus T
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antigens, as is the high percentage (17 %) of basic residues. 
If the E6 orf does encode an enhancer activator (Berg et al., 
1986b), its nuclear protein product may indeed bind to an 
enhancer sequence. It may therefore effect transformation by 
activating, and functioning cooperatively with, an oncogene. 
The alteration of E6 function in the internally spliced E6* 
orf has not been tested.
1.2.5.(ii). The E5 orf.
The intrinsic transformation function of BPV1 class VI cDNA’s 
in C127 cells (Yang et al., 1985a) was mapped by analysis of 
deletion and translation termination mutants of the orf's of 
this region of the viral genome (Schiller et al., 1986). It
was found that transforming activity could only be abolished
by lesions affecting the 31 half of the E5 orf.
The E5 orf encodes a polypeptide of amino acids, beginning 
at the first methionine. The amino acid sequence is 33 % 
leucine, and includes an unbroken stretch of 27 hydrophobic 
residues. Antisera to a synthetic peptide corresponding to 
the 29 C-terminal amino acids of E5 precipitated a 7 kD 
protein from the membrane fraction of C127 cells transformed 
by the E5 orf contained in a MMSV expression vector. 
Non-denaturing electrophoretic analysis of the 
immunoprecipitated protein also revealed a 15 kD form,
presumably a homodimer which could be formed by the 
cross-linking of the Cys-X-Cys motif conserved in the E5 
orf’s of BPV’s 1 and 2, HPV’s 6 and 11 and the deer
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papillomavirus. Pulse-chase analysis showed that the protein 
had a half-life of only two hours (Schlegel and Wade-Glass, 
1987).
The E5 orf therefore encodes the smallest transforming 
polypeptide yet found. Although it occurs downstream of other 
orf's in papillomavirus transcripts, it appears to be 
preferentially translated due to a favourable AUG sequence 
context (Ahola et al., 1987). Expression of E5 in transformed 
C127 cells and in BPV1-induced sarcomas in hamsters is quite 
high, yet the tumour bearing animals do not have antibodies 
to the protein, presumably because it is deeply buried in the 
cell membranes (Schlegel and Wade-Glass, 1987).
The E6 and E5 orf’s are now established in the literature as 
transforming genes. However, neither acts In vivo to 
transform cells to malignancy in the majority of 
papillomavirus infections, even though transcripts encoding 
these genes are present in benign lesions. A true appraisal 
of their function awaits further analysis, as do other 
factors synergistic in the transformation of their host 
cells.
1*2.6. E4 orf expression in HPV1-induced papillomas.
Antisera against a bacterially synthesised E4 protein reacted 
with a variety of proteins in HPV1-induced warts (Doorbar et 
al.. 1986). A 16/17 kD doublet and a 10/11 kD doublet
accounted for up to 30 % of total cellular protein in warts, 
and minor species included a single 45 kD protein and 
doublets of 32/34 kD and 21/23 kD. Several isoelectric 
variants were found for each pair. The large amount of E4 
protein in papillomas correlates with the relatively high 
level of transcripts encoding E4 and E4-fusion orfs in 
papillomas and condylomas induced by HPV's 1, 6b and 11 
[class (a), Fig. 4; Chow et al., 1987a,b] and in
fibropapillomas induced by BPV1 (class C, Fig. 2; Baker and 
Howley, 1987).
A cDNA representing the major transcript of HPV11 contained 
an E4 fusion orf potentially expressed by the transcript 
(Nasseri et al., 1987). The similarity between this cDNA and
the class C major cDNA's of BPV1 (Fig. 2; Baker and Howley,
1987) and the major transcripts of HPV6b and HPV1 (Fig. 4; 
Chow et al., 1987a,b) indicate that the E4 protein is encoded 
by the major papillomavirus transcript in benign tumours. 
These findings were confirmed in a more detailed analysis of 
E4 proteins in skin warts containing HPV1 (Breitburd et al.,
1987). To establish the site of production of each of the E4 
protein variants, warts were sectioned parallel to the skin 
surface and the proteins in each section analysed. The 
differentiated layers present in each section were recognised
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by the pattern of keratins present in the lysate. The 17 kD 
protein was expressed at a high level in the basal layer, and 
at progressively decreasing levels in the differentiating 
layers. As expression of the 17 kD variant decreased, 
expression of the 16 kD protein increased, reaching its 
highest level in the middle layers of the warts but 
decreasing again in the superficial layers. Expression of 
both these species was barely detectable in the outer layers. 
The 10/11 kD doublet appeared in the middle layers and 
accumulated as the 16/17 kD proteins decreased, becoming the 
most abundant protein in the superficial layers. The other E4 
variants of 45 kD, 32/34 kD and 21/23 kD were found in the 
middle layers by Western blot analysis.
The 17 kD protein was considered to be the full-length E4 
gene product on the basis of predicted molecular weight, and 
the 16 kD protein a post-translational modification 
thereof. The 10/11 kD doublet may be a cleavage product of 
the larger polypeptide, or may be translated from a 
differentially spliced RNA (Fig. 4; Chow et al.. 1987b). The 
latter explanation would correlate with the activation of a 
late promoter in the more differentiated layers of the 
papilloma, as is seen in BPV1 in fibropapillomas (Baker and 
Howley, 1987). The larger E4 proteins could result from 
dimerisation and polymerisation of the smaller species. 
Papillomas are characterised by two populations of 
differentiating cells. In productively infected cells, 
vegetative viral replication takes place and eosinophilic 
inclusions accumulate; in other cells, no inclusions are
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seen, and vegetative viral replication is never detected at 
any stage of differentiation (Croissant et al., 1985).
Immunoblotting of wart sections showed that the 16/17 kD 
polypeptides only occurred in cells which had inclusions in 
the cytoplasm^and apparently aggregated in the inclusions. 
The non-productively infected cells appeared to undergo 
normal terminal differentiation and produced keratins known 
to be specific for this process. By contrast, the cells 
containing the E4 proteins did not express these keratins at 
any stage of their differentiation.
The functions of the E4 proteins are as yet unknown. Their 
existence as doublets, and their capacity to accumulate into 
granules are similar to the properties of filaggrin, a 
component of keratohyalin granules (Harding and Scott, 1985). 
Together with these characteristics, their great abundance 
and the absence of differentiation-specific keratins in cells 
containing E4 proteins, suggest that they are involved in the 
subversion of epithelial differentiation to favour viral 
replication and maturation. The E4 orf’s of different 
papillomaviruse are not well conserved with regard to amino 
acid sequence and this has been taken to indicate tissue 
specificity (Giri and Danos, 1986). This may explain why 
productive infection by papillomaviruses is highly tissue 
specific.
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1.2.7. Summary.
When the results of genomic, transcriptional and jln situ 
immunohistochemical analyses are taken together, an emerging 
pattern of the molecular biology of papillomavirus infection 
can be seen, which reflects its biological aspects and opens 
up a large field of potential research.
As was suspected on the basis of histological data, the late
or capsid genes are only expressed in the most differentiated 
layers of benign papillomas, and their transcription appears 
to be dependent on a ,Twart-specificM promoter. This implies 
viral interaction with a factor present only in 
keratin-producing cells. The smaller E4 proteins of HPV1a are 
also concentrated in the outer epidermal layers; this may
correlate with the activation of P^ , producing a spliced 
transcript expressing an E4 fusion orf, smaller than the full 
E4 orf
A replication factor also required for maintenance of the
episomal state has been mapped to the 3f end of the E1 orf. A 
replication repressor function has been mapped to the 5' end 
of this orf (Roberts and Weintraub, 1986). Extensive viral 
replication occurs in differentiated epithelial cells in 
vivo: this indicates a requirement to overcome the
replication repressor.
The role of sane of the early genes is unclear. E6 is an 
accepted transforming gene, present and transcribed in most 
cancers with integrated papillomavirus sequences; however its 
sequence is not conserved so it may not have the same
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function in all papillomaviruses. The cys-x-x-cys motif is 
not confined to E6 sequences of oncogenic papillomaviruses 
(Giri and Danos, 1986), so cellular transformation is not 
necessarily mediated through E6 DNA binding properties. 
Enhancer/promoter activation or repression is likely to be an 
important role in a differentially regulated virus. The E2 
orf’s of all papillomaviruses encode transcriptional 
enhancers, and at least in BPV1, a transcriptional repressor 
is translated from the same orf, suggesting a modulated 
system of transcriptional control. In addition, the E6/E7 orf 
may encode an activator of transcription, involved in 
replication control in the early stages of papillomavirus 
infection.
Papillomavirus transcripts are in most cases differentially 
spliced, which is to be expected for the expression of the 
large amount of genetic information contained in a very 
compact genome. Transcripts starting from the same 5’ site 
may splice to completely different sites thousands of base 
pairs apart on the genome, and be expressed in different 
levels. The effect of variable 5’ untranslated leaders in 
papillomavirus transcripts is unknown but must surely be 
significant. The simplest explanation would be that these 
sequences modulate translation. Translation of polycistronic 
messages is also modulated by the proximal sequence context, 
and the expression of downstream orf’s may therefore occur 
preferentially in certain transcripts. Leader sequences may 
also have some bearing on differential splicing of 
papillomavirus transcripts.
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Finally, the expression of an orf may provide a lot of data 
on its function and enable in vivo proteins to be isolated 
and biochemically analysed; however, these orf’s may never 
actually be translated in their genomic form from wild type 
viral transcripts (e.g. E6/E7, E1/E4 fusions in BPV1), with
the result that the isolated proteins may be different to 
their expected form (e.g. E4 of HPV1a). The production and 
cloning of cDNA’s of mRNA’s from productive papillomas 
circumvents this potential problem in papillomavirus analysis 
while providing further data on the transcripts and making 
possible more accurate jlq  vitro modelling of viral functions.
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1.3* BPV4 and bovine upper alimentary squamous
carcinoma: a large animal model for papillomavirus 
infection and oncogenic function.
1.3.1 BPV4 in bovine upper alimentary sauamous papillomas 
and carcinomas.
The high incidence of squamous carcinoma of the upper 
alimentary tract of cattle in certain areas of Scotland 
prompted an investigation which provided possibly the best 
known model for the study of papillomavirus-associated 
oncogenesis.
Invasive, highly metastatic squamous cell carcinomas occur at 
five specific sites in the bovine upper alimentary tract: the 
tongue, soft palate and oropharynx, oesophagus, oesophageal 
groove and cardia. Epithelial papillomas are found at the 
same sites and all histological gradations have been found 
from benign to malignant tumours (Jarrett et al., 1978b).
In a study of 7746 cattle slaughtered at Glasgow abattoir 
(Table 4), it was found that 19% had alimentary papillomas at 
one or more of the above sites. The incidence of alimentary 
cancer was 2-5%, one of the highest known. Farms of origin 
of the affected cattle were located; the geographical 
distribution of these was entirely within that of the bracken 
fern, Pteridium aauilinum, in Scotland and all had a history 
of outbreaks of bracken poisoning in their herds (Jarrett et 
al., 1978a; 1980).
Virions identical in e.m. morphology to papillomaviruses were
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extracted from these papillomas (Jarrett et al., 1980). The
purified virus was subjected to molecular biological analysis 
(Camdo et al.T 1980). The size (approximately 7200 bp) and 
restriction map of the viral DNA differed from those of BPV’s 
1 and 2, the only other BPV’s known at that time; nor did it 
hybridise to the DNA of these viruses even under 
non-stringent hybridisation conditions. No serological 
cross-reaction to other virions was found, and it was 
concluded that this was a new, epitheliotropic BPV. It was 
later designated BPV4 (Campo et al., 1981).
Experimental injection of BPV4 into the oesophagus and palate 
of calves resulted in the development of papillomas 
histologically identical to those in the field. A typical 
pattern of epithelial papillomavirus infection was presented: 
following a 3-week latency, Stage 1 lesions appeared as 
small, white plaques. Viral replication occurred at a high 
level in the immediate sub-keratin layer (i.e. the mucosal 
equivalent of the stratum granulosum); viral genome copy 
number was as high as 100,000 in these cells (Campo et al., 
1985b). Electron microscopy of the keratin layer revealed 
crystalline arrays of virions embedded in keratin. Stage 2 
papillomas, if they had not been abraded by the passage of 
food, had long, hyperkeratinised fronds; they varied in size 
between a few millimetres and as much as 30 centimetres 
across. Viral replication was minimal in mature papillomas 
and viral content was decreased. 8 months after infection, it 
was difficult to find any viral DNA in the tumours, even 
though their appearance had not changed; they regressed
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completely within 12 months ( Jarrett et al., 1980; Jarrett, 
1985).
In experimental animals injected with BPV4 and fed a bracken 
containing diet, a different scenario emerged . The number 
of both initial and persisting papillomas was greatly 
increased, reflecting identically the situation in the field. 
The persisting papillomas lasted six years in this report, 
during which some animals had to be euthanased due to the 
development of urinary bladder cancers, which were found post 
mortem to contain BPV2 DNA; in one case, however, a carcinoma 
of the upper alimentary tract developed, thus reproducing the 
syndrome encountered in the field (Campo and Jarrett, 1987). 
The toxicity and carcinogenicity of bracken fern is well 
documented. It has a strong immunosuppressant effect as it 
contains factors toxic to rapidly dividing cells, inducing 
aplasia in bone marrow with concomitant leucopaenia and 
thrombocytopaenia (Evans, W. et al., 1982). A bracken diet is 
also known to cause chronic haematuria and bladder tumours in 
cattle (Ushijima et al., 1983). In guinea pigs fed on
bracken, those which survive the initial haematuria go on to 
develop urinary bladder carcinomas and carcinomas and 
adenomas of the small intestine. Even rats are susceptible to 
the carcinogenic effects of bracken, developing similar 
cancers to the above animals (Pamucku et al., 1980)
Quercetin, a flavonoid product of bracken fern, has been 
identified from 40 plant flavonoids as the most mutagenic in 
Salmonella tvphimurium (MacGregor and Jurd, 1978). When 
included in the diet of rats, it induces the same
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distribution of cancers as bracken (Pamucku et al., 1980).
On the basis of these studies, Campo and Jarrett (1986) 
included other experimental groups in their study. Animals 
immunosuppressed by the drug azathioprine also contracted 
BPV2-associated cancers of the urinary bladder and intestine, 
and, when infected with BPV4, developed a high number of 
persisting upper alimentary papillomas.
The identical progress of these experimental animals to those 
in the abattoir survey shows that it is the ingestion of 
bracken fern over a protracted period which is responsible 
for amplified and persistent BPV4-induced papillomatosis, and 
probably the malignant progression of the benign lesions.This 
may be due entirely to its immunosuppressive effects, but the 
action of a tumour promoter cannot be ruled out.
The BPV4-bracken syndrome therefore appears entirely 
analogous to that of the Shope complex and EV-associated 
carcinoma. It is a large-scale _in vivo model system which 
lends itself to investigation of the interactions between 
papillomavirus and environmental co-factors in oncogenesis.
1.3.2. BPV4 as a carcinogenic papillomavirus.
1.3-2.(i). Transforming activity and state of BPV4 DNA 
in cells.
The oncogenic potential of BPV4 is, by currently accepted 
criteria, beyond doubt. It induces malignant sarcomas when 
inoculated into hamsters (Moar et al., 1986), and molecularly
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cloned BPV4 DNA transforms NIH 3T3 fibroblasts _in vitro to 
anchorage independence, ability to grow in soft agar and 
aggressive tumourigenicity in nude mice (Campo and Spandidos,
1983). A cloned subgenomic fragment of 3*5 kb was also found 
to be capable of transforming NIH 3T3 at efficiencies 
approaching that of the intact viral genome. This fragment 
was later shown to correspond in BPV4 to the transcribed 
region of HPV's in carcinoma cell lines (M. S. Campo, 
unpublished data). C127 cells exhibit a partially transformed 
morphology when transfected with cloned BPV4 DNA, but are 
still contact-inhibited and anchorage dependent. Treatment of 
such cells with TPA induces full transformation. However, no 
cells of bovine origin have yet been transformed by BPV4 DNA 
(Smith et al., 1987).
BPV4 DNA exists in papillomas as a typical high copy number 
episome (Campo et al., 1980); similarly in NIH 3T3 cells the
cloned viral DNA persists as a monomeric episome, but only at 
3 to 30 copies per cell (Campo and Spandidos, 1983). In TPA 
treated C127 cells BPV4 DNA was isolated in high molecular 
weight structures . Southern analysis of restriction 
endonuclease digests of cell DNA suggested that the viral DNA 
existed as head-to-tail tandem repeats, having lost the 
plasmid DNA. The presence of an intense extra 4 kb band in an 
Eco R1 digest, and the low intensity of a wild type band, 
indicated that the viral DNA had undergone integration or 
rearrangement (Smith et al., 1987). Recent work has
demonstrated that BPV4 DNA is integrated into the cell 
chromosomes in these cells (K. T. Smith, unpublished data).
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In secondary transformants, the faint wild type Eco R1 band 
had disappeared, but the 4 kb band was still present. The 
restriction pattern of BPV4 DNA in mouse tumours induced by 
these cells was identical (Smith et al., 1987).
Continued culture of BPV4-transformed C127 cells results in 
the disappearance of the viral DNA according to current 
detection sensitivities of 0.1 genome per cell (K. T. Smith, 
unpublished data). This heretofore unreported phenomenon may 
model the In vivo situation: although BPV4 DNA was found in
papillomas, no papillomavirus DNA of any type could be 
detected in 68 of 70 bovine upper alimentary squamous 
carcinomas associated with BPV4 virion-productive papillomas 
(Campo et al., 1985a). Interestingly, cells explanted from
alimentary papillomas exhibit a transformed phenotype and 
lose the resident BPV4 DNA on prolonged in vitro culture 
(Campo et al., 1985b).
These data led to the conclusion that BPV4 genetic 
information is not required for maintenance of the 
transformed phenotype, and suggest that viral transformation 
is an early event in the papilloma-carcinoma system. The 
suspected involvement of bracken as an oncogenic promoter of 
papilloma cells is supported by observation of the effect of 
TPA on C127 cells partially transformed by BPV4 DNA. 
Transcription in these cells is at a barely detectable level, 
but after TPA treatment both the level of transcription and 
the number of viral transcripts increases (Smith et al.. 
1987). Activation of these viral transcripts by the tumour 
promoter may be an event in the oncogenic process.
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1.3.2.(ii) Possible mechanisms of BPV4-mediated
carcinogenesis.
The characterisation of BPV4 so far has identified it as an 
oncogenic papillomavirus with an infective aetiology similar 
to those of HPV's 16 and 18 in human cervical cancer, CRPV in 
domestic rabbit squamous carcinomas and BPV1 in transformed 
cells. A minimum transforming region has been defined in NIH 
3T3 cells. Transformation of C127 cells by BPV4 DNA can only 
be acheived in the presence of a tumour promoter: this may
reflect the apparent dependence of malignant progression in 
vivo on factors contained in bracken.
However, the loss of integrated BPV4 from transformed C127 
cells without phenotypic alteration, and the absence of BPV4 
DNA in the vast majority of papilloma-associated bovine 
alimentary carcinomas represents a departure from current 
dogma and prompts a re-examination of the role of 
papillomaviruses in oncogenesis. Several formal hypotheses 
have been submitted (Campo et al., 1985b) :
1. Papillomaviruses are initiators. The virus directs 
cellular transformation as an early event and therefore acts 
as an initiator, causing one or more heritable changes in 
cellular DNA. This is supported by the transformed phenotype 
seen in cultured cells explanted from papillomas. Bracken 
supplies a carcinogen and/or promoter causing full 
progression to malignancy , and an immunosuppressant allowing 
expansion of both initiated cells (thus amplifying the 
probability of a second, transforming event) and malignant
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cells without interference from host cell-mediated defences. 
Finally, the loss of cell differentiation leads to 
non-permissivity and viral DNA rejection.
2. Indirect action. Papilloma cells may produce growth 
factors, or growth factor receptors which stimulate the 
expression of cellular proto-oncogenes in neighbouring
non-infected cells. An increase in epidermal growth factor 
receptors has been observed in bovine cells transformed by 
BPV2 (Smith et al., 1987). Proliferation of cells due to
stimulation by growth factors may increase the chances of a
second transforming "hit" by a carcinogen. This type of event 
has been observed in experiments on the haemopoietic system 
(Wyke et al., 1986) in which lesions were induced in
non-infected cell lineage by v-src expression in neighbouring 
retrovirus-infected stromal cells in bone marrow cell 
cultures.
3. The virus acts as a promoter. Papillomavirus infection 
causes proliferation of epithelial cells, clonally expanding 
initiated cells.
Whatever the mechanism of transformation may be, it appears 
that in the case of BPV4 at least, the viral DNA is not 
required for the maintenance of the transformed phenotype. 
This finding favours models in which early oncogenic events 
are important in malignant progression, which may be due to a 
statistical effect such as the amplification of the target 
site of later oncogenic events.
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1.3.2.(iii). The BPV4 system as a large animal model for
papillomavirus-associated oncogenesis.
The information presented above shows BPV4 to be a typical 
carcinogenic papillomavirus, and its study has several 
advantages over other models. It is in a controllable animal 
system which provides a large amount of material for 
experimentation, and is the only such system presently 
studied in which a papillomavirus in its natural host, 
infecting its permissive site, is associated with papillomas 
which progress to malignancy. This represents a more accurate 
model than, for instance, the Shope system in domestic 
rabbits. BPV4 is also a purely epitheliotropic 
papillomavirus, unlike BPV1, but is capable of transforming 
mouse fibroblasts _in vitro and is known also to cause cancer 
in an heterologous host. Like some of the HPV’s associated 
with genital cancer, BPV4 affects mucosal epithelium, and 
strong homologies are found between the coding sequences of 
these viruses (Patel et al., 1987).
1.3.3. The genomic organisation of BPV4.
The entire nucleotide sequence of the 7261 bp BPV4 genome is 
now known (Fig. 8; Patel et al., 1987). Eleven major orf’s, 
all present on one strand of the DNA, have been assigned 
numbers by amino acid sequence homology with those of other 
sequenced papillomaviruses. Examination of the genomic 
sequence also identified putative regulatory sequences.
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Figure 8. Genomic organisation of BfV4«
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Table 5 . Transcriptional control sites and potential regulatory 
signals in BFV4*
Polyadenylation sites* nt nt nt
A T T A A A 4009 CA 4028 G /T  cluster 4040
A A T A A A 7151
A A T A A A 7187 CA 7209 G /T  cluster 7212
splice sitest Sequence
Donor T A G .G T A A G T
A A G C .T A C T A  
C A G .G T A G A T  
C A G .G T G G A A  
A A G .G T G T A G  
A A G .G T A A A A  
A A G .G C T A G T  
A A G .G T G C T G  
A A G .G T G T C A  
C A G .G T T G A G  
A A G .G T C A G A  
C A G .G T T A A A  
Acceptor C T T T G A C A A G . A
(T ^ Q T J jC T fQ jT C T G T T A C C A G  .T  
G T T C G T G C A G .C  
C C (T )„C T A C A T C C C A G  .T  
T G T T T T A C A G . A
Nucleotide position
204
1016
1350
1779
2188
2922
2932
3770
3962
5033
5225
6908
1553
3376
4028
5541
5595
Site
Spl binding site A C C C G C C T T G  1
T C C C G C C T G A  5481
(3 ^ C C C G C C V ^  5')
E2 binding site A C C G a ttG C G G T C G  176
A C C G a a tC G G G T G C  267
A C C G aaa A C G G T C  7046
(A C C G nn n^C G G T G C )
NF1 binding site T G G C c g a ..G C C A A  96
T G G C ttttg G C C A  142
TA G A tccgcG C C A A  1276
(TG G ^nnnnnG C C A A )
5 'enhancer C T G T G T A A A G (N ), ,C A C A C C  24
( N T G T G G ^ G )
3' enhancer G C T A C A C A C C  4217
A C A C A T C  4519
3' C C G A C A C A T  5' 6066
(G G T A C A C A C C (N )jC C G (N ), .C C A C A T C )
Transcription promoter T G T A C C T A A C A  213
(G G T  A C C T  A A C C )
C A A A  86
T A T A  A 115
C A A T  1242
T A T  A  A 1316
C A A T  5466
T A T A  A 5491
* The polyadenylation sites are numbered from the first nucleotide.
f  The splice sites are numbered from the nucleotide preceding the splice in the donor or following it in the 
acceptor, and the dots indicate the splicing nucleotides.
The sequences in parentheses are the consensus sequences o f the binding sites o f Spl (Kadonaga eta!., 1986) 
N F l (Hennighausen &  Fleckenstein, 1986) and E2 (Androphy et al., 1987); the enhancer core sequence (Sassone  ^
Corsi &  Borrelli, 1986); the BPV-1 3' enhancer (W eiher &  Botchan, 1984). and the first domain o f the SV40 lati 
promoter (Brady et al., 1982). All the sequences are shown 5' to 3', except where indicated. The lower case letter? 
indicate variable nucleotides.
from Patel et al»t 1987*
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1.3-3-Ci) Potential regulatory elements.
The most notable feature of the BPV4 genome is the presence
of two short non coding regions rather than the single ncr
found in all other papillomavirus genomes so far sequenced. 
One occurs in the same position as in the other viruses, 
between the 3’ end of the L1 orf at nt7112 and the beginning 
of the early region at nt237. This is designated ncrl (Fig.8) 
and is only 385 bp long, compared to the average 1000 bp
papillomavirus ncr. The other non coding region, ncr2, lies 
between the L2 and L1 orf’s (nt5085 - nt5550) and is
therefore 464 bp in length.
Transcriptional control signals are clustered in the ncr’s, 
but also occur elsewhere in the genome (Table 5). Three 
polyadenylation signals are present: one at nt4009 at the 31
end of the transforming region and two at the 3' end of the 
late region, at nt7151 and nt7l87. Three TATA boxes are 
found, one at nt115 in ncrl, one at nt13l6 between the E6 and 
E7 orf’s, and one in ncr2 at nt5491. Those in the ncr’s are 
preceded by a CAAT box 29 and 25 nucleotides upstream, 
respectively; another CAAT box lies 74 nucleotides upstream 
of the TATA box at nt13l6. Between the CAAT and TATA
sequences lie single nuclear factor I (NF1) binding sites in 
the first two instances; a SP1 binding site is found between
the same sequences in ncr2. There is also an SP1 binding site
at nt1. An 11 nucleotide sequence starting at nt213 is
closely homologous to the late promoter of SV40. This may 
represent P^  of BPV4, by analogy to BPV1.
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Enhancer core sequences (Sassone-Corsi and Borrelli, 1986) 
are found at nt24, nt4217 and nt4519* Three E2 binding site
consensus sequences (Androphy et al., 1987) are found at
nt7046, nt176 and nt267; these are not paired as in BPV1, but 
the spacing of the latter two is similar to that in E2RE^  
(Spalholz et al., 1987). It is interesting to note that the
E2 and NF1 binding sites are inverted forms of one another. 
Splice donor and acceptor sites are scattered throughout the 
genome. There are 12 potential donor sites but only 5 
acceptor sequences.
1.3.3.(ii). The late region.
The late region of BPV4 differs from those of other kncwn 
papillomaviruses (Fig. 1) in two respects: the two major
orf’s, L1 and L2, neither abut nor overlap but are separated 
by ncr2; and the L2 orf is some 400 nucleotides shorter than 
the average. In addition, an orf of 341 nucleotides, 
containing an ATG, is found within the coding sequences of 
the L1 orf: this is designated L3. A similarly sized orf is
found in the deer papillomavirus, overlapping the 3’ end of 
the L2 orf (Groff and Lancaster, 1985).
The amino acid sequence of L1 shows a high degree of homology 
with that of other papillomaviruses, as do the first 100 
amino acids of L2. This is consistent with previous 
comparisons between papillomavirus orf’s (Danos et al.T
1984).
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1-3.3-(iii) The earlv region.
The minimal transforming region of BPV4 is indicated in 
Fig.8. The early region of BPV4 comprises 55% of the genome, 
as compared with 69% in BPV1, and most of the early orf’s are 
shorter than in other papillomaviruses. In particular, the E1 
orf is 500 to 800 nucleotides shorter than other E1 orf’s, 
but this does not affect viral replicative functions in vivo. 
It is significant that BPV4 DNA used for cell transfections 
was cloned into the plasmid pAT153 (Twigg and Sherratt, 1980) 
at the unique Bam H1 restriction site in the 3* half of the 
E1 orf; this may explain the low copy nunber in NIH 3T3 
cells, and the integration of the viral DNA in C127 cells. 
Homology between the amino acid sequences of E2 of BPV4 and 
those of other papillomaviruses is greatest among the 
C-terminal 100 residues, varying from 28.8 % with HPV16 to 
45.6 % with CRPV. This would be expected if the E2 orf of
BPV4 regulates viral transcription in the same way as has 
been defined for all other papillomaviruses so far 
characterised.
The other early orf’s are widely divergent among 
papillomaviruses, and numbers were assigned with some 
difficulty to those of BPV4. BPV4 contains an E3 orf, which 
has only previously been identified in BPV1. The E8 orf 
contains an unusual peptide motif, Cys-X^-Cys-X^-Cys-X^-Cys, 
thought to be a potential metal binding domain (Berg, 1986). 
The E5 orf is split into two separate orf’s, as in HPV6, 
except that the two are contiguous and separated only by a
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stop codon. The E5b orf contains no ATG; nor do the E4 or E7 
orf's.
1.3.4. Transcriptional organisation of BPV4.
The transcriptional organisation of BPV4 in productive 
papillomas and transformed C127 cells is shown beneath the 
genome map in Fig. 9.
1.3.4.(i) BPV4 transcripts in productive papillomas.
BPV4-specific RNA from upper alimentary papillomas was mapped 
by Northern hybridisation and S1-nuclease protection analysis 
(Smith et al., 1986). Seven size classes were identified in
Northern blots: three major classes of 4.2, 2.8 and 1.0 kb,
and two minor classes of 3*0 and 1.6 kb were found in all RNA 
preparations; two other transcripts of 3 .6 and 1.9 kb were 
extremely rare and occasionally absent. The 1.0 kb size class 
was very much the most abundant in all preparations.
Probing of Northern blots with subgenomic fragments showed 
that the 4.2 and 2.8 kb major transcripts hybridised to the 
late region, and all transcripts hybridised to at least one 
part of the early region.
The splicing organisation was elucidated using S1-nuclease 
mapping in conjunction with the results of Northern analysis. 
The 4.2 and 2.8 kb transcripts terminated at nt45, 119
nucleotides downstream of the nearest polyadenylation site; 
the 3.6 kb transcript was too rare to be mapped, but all the
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Figure 9. Transcriptional organisation of BFV4«
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other transcripts terminated at the early polyadenylation 
site. Transcripts which originated from one strand only of 
the BPV4 genome were found, as predicted by the genomic 
analysis. The splicing arrangement was unusual in comparison 
to the transcriptional organisation of the other 
papillomaviruses. The 4.2 kb transcript was spliced three 
times; according to the predicted splice sites in the genomic 
sequence, splice junctions would have joined the following 
pairs of sites: nt10l6 to nt1553; nt2932 to nt4028 and nt5225 
to nt5595. A number of translatable orf’s would be present in 
this transcript. From the 5’ end at nt654, these include the 
E6 orf; a fusion of E1 to 4 codons from the end of the E6 
region; a fusion of L2 to 13 codons from the E3 region; the 
L3 orf and the L1 orf. Which of these is expressed is a
matter of speculation as none of the available AUG codons
appears to be in a favourable translational initiation
context over any of the others. Only the expression of a cDNA
of this transcript, or any other viral transcript would 
provide any opportunity to analyse its translational control. 
The 2.8 kb transcript contained two exons, one from nt204 to 
nt10l6 spliced to another from nt5595 to the late termination
site. It encodes the L1 and L3 orf’s, and the E8 and E6 orf’s
could also be translated from it.
The major early transcript of the 1.0 kb size class was
mapped as a single exon from nt3376 to nt4030. A short distal 
exon such as those found in the transcripts of other 
papillomaviruses may have been present in the 1.0 kb 
transcript. The coincidence of the mapped 5’ end and a splice
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acceptor site, and the small size of the transcript (655 
nucleotides) add weight to this argument. Also the sequence 
of this transcript does not contain an AUG codon in front of 
an orf of significant size, whereas a 5* exon could fuse a 
short leader orf onto the E2, E4 or E5a orf's. The abundance 
of this transcript indicates that it encodes the E4 protein 
of BPV4, similarly to the class (a) transcript of HPV1 
(Doorbar et al., 1986; Breitburd et al., 1987; Chow et al.,
1987b).
The exon represented by the 1.0 kb transcript was common to
all the early region transcripts. The 3.0 kb transcript
contained three exons, the first two of which had the same 
coding capacity as the first two exons of the 4.2 kb late 
transcript, although the start site of this transcript was at 
nt354. Apart from the E6 orf and the E1 fusion orf, this 
transcript encodes a fusion orf consisting of the first 52 
codons of the E3 orf, after the first AUG, spliced to the 3' 
three quarters of the E2 orf, and another between the 13 
codons from the E3 region and the E5a orf. As the full-length 
E2 orf is not encoded by any of the mapped transcripts, the 
E3/E2 may be a fusion analogue of the E2 trans-activator.
The 1.9 kb species consisted of two exons; it was initiated
at nt1153 and spliced from nt2932 to nt3376, the acceptor
site of the common downstream exon. The 1.6 kb message 
initiated at nt1142 and was spliced from nt2l88 to the 
downstream exon. This transcript, which was presunably 
directed by the same promoter as the 1.9 kb transcript, could 
express a fusion of the 5’ part of E1 with the E5a orf.
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The coding capacities of these transcripts are only assumed 
according to the consensus splice signals seen in the genomic 
sequence. Analysis of cDNA’s of transcripts is required if 
these splice junctions are to be properly defined and if 
functional analyses are to be carried out.
1.3.4.(ii). Viral transcription in BPV4-transformed cells
The level of viral transcription in BPV4-transformed NIH 3T3 
cells and partially transformed C127 cells was extremely 
low, and only one size class of 1.6 kb could be detected 
(Smith et al., 1987). Treatment of these cells with
cycloheximide for 2.5 hours resulted in a greatly increased 
level of transcription. Three more size classes of RNA 
appeared in Northern blots of RNA from BPV4-containing C127 
cells treated in this way, of 4.7, 3*1 and 2.8 kb, as well as 
an increased level of the 1.6 kb transcript. The 4.7 and 3-1 
kb size classes also appeared in the cycloheximide treated 
NIH 3T3 cells.
The amplification of viral transcription on treatment with an 
inhibitor of protein synthesis was also seen in ID13 cells 
(Kleiner et al., 1986), and may in the case of BPV4 also be
due to degradation of the labile E2TR (Lambert et al., 1987). 
TPA treatment of the BPV4-transfected C127 cells resulted in 
a similar transcriptional activation in fully transformed 
cells, in which no further increase in transcriptional levels 
could be induced by treatment with cycloheximide (Smith et 
al•, 1987). As has already been mentioned , the viral DNA in
110
TPA-treated cells may be integrated. The integration of HPV’s 
16 and 18 and of CRPV in their host cell chromosomes results 
in the disablement of the E2 orf; if the integration of BPV4 
DNA follows a similar pattern, then the E2 repressor would be 
disabled, leading to an increase in transcription.
The transcripts of transformed C127 cells were roughly mapped 
by hybridisation to subgenomic probes. Assuming that the same 
promoters and splice sites are utilised in cultured cells as 
in vivo, the approximate transcriptional map is shown in 
Fig.9. The 4.7 kb transcript was not polyadenylated and was 
therefore considered to be a nuclear precursor. No structural 
transcripts were found, as is typical of papillomavirus 
infections of cells in vitro. The 1.0 kb transcript was not 
found in detectable amounts in cell lines, indicating that it 
is also a wart-specific transcript and lending weight to the 
argument that it encodes the E4 transcript.
1.3*5. Functional analysis of BPV4.
The functional dissection of BPV4 has yet to be addressed. 
Characterisation of other papillomaviruses, particularly 
BPV1, and the similarities of papillomaviruses in terms of 
genomic and transcriptional organisation, puts us in the 
fortunate position of being able to direct our analysis more 
precisely at areas of possible functional significance. 
Previous studies on papillomaviruses also show that 
differential splicing of viral transcripts often renders 
direct assessment of genomic orf functions inapplicable to
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the _in vivo situation. Functional analyses of relevance to 
the papillomavirus life cycle can in these cases only be 
carried out using cDNA’s synthesised from viral RNA’s.
The aim of the project described in the remainder of this 
thesis was to produce a cDNA library from RNA from 
BPV4-induced bovine upper alimentary papillomas, and to 
isolate and analyse cDNA’s which would provide details of the 
splicing patterns and 5’ termini of viral transcripts, and a 
suitable system for the functional dissection of BPV4.
SECTION 2 
MATERIALS AND METHODS
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2.1. MATERIALS
2.1.1. Chemicals
Analytical reagent grade chemicals were used. Chemicals were 
purchased from the following companies :
Amersham International pic.
Oligo-(dT)^ , universal sequencing primer, reverse 
sequencing primer, M13 sequencing kit and radiolabelled 
nucleotides as listed below :
Nucleotide Catalogue no Specific activitv
[a32P]-dATP PB10204 >111 TBq mmol-*
[a32P]-dCTP PB10205 >111 TBq mmol-*
[0f32P]-dATP PB10218 >185 TBq mmol-*
[a35S]-dATPaS SJ304 >22.2 TBq mmol-*
Gibco-BRL Ltd (BRL Ultrapure Reagents).
Caesium chloride, guanidinium isothiocyanate, guanidinium-HCl 
oligo(dT)-cellulose, agarose, low melting-point agarose, urea
BCL.
Tris(hydroxymethyl)aminomethane (Tris).
Pharmacia
100 mM "minimum diphosphate" deoxynucleotide triphosphates : 
dATP, dCTP, dGTP, dTTP.
10mM dideoxynucleotide triphosphates:
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ddATP, ddCTP, ddGTP, ddTTP.
Unless otherwise stated, all other chemicals were obtained 
from BDH Ltd., or Sigma Chemical Company.
2.1.2. Enzymes.
Restriction enzvmes were obtained from either BCL or BRL with 
the exception of Bbv1 which was supplied by New England 
Biolabs.
Other enzvmes were purchased from :
BCL
Deoxyribonuclease-1, Escherichia coli DNA polymerase-1 (DNA 
pol-1), Klenow fragment of DNA pol-1, S1-nuclease, 
T4-polynucleotide ligase.
BRL
Bacterial alkaline phosphatase (BAP), cloned MMTV-reverse 
transcriptase, ribonuclease-H (RNase-H), T4-DNA polymerase, 
T4-polynucleotide kinase.
Bio-Rad Laboratories 
AMV-reverse transcriptase.
Pharmacia
AMV-reverse transcriptase.
Sigma Chemical Company
Lysozyme, ribonuclease-A (RNase-A).
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2.1.3. Other materials.
BRL: Nucleic acid size markers-
Lambda DNA Hind III digest 
J^[X174 DNA Hae III digest 
RNA ladder
Eastman-Kodak Company: X-Omat XAR5 film.
PALL Process Filtration Ltd.: Biodyne nylon transfer membrane 
Schleicher and Schuell: Elutip-d columns
2.1.4. Centrifugation
Preparative ultracentrifugation was carried out in a Kontron 
Instruments Centrikon T-2070. A Du Pont Instruments Sorvall 
RC-5B centrifuge was used for large-scale preparations, and a 
MSE Mistral 4L low speed centrifuge for pelleting bacteria. 
An Eppendorf 5414 "microfuge" was used for general 
small-scale bench-top centrifugation.
2.1.5. Stock solutions 
T.E. buffer
10 mM Tris-HCl (pH 8.0)
1 mM EDTA
10 x E buffer 
36 mM Tris
30.5 mM NaH^PO^ This gave a stock solution of pH 7*5
118
10 mM EDTA 
10 x TEA 
40 mM Tris
20 mM sodium acetate
20 mM NaCl The pH of this buffer was adjusted to
20 mM EDTA 8.15 with acetic acid.
10 x TBE 
0.89 M Tris
0.89 M boric acid This gave a stock solution of pH 8.3
25 mM EDTA 
20 x SSC 
3 M NaCl
0.3 M sodium citrate
Large volume stock solutions (i.e. ^ 100 ml) were prepared in 
deionised, purified water. Small volume stocks, e.g. enzyme 
buffers, were prepared using reagent grade ultrapure water. 
Phenol/chlorof orm
25:25:1 (v/v) T.E.-saturated phenol: chloroform: propan-2-ol. 
Distilled phenol was obtained from Rathburn Chemicals. 
Formamide (Fluka AG)
Formamide was deionised by stirring with Bio-Rad AG501-X8(D) 
mixed bed ion-exchange resin for 30 min, filtered and stored 
at -20°C.
2.1.6. Media.
L-Broth:
1% (w/v) bacto tryptone (Difco)
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0.5% (w/v) bacto yeast extract (Difco)
170 mM NaCl 
L-Agar
1.5% (w/v) agar (Difco) in L-Broth, autoclaved and cooled to 
42°C before the addition of any required antibiotic, etc.
2.1.7. DNA vectors and bacterial strains.
Plasmids pUC8, pUC13 (Vieira and Messing, 1982); pAT153 
(Twigg and Sherratt, 1980) were used. pUC plasmids were 
obtained from Pharmacia.
Bacteriophage M13mpl8 and M13mp19 (Norrander et ad., 1983) 
were used as cloning vectors for DNA sequencing. M13 vectors 
were obtained from BRL
The pUC plasmids and recombinants were propagated in E. coli
strain JM83; Plasmid pAT153 and the recombinant pBV4 were
propagated in E. coli strain HB101. Ml 3 recombinants were
grown in E. coli strain JM101.
2.1.8. 01igonucleotides.
Oligonucleotides were synthesised at the University of 
Glasgow Biochemistry Department by Dr. V. Math.
2.1.9. Biological samples.
Bovine upper alimentary papillomas were supplied by the 
University of Glasgow Veterinary School.
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2.2. METHODS
2.2.1. General
2.2.1.(i) Sterilisation
All glassware and most solutions were sterilised by 
autoclaving for 20 min. in a pressure cooker, using 3M 
autoclave tape as an indicator. Solutions containing 
heat-labile components were filtered through Gelman Acrodisc 
filter discs of pore size 0.2 pm. Glassware used for RNA work 
was first siliconised by immersion in 2% (v/v) Baysilone
siliconising fluid (Bayer) for 15 min.,followed by two washes 
in water. It was then rendered RNase-free, as were all 
solutions used for RNA manipulation, by the addition of 0.1# 
(v/v) DEPC with vigourous shaking. After several hours' 
treatment, traces of DEPC were removed by autoclaving.
2.2.1.(ii) Storage
DNA samples were dissolved in T.E. (pH 8.0) and RNA in water. 
DNA samples which would be used within a few days of 
preparation were stored at 4°C. RNA, and samples of DNA which 
were not required immediately, were stored at -20°C. 
Small-volume (£1 ml) stock solutions, e.g. restriction enzyme 
buffers, were frozen at -20°C. All frozen samples were stored 
in small aliquots to avoid repetitive thawing and 
re-freezing. All enzymes used in this project were stored at 
-20°C. Papillomas were plunged into liquid nitrogen upon 
collection, and stored at -70°C thereafter. Bacterial stocks
were also stored at -70°C.
2.2.1.(iii) General procedures in nucleic acid work.
Steps were taken to ensure the minimum possible exposure of 
nucleic acids to degradative conditions.
General procedures (1): extraction and purification. 
Extraction procedures for the purification or concentration 
of DNA common to most of the protocols detailed in this 
thesis are described below.
Phenol extraction
This was used to remove contaminating proteins, or enzymes 
not required for the next step in a protocol. An equal volume 
of phenol/chloroform (2.1.5.) was added to the DNA solution, 
thoroughly dispersed by vortexing for 15 s. and centrifuged 
for 2 min. in the microfuge. The aqueous top layer was then 
removed to a clean tube.
Ether extraction
Phenol/chloroform extractions were always followed by an 
ether extraction step to ensure the removal of any traces of 
phenol. Two volumes of diethyl ether were added and dispersed 
by shaking. The ether phase was removed after brief 
centrifugation.
Butanol extraction
When a large solution volume precluded the effective recovery
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of DNA by precipitation, this volume was reduced by butanol 
extraction. An equal volume of butan-2-ol was added and 
dispersed by shaking. After brief centrifugation, the upper 
layer of water-saturated butanol was removed and further 
extractions performed as required.
Ethanol precipitation
DNA was precipitated from solution by the addition of 
one-tenth volume of 3 M sodium acetate followed by two 
volumes of absolute ethanol. The ethanol was added straight 
from storage at -20°C, mixed by inversion and left on dry ice 
(-70°C) for 5 to 10 min. The DNA precipitate was then 
pelleted by centrifugation in the microfuge for 15 min. This 
procedure is effective in sedimenting a high percentage even 
of nanogram quantities of DNA (Focus £ no.4, 1985). After
centrifugation, the supernatant was poured off carefully and 
excess salt removed from the pellet by washing in 1 ml of 70% 
(v/v) ethanol. After a further 5 min. centrifugation, the 
supernatant was again poured off and the pellet lyophilised. 
Where very small (ng) quantities of DNA were to be 
precipitated, yeast tRNA was added as a carrier to ensure 
good recovery.
TCA precipitation
To calculate the incorporation of radiolabelled nucleotides 
into newly-synthesised DNA, two small aliquots of the 
synthesis reaction were dried onto 5 mm squares of Whatman 
3MM filter paper. One was assayed immediately by
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scintillation counting; the other was washed twice in 
ice-cold 5% (w/v) TCA, once in absolute ethanol and dried 
before scintillation counting. DNA precipitates in ice-cold 
TCA and is therefore deposited on the filter paper while free 
nucleotides are washed away: hence comparison of figures 
obtained from scintillation counting gives an estimate of the 
incorporation of radioactive nucleotide.
General procedures (2): Quantitation of nucleic acids.
Optical density (O.D.) readings of solutions of DNA in T.E. 
(pH 8.0), or RNA in water, were carried out at a wavelength 
of 260 nm. Approximate concentrations were calculated 
according to the following data (Maniatis et al., 1982).
The approximate concentrations of solutions of various types 
of nucleic acids giving an °*D«260nm 1,0 in a cluartz
cuvette of lightpath 1 cm are:
DNA 50 ug ml" 1
RNA 40 pg ml" 1
-1oligodeoxynucleotides 20 ug ml
2.2.1.(iv) Handling of bacteria
Recombinant bacterial work was carried out under Category 1 
containment.
Frozen stocks of bacteria.
Bacteria were grown in liquid culture from single colonies 
obtained by streaking a bacterial culture onto an agar plate.
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1 ml of a 5 ml overnight culture was then mixed with 1 ml of 
40% (v/v) glycerol in growth medium. 0.5 ml aliquots were
placed in sterile screw-cap microfuge tubes, chilled on ice 
and then flash-frozen in liquid nitrogen. Stocks were stored 
at -70°C. New cultures were inoculated with scrapings of 
frozen cells from the top of the glycerol stock (Hanahan, 
1985).
2.2.2. Collection of tumour material.
Bovine upper alimentary papillomas were collected from the 
affected animal as soon as possible after slaughter. They 
were plunged directly into liquid nitrogen to prevent 
degradation of DNA and RNA by endogenous nucleases. 
Papillomas from different sites were segregated in order to 
study possible variations in their content of BPV4-specific 
DNA and RNA.
2.2.3* Nucleic acid preparation.
2.2.3.(i) Preparation and separation of DNA and RNA from 
tumour material.
The method of Chirgwin et al. (1979) was chosen. This
minimises contact between RNA and endogenous RNases by the 
rapid disruption of the latter in a concentrated solution of 
the chaotropic agent guanidinium isothiocyanate. The presence 
of 2-mercaptoethanol reduces protein disulphide bonds,
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rendering the nucleases inactive. DNA and RNA are then 
separated by centrifugation through 5.7 M caesium chloride. 
For each preparation, approximately 1 g of frozen papillomas 
was ground up in 3 ml of 4 M guanidiniun isothiocyanate , 
0.1 M 2-mercaptoethanol, 25 mM sodium citrate, 0.5% (w/v)
sodium N-lauryl sarcosine (pH 7.0), in a pestle and mortar. 
The addition of a little sand assisted in the grinding of the 
tissue. The resulting suspension was centrifuged at 4 000 x 
gmax for 5 mins to sediment the sand and remaining solid 
tissue. The supernatant was set aside while the grinding up 
process was repeated twice on the remaining tissue. 
Supernatants were pooled and incubated at 37°C for a few 
hours. This incubation increases RNA yields, presumably 
through greater disruption of proteins.
The tissue lysate was then carefully layered onto 4 ml of 
filtered, DEPC-treated 5.7 M caesium chloride, 25 mM sodium 
acetate (pH 5.0), of refractive index 1.3990, in a 14 x 95 mm 
polyallomer tube. It was then covered by a layer of liquid 
paraffin and centrifuged at 190 000 x in a Kontron
TST41.14 rotor for 24 hr at 20°C.
After centrifugation, the DNA could be seen as thick strands 
in the caesium chloride, while the RNA was in the form of a 
gelatinous pellet at the bottom of the tube. The guanidinium 
isothiocyanate layer was discarded, and the DNA precipitated 
from caesium chloride by adding 3 volumes of 70% (v/v)
ethanol and storing at 4°C overnight. This prevented the 
precipitation of caesium chloride which would occur under 
normal ethanol precipitation conditions. The DNA precipitate
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was recovered by centrifugation at 16 000 x gmax for 10 mins 
at 4 °C. The pellet was resuspended in T.E. (pH 8.0),
phenol/chloroform extracted twice and ethanol precipitated. 
After resuspension, °*D«260nm was read and yield calculated. 
The RNA pellet was resuspended in 1 ml of 7-5 M 
guanidinium-HCl, 25 mM sodium citrate, 5 mM dithiothreitol 
(pH 7.0) to destroy any co-sedimented RNase activity, then 
precipitated by the addition of 0.025 volumes of 1 M acetic 
acid and 0.5 volumes of absolute ethanol, at -20°C. The RNA 
precipitate was centrifuged in the microfuge for 15 min., 
dried, and resuspended in 0.5ml of water. A small sample was 
kept for an O.D. reading, and the rest frozen at -20°C.
2.2.3.(ii) Isolation of polvadenvlated RNA
The polyadenylated fraction [poly(A)+RNA] of total RNA
extracted from papillomas was separated by binding to an
oligodeoxythymidylic acid-cellulose [oligo(dT)-cellulose)
column (Aviv and Leder, 1972). 01igo(dT)-cellulose was first
equilibrated with "binding buffer +" (BB+): 0.5 M NaCl,
10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 0.5% (w/v) SDS (BRL
recommended buffer). Fines were removed by aspiration. A
1 cm x 2 cm column was poured and rinsed with 0.1 M NaOH,
followed by neutralisation with BB+. About 1 mg of total RNA
in 0.5 ml of water was added to 0.5 ml of 2 x BB+ and
denatured by incubation at 65°C for 10 min. It was then
loaded straight onto the column, as cooling on ice caused
•fa,
precipitation of the SDS, and run through. The eluant was
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collected and run through the column a second time. This
eluatfc, the poly(A)” fraction, was stored at -20°C. The
column was then washed with 6 column volumes of BB+, followed
by 8 volumes of BB-. BB- was of the same composition as BB+
except that it contained no SDS. It was used to wash out SDS
which would otherwise inhibit the enzymatic reactions to
which the RNA was later subjected. This step was found to be
more effective if the buffers were both heated to 37°C prior
to loading, as SDS precipitated in the column at room
temperature on cooler days. Poly(A)+RNA was eluted with 2 ml
of water, and ethanol precipitated, without washing, after
reading 0*D*260nm’ ^  was resusPen^ed in 1 M LiCl and
precipitated by the addition of 7 volumes of absolute
ethanol. This effected the removal of any remaining traces of
SDS. After resuspension in water at a concentration of
<1
approximately 1 jig ]il~ , poly(A)+RNA was divided into 5 Ug 
aliquots and stored at -20°C.
2.2.3*(iii). Large-scale preparation of plasmid DNA 
(plasmid preps).
Large-scale preparations yielding mg quantities of plasmid 
DNA were carried out according to a method described by 
Maniatis et al. (1982), based on the small-scale preparation 
method of Birnboim and Doly (1979).
The principles of the technique are as follows: a buffered
suspension of lysozyme-treated bacterial cells is brought to 
pH 12.0 - 12.5, and the cells lysed completely, by the
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addition of alkali and SDS. At this pH, most of the high Mr 
DNA is denatured, while supercoiled, circular plasmid DNA 
remains double-stranded . Upon neutralisation of the 
solution, the chromosomal DNA renatures in a complex network 
and is precipitated along with protein-SDS complexes. The 
precipitated DNA and protein are then removed by 
centrifugation. Plasmid DNA remaining in the supernatant is 
then precipitated by addition of isopropanol, resuspended in 
a solution of caesium chloride and ethidium bromide dye and 
subjected to isopycnic centrifugation. Supercoiled plasmid 
DNA binds more dye than does open circular or linear DNA, and 
therefore bands further down the density gradient (Radloff et 
al., 1967).
The protocol used was as follows: 5 ml of L-Broth containing
selective antibiotic (in this case, ampicillin at 50 ug ml ) 
was inoculated with plasmid-transformed bacteria. This was 
incubated at 37°C in an orbital incubator for 8 hr., then 
added to 500 ml of L-Broth plus antibiotic. The 500 ml 
culture was shaken at 37°C for 16 hr., decanted into Sorvall 
centrifuge bottles and centrifuged at 4 000 x gmax for 10 
min at 4°C. The supernatant medium was discarded and the 
sedimented cells resuspended in 10 ml of 50 mM glucose, 25 mM 
Tris-HCl (pH8.0), 10 mM EDTA, 2 mg ml~^  lysozyme (Solution I) 
This suspension was left at room temperature for 5 min., 
after which 20 ml of ice cold, freshly prepared 0.2 M NaOH, 
1% (w/v) SDS (Solution II) was added. This was mixed rapidly 
but gently by inversion to ensure efficient buffering of the 
alkali and thorough lysis of the cells, while minimising the
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shearing of chromosomal DNA. After 10 min. on ice, 15 ml of 
3 M potassium acetate (pH 4.8) (Solution III) was added and 
mixed by rapid inversion. The lysate was left on ice for a 
further 10 min. and then centrifuged at 4 000 x gmax for 10 
min. at 4°C to sediment the precipitated DNA and protein. The 
supernatant was filtered through sterile gauze into 0 .6  
volumes of propan-1-ol, mixed and left at room temperature 
for 15 min. to precipitate the plasmid DNA. This was 
recovered by centrifugation at 16 000 x 8^ ^  f°r 10 mi-n at 
roan temperature, and the DNA pellet washed with 10% (v/v)
ethanol and air-dried.
The plasmid DNA was then resuspended in 6 ml of T.E. (pH 8.0)
-1containing 600 pg ml of ethidium bromide. Exactly 6 g of 
caesium chloride was dissolved in this; adherence to this 
measurement obviated the use of a refractometer. This 
solution was placed in a Kontron 13.5 ml thin-wall 
polyallomer tube, covered by a layer of liquid paraffin and 
centrifuged in a Kontron TFT65.13 fixed-angle rotor at 
96 000 x gmax for 60 - 72 hr. at 20 °C.
Centrifugation developed a density gradient of caesium 
chloride in which two separate bands of DNA formed, about 
0.5 cm apart, halfway down the tube. Ethidium bromide 
staining was normally sufficiently heavy to enable 
visualisation of the bands by daylight illumination; in preps 
giving a low-yield, plasmid bands were visualised using 
ultra-violet illumination. The lower band, containing 
supercoiled plasmid DNA, was recovered and the ethidium 
bronide removed immediately by several extractions with
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caesium chloride-saturated propan-1-ol, as light-activated 
ethidium bromide induces single-stranded breaks in DNA. In 
order to remove caesium chloride, the solution was dialysed 
against two changes of T.E. (pH 8.0) for 20 hr. It was then 
ethanol precipitated, resuspended in T.E. (pH 8.0), and 
quantitated by measurement of 0 *D*260nm* Routinely, 4 -5 mg 
of pAT153- or pUC-derived plasmid was recovered from a 500 ml 
bacterial culture.
2.2.3.(iv). Preparation of test samples of plasmid DNA.
The "mini-prep" method of Birnboim and Doly (1979) was used.
5 ml bacterial cultures were set up as described in
2.2.3.(iii) and incubated overnight. 1.5 ml of each culture 
was aliquoted into a 1 .5 ml microfuge tube and centrifuged
for 5 min. All centrifugation in this protocol was carried
out in the Eppendorf microfuge. The pelleted cells were
resuspended in 100 pi of Solution I and left for 5 min. at 
room temperature. 200 pi of ice-cold, freshly prepared 
Solution II was added, mixed by inversion and left on ice for 
5 min. Next 150 pi of Solution III was added and mixed by 
light vortexing. After another 5 min. on ice, the 
precipitated material was removed by centrifugation for 5 
min., and the plasmid-containing supernatant was extracted 
twice with phenol/chloroform, once with diethyl ether, and 
finally precipitated by the addition of 2 volumes of absolute 
ethanol. The precipitated plasmid DNA was centrifuged down 
after 5 min. at room temperature, washed in 10% ethanol,
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lyophilised and resuspended in 50 jil of T.E. (pH 8.0) 
containing 20 jig ml of pre-boiled RNase-A. Mini-preps were 
generally used for restriction analysis, and the incubation 
period of these was sufficient to ensure the degradation of 
all contaminating RNA. However, this method yields plasmid 
DNA in a sufficiently pure form to allow sequence analysis, 
so mini-preps for plasmid sequencing were pre-incubated at 
37 °C for 30 mins, followed by phenol/chloroform and ether 
extractions and ethanol precipitation.
2.2.4. Gel electrophoresis.
All gel electrophoresis techniques were carried out as 
described by Maniatis et al. (1982).
2.2.4.(i). Agarose gel electrophoresis of DNA.
Vertical gels 10 cm in height and 3 mm in thickness were cast 
using combs with 4 mm teeth to make loading wells. Agarose 
was melted in 1 x E buffer; Low Melting Point (LMP) agarose 
for separation and extraction of DNA fragments was melted in 
1 x TEA buffer. The same respective buffers were used for 
electrophoresis. The percentage of agarose in the gel was 
selected to suit the size range of fragments to be separated. 
Loading buffer was 30% (w/v) Ficoll 400 (Pharmacia), 0.025% 
(w/v) Orange E dye in 1 x E ; one-fifth volume was added to 
30 pi restriction digests. Electrophoresis was in all cases 
carried out at 5 V cnf\ with recirculation of buffer
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effected by a peristaltic pump. DNA fragments were stained by 
soaking the gel in a solution of 0.4 ug ml ethidium bromide 
in electrophoresis buffer for 20 min., and visualised and 
photographed on an ultra-violet transilluminator.
2.2.4.(ii). Denaturing (alkaline) agarose gels.
Single- stranded nucleic acid molecules adopt different 
conformations due to secondary structure caused by 
intra-strand base pairing. This affects electrophoretic 
mobility to the extent that these molecules cannot be 
accurately sized unless they are fully denatured. Denaturing 
agarose gels were therefore used for size analysis of first- 
and second-strand reaction products of radiolabelled cDNA 
synthesis.
A 1.4% agarose gel was prepared in 50 mM NaCl, 1 mM EDTA, 
then soaked for at least 30 min. in alkaline electrophoresis 
buffer (30 mM NaOH, 1 mM EDTA). Samples were ethanol 
precipitated and resuspended in 0.5% (w/v) Ficoll 400, 0.025% 
Orange E in electrophoresis buffer before loading. After 
running at 5 V cnT^  for 2.5 hr., the gel was soaked in 7% TCA 
for 30 min. and washed with water. It was then placed on 
Whatman 3MM filter paper, covered with a sheet of cellophane 
and dried on a slab gel dryer for autoradiography.
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2.2.4.(iii). Agarose gel electrophoresis of RNA.
RNA secondary structure affects its mobility under 
electrophoresis and leads to inaccurate sizing of individual 
transcript types. It is therefore always run in a denatured 
conformation in electrophoretic gels.
1% (w/v) agarose gels containing 2.2 M formaldehyde were
used for this purpose. The gel running buffer stock was 0.2 M 
morpholinopropanesulphonic acid (MOPS) (pH 7.0), 50 mM sodium 
acetate, 1 mM EDTA, diluted ten times before use. Gels were 
prepared by melting agarose in water, cooling to 60 °C and 
adding 10 x MOPS buffer and formaldehyde to give the 
appropriate final concentrations. 20 pg of total RNA in
4.5 pl of water was added to 2 pi of 10 x MOPS buffer, 3*5 pi 
of formaldehyde and 10 pi of formamide and denatured by 
incubation at 55 °C for 15 min. before loading. RNA gels were
_i
run at 10 V cm for 3 hr. RNA size markers were stained by
first soaking the gel in 0.1 M ammonium acetate for 1hr, then 
-1in 0.4 pg ml ethidium bromide in water for 30 min. followed 
by destaining in water for at least 2 hr s. They were 
visualised and photographed in the usual way.
2.2.4.(iv). Extraction of DNA fragments from LMP-agarose gels
The method of Weislander (1979) was used, as described by 
Maniatis et al. (1982). The required band was located by U.V. 
visualisation, excised and melted at 69 °C in an equal volume 
of 1 x TEA buffer. After equilibration at 37 °C for 10 min.,
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the melt was extracted with an equal volume of ice-cold,
T.E.-saturated phenol. The use of ice-cold phenol for this
step was found to greatly improve the efficiency of the
extraction procedure. Two phenol/chloroform extractions were 
carried out followed by ether extraction and ethanol
preciptation. DNA purified in this way was suitable for nick 
translation, 5' end-labelling and ligation to other DNA
molecules.
2.2.4.(v). Polyacrylamide eel electrophoresis.
Polyacrylamide gels were poured between two 48 cm x 20 cm
glass plates, one of which was "notched”, held apart by
spacers of required thickness and sealed with waterproof
tape. The notched plate was siliconised using 2%
dimethyldichlorosilane in 1,1,1-trichloroethane to facilitate 
its removal after electrophoresis. A 50% (w/v) stock solution 
was prepared, containing acrylamide and N,Nf-methylene
bisacrylamide in the ratio 19:1 by weight, and gels were 
made up by adding this stock and 10 x TBE to water to give 
the required percentage of acrylamide in 1 x TBE.
Polymerisation was brought about by the addition of 100 pi of 
TEMED and 200 pi of freshly prepared 10% (w/v) ammonium
persulphate per 50 ml.
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2.2.4.(vi). Thin denaturing polyacrylamide nseQuencing,t gels.
Single-stranded DNA fragments are separated with high 
resolution on 0.4 mm denaturing polyacrylamide gels, which 
are also easily dried down for autoradiography. Nucleic acid 
sequencing reactions are therefore run on these gels. 
Sequencing gels in this project contained 6% (w/v) acrylamide 
and 8 M urea and were run at 1400 V; the high concentration 
of urea and the high running temperature (60 °C) ensured that 
DNA sequencing fragments were maintained in the denatured 
state during the run. However, the high temperature also 
presented potential problems such as cracked plates and 
uneven sequencing ladders due to temperature differentials 
across the plates. These were circumvented by clamping 
aluminium sheets to both sides of the gel. Gels were dried 
down onto Whatman 3MM paper after covering with cellophane 
and without fixing, and autoradiographed in X-Ray cassettes.
2.2.4.(vii). Non-denaturing polvacrvlamide gels for strand 
separation.
When a double-stranded (ds) DNA fragment is denatured and run 
into a non-denaturing gel, in most cases the separated 
strands migrate at slightly different rates, eventually 
resulting in their clear separation and enabling their 
separate recovery. The differential migration rate is thought 
to be due to differences in intra-strand duplex conformations 
(Maniatis et ai., 1982).
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Radioactively labelled single strands of DNA were separated 
on 6% (w/v) polyacrylamide gels of thickness 1.5 mm. The
running temperature was kept low by applying a low voltage (6 
V cm ) in order to prevent denaturation of the strands once 
they were in the gel. DNA samples were resuspended in 
80% (v/v) formamide containing marker dyes, denatured by
boiling for 3 min. and loaded into 1 cm wells. After running, 
the top plate was removed and the gel covered by plastic 
sheet and autoradiographed. High specific activity labelling 
allowed for autoradiographic exposures of only 2 min., during 
which time alignment marks were made for use in the 
extraction procedure.
2.2.4.(viii). Recovery of DNA from strand-separating gels.
To extract single strands of DNA from a polyacrylamide gel,
an aligned autoradiograph of the gel was used as a template
to cut out a slice of gel containing the radioactive band of
interest. Gel slices were then chopped up finely and eluted
into 250 pi of 0.5 M ammonium acetate, 1 mM EDTA in a sealed
1 ml pipette tip with a plug of siliconised glass wool at the
end. After overnight incubation at 37 °C, the liquid was
drained out through the glass wool, which filtered out
particles of polyacrylamide. A further 250 pi of elution
k
buffer was flushed through the gel, and eluant volume was 
reduced to about 25 pi by butanol extraction. The DNA was 
then ethanol precipitated. Recovery was 90 - 100% in most 
cases.
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2.2.5. Restriction endonuclease digestion.
Restriction endonucleases were used according to the
manufacturers’ specifications. Latterly, suitable buffers 
were supplied by BRL and BCL with each enzyme, and these were 
used where appropriate. Up to 10 ug of DNA was digested in a 
30 ul reaction volume. Double digests were carried out where 
an optimal buffer for both enzymes could be prepared;
otherwise DNA samples were phenol/chloroform extracted and 
ethanol precipitated between digests.
2.2.6. Southern blot hybridisation analysis.
Restriction endonuclease digests of genomic DNA from
papillomas, or of plasmids containing cDNA inserts, were
analysed after agarose gel electrophoresis by the method of 
Southern (1975). This involves the transfer of DNA from the 
gel to nylon membrane in such a way that the precise 
distribution pattern of fragments in the gel is preserved on 
the membrane. Hybridisation to a specific, radiolabelled 
probe is then used to identify and map restriction fragments.
2.2.6.(i). Preparation of agarose gels for Southern 
transfer.
Gel markers were photographed next to a ruler for accurate 
sizing of bands appearing in Southern hybridisation analysis. 
The gel was then placed in 0.25 M HC1 for 15 min.: this
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brought about partial depurination of the DNA, which assists 
in the transfer of large molecules. It was then soaked in
1.5 M NaCl, 0.5 M NaOH for 20 min. to neutralise the acid and 
denature the DNA, followed by 0.3 M Tris-HCl (pH 7.5), 0.2 M
NaCl for 45 min. to neutralise the alkali.
The gel was then laid on top of a 2.5 cm pile of Whatman 3MM 
paper saturated in 20 x SSC. About 1 1 of SSC was poured 
around the paper to act as a reservoir. PALL Biodyne nylon 
membrane was cut to the exact size of the gel and layered 
onto it, excluding air bubbles. The buffer was soaked up 
through the gel by placing paper towels on top of it. By this 
process, DNA travels up through the gel with the buffer and 
becomes trapped in the membrane in the same distribution 
pattern as in the gel. After about 16 hr., the DNA was baked 
onto the membrane at 80 °C for 1 hr.
2.2.6.(ii) Radiolabelling of DNA probes bv nick-translation.
DNase-1 in sufficiently low concentrations induces 
single-stranded "nicks” in ds DNA. These nicked fragments 
serve as primers for E. coli DNA polymerase-1 (pol-1), which 
digests away the 5 ' end of the downstream fragment and 
resynthesises the strand onto the 3 * end of the primer, using 
the intact complementary strand as template (Kelly et al., 
1970). By supplying the enzyme with radioactively labelled 
nucleotides, the newly synthesised strands become labelled 
(Rigby et al., 1977) and therefore detectable by
autoradiography when hybridised to homologous sequences
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immobilised on a Southern blot.
The method of Maniatis et al. (1982) was followed. 1 jig of 
DNA probe was nick-translated in 50 mM Tris-HCl (pH 7.2), 
10 mM MgSO^ , 0.1 mM dithiothreitol, 50 jig ml”"* BSA, 
containing 20 jiM dGTP and dTTP and 1.85 MBq each of 
[<x^P]-dATP and [o^P]-dCTP. DNase-1 at a final concentration
_ i
of 1 ng ml and 1 unit of pol-1 were added to start the 
reaction which was incubated at 16 °C for 1 hr. Incubation at 
this temperature ensures more uniform labelling of the DNA as 
it minimises "snapback synthesis" in which the polymerase 
transfers to a displaced strand. Incorporation of label was 
measured by the TCA precipitation method. This was 
routinely around 50%, giving a specific activity in excess 
of 10® dpm jig”"*.
The labelled probe was separated from unincorporated 
radioactive nucleotides using an Elutip-d column. The 
nick-translation reaction was loaded onto the equilibrated 
column in 1 ml of 0.2 M NaCl, 20 mM Tris-HCl (pH 7.5), 1 mM
EDTA. The column was flushed through with this buffer, 
leaving bound DNA which was then eluted in 0.7 ml of 1 M NaCl 
20 mM Tris-HCl (pH 7.5), 1 mM EDTA.
2.2.6.(iii). Pre-hvbridisation and hybridisation of Southern 
blots.
Liquid hybridisation of complementary DNA strands is
optimised at (T -25) °C, where T is the temperature at which m m
half the DNA molecules in a solution are denatured. Tm is
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also related to [Na+], the concentration of sodium ions in 
the solution, and to %GC, the percentage of dG and dC 
residues in the DNA molecule, according to the following 
formula (Marmur and Doty, 1962):
Tfl = 16.6 log [Na+] + 0.41 (%GC) + 81.5 °C 
Hybridisation of BPV4 DNA, which contains about 40% dG and dC 
residues, was carried out in 2 x SSC, i.e. at a sodium ion 
concentration of 0.33 M. under these conditions was 90 °C, 
so hybridisation temperature was set at 65 °C.
Radiolabelled DNA also binds to non-homologous sites on nylon 
and other transfer membranes, so these sites must blocked by 
other ligand-binding molecules prior to hybridisation of the 
probe (Denhardt, 1966). Southern blots were pre-hybridised 
overnight in plastic bags containing the hybridisation medium 
(2 x SSC, 10 x Denhardt’s solution), at the hybridisation 
temperature in a shaking water bath. 10 x Denhardt’s 
contained 0.2% (w/v) each of Ficoll-400, bovine serum albumin 
and polyvinylpyrollidone. Calf thymus DNA, sheared by 
sonication and denatured by boiling, was added at a rate of 
200 jig ml to bind non-homologous DNA sites. When particular 
sequences of DNA were required to be blocked, an excess 
quantity of unlabelled DNA of homologous sequence was 
denatured and added at the pre-hybridisation stage.
Probes were denatured by boiling and added directly to bags 
containing Southern blots in hybridisation medium. 
Hybridisation was carried out for up to 24 hr.
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2.2.6.(iv). Pre-hybridisation and hybridisation of Northern
blots.
Hybridisation of DNA probes to RNA blots is carried out in 
the presence of formamide which favours the formation of 
complementary DNA:RNA hybrids (Casey and Davidson, 1977).
The method of Thomas (1980) was used. The hybridisation 
medium was 5 x SSC, 5 x Denhardt’s, 50 mM sodium phosphate
(pH 6.5), 0.1% (w/v) SDS, 50% (v/v) formamide. 200 pg ml-”* of 
sonicated, denatured calf thymus DNA was added immediately 
before pre-hybridisation. Hybridisation was carried out as 
previously described at 42 °C in a shaking water bath.
2.2.6.(v). Hieh-stringencv washing of hybridised blots.
Southern and Northern blots were washed immediately after 
hybridisation in 2 x SSC, 0.1% (w/v) SDS, with agitation, to 
remove free probe. This wash was repeated and the blots were 
then subjected to a "high-stringency” wash in 0.1 x SSC, 
0.1% (w/v) SDS at 55 °C in a shaking water bath (protocol
supplied by PALL Process Filtration Ltd.). This wash, at 
Tm - 12 °C, was carried out to remove any non-specifically 
bound probe. Two 15 min. washes at this temperature were 
normally sufficient to remove non-specific signals, but in 
exceptional cases with Southern blots, more persistent 
contamination could be removed in the same solution at 65 °C 
without significant loss of signal.
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Washed blots were dried by pressing between sheets of Whatman 
3MM paper, and wrapped in plastic sheeting for 
autoradiography in X-Ray cassettes.
Blots could be stripped of labelled probe for 
re-hybridisation by incubating in 10 mM sodium phosphate 
(pH 6.5), 50% (v/v) formamide at 65 °C for 1hr, followed by 
washing in 2 x SSC, 0.1% (w/v) SDS at room temperature for 15 
min. The membrane could then be pre-hybridised and hybridised 
with the relevant probe.
2.2.7. Synthesis of cDNA from polv(A)+RNA.
cDNA was synthesised from oligo(dT)^-primed poly(A)+RNA 
isolated from papillomas, using the method of Gubler and 
Hoffman (1983). RNA-dependent DNA-polymerase (reverse 
transcriptase) catalyses the synthesis of DNA complementary 
to an RNA template by sequential addition of nucleotides onto 
a heteroduplexed DNA primer. The use of oligo(dT) as a primer 
ensures the reverse transcription of all messenger RNA’s as 
it hybridises to poly(A) tails. Once a complementary strand 
of DNA has been synthesised (cDNA first strand synthesis), 
the hybridised RNA molecule is "nicked" at regular intervals 
using RNase-H, a RNA endonuclease specific for RNA:DNA 
hybrids. The nicked fragments provide suitable 3’-hydroxyl 
primers for pol-1, which is then used to synthesise the 
second strand of cDNA. Second strand synthesis is therefore 
closely analogous to the nick-translation method. T4-DNA 
polymerase is used to fill in recessed 3 ' ends, producing a
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flush-ended cDNA molecule suitable for cloning.
2.2.7.(i). First-strand synthesis of cDNA.
The following protocol was used (A. Hall, Chester Beatty 
Institute, London, pers. comm.):
10 pg poly(A)+RNA in water was heated to 90 °C for 10 min. to 
denature secondary structure, and immediately cooled on ice. 
The denatured RNA and 5 Pg of oligoCdT)^ were added to a 
solution such that the final concentrations of all components 
were: 50 mM Tris-HCl (pH 8.3 at 42 °C), 140 mM KC1, 10 mM
MgCl^ , 10 mM dithiothreitol, with each of the four dNTP's at 
2 mM. The solution was kept on ice while 120 units of reverse 
transcriptase was added and mixed, and one-tenth volume was 
removed to another tube containing 0.37 MBq of [cr^ P]-dCTP. 
The reactions were then incubated at 42 °C for 1 hr. EDTA 
was then added to a concentration of 50 mM to stop the 
reactions, which were then phenol/chloroform extracted, ether 
extracted and ethanol precipitated. The radioactive sample 
was divided in half: one was assayed for radioisotope
incorporation by TCA precipitation, and the other was run on 
an alkaline agarose gel next to radiolabelled size markers to 
obtain a record of size distribution of first-strand 
synthesis products.
N.B. A pilot synthesis was first performed using globin mRNA 
(BRL) to check reagents before limited stocks of papilloma 
RNA were used.
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2.2.7.(ii). Second-strand synthesis of cDNA.
Non-radioactive first-strand reaction products were 
resuspended in 40 mM Tris-HCl (pH 7.5), 200 mM KC1, 10 mM
MgCl^ , 10 mM dithiothreitol, with dNTP’s each at 0.1 mM. 
1.48 MBq of [cr^Pl-dCTP was added, followed by 1 unit of 
RNase-H and 25 units of pol-1. The reaction was mixed and
incubated at 12 °C for 1 hr., then at 22 °C for 1 hr.
The reaction was terminated by the addition of EDTA to 100 mM
followed by phenol/chloroform extraction, ether extraction 
and ethanol precipitation. On resuspension, a tenth aliquot 
of second-strand reaction products was kept aside for 
analysis as above. An estimate of the amount of cDNA
synthesised was calculated using radioisotope incorporation 
data and the median size of second strands as shown by 
autoradiography of the alkaline agarose gel.
2.2.7.(iii). Conversion of ds cDNA to flush-ended DNA using 
T4-DNA polymerase.
cDNA molecules synthesised by the Gubler and Hoffman method 
may be unsuitable for blunt-end ligation due to incomplete 
second strand synthesis leaving protruding 5’ ends 
corresponding to the 3' end of the original RNA molecule. The 
3’ recess may be filled in using T4-DNA polymerase, which in 
the presence of all four dNTP’s synthesises DNA complementary 
to the protruding strand onto the recessed 3 f-hydroxyl group 
(Maniatis et al., 1982).
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Products of the second strand synthesis reaction were 
resuspended in 33 mM Tris-acetate (pH 7 .9), 66 mM potassium
acetate, 10 mM magnesium acetate, 0.5 mM dithiothreitol and 
dNTP’s at 0.1 mM. 4 units of T4-DNA polymerase were added and 
mixed and the reaction was incubated at 37 °C for 10 minutes. 
The reaction was terminated by the addition of EDTA to 50 mM, 
phenol/chloroform and ether extracted and ethanol 
precipitated. The reaction time was short because as the 
concentration of free nucleotides decreases, the 3 ’-5 ’ 
exonucleolytic activity of T4-DNA polymerase becomes dominant 
and, together with its 5 ’-3 ’ nuclease, the enzyme starts to 
degrade the DNA.
2.2.8. Construction of a cDNA library in dUC1^ .
A cDNA library was constructed by the cloning of flush-ended 
cDNA into the plasmid vector pUC13 (Vieira and Messing, 
1982).
2.2.8.(i). Preparation of the vector.
pUC13 was linearised using the restriction endonuclease Smal 
which induces a double-stranded break in the multiple cloning 
site (Figure 10). In the ligation step, recircularisation of 
the vector is favoured over ligation to heterologous 
molecules; this was prevented by removal of the 5'-phosphate 
groups of the linearised vector, so that only ligations 
between 3 ’-hydroxyl groups of the vector and 5’-phosphate
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groups of the cDNA took place.
The vector was therefore prepared as follows:
1 pg of Sma1-linearised pUC13 was resuspended in 50 pi of 
50 mM Tris-HCl (pH 8.8) and 50 units of bacterial alkaline 
phosphatase added. After incubation at 60 °C for 30 min., 
EDTA was added to 10 mM and the solution subjected to two 
phenol extractions followed by ether extraction and ethanol 
precipitation. Rigourous adherence to this method ensured 
that no contaminating phosphatase activity was carried 
through to the ligation reaction.
2.2.8.(ii). Ligation of vector to cDNA.
T4-DNA ligase catalyses the formation of phosphodiester bonds 
between 5'-phosphate and 3'-hydroxyl groups on adjacent 
molecules of DNA, accompanied by hydrolysis of ATP (Weiss 
et al., 1968). Hence the phosphatased vector is unable to
religate, ensuring that only recombinant molecules may be 
propagated in bacteria. A large excess of vector over cDNA 
favours reactions between heterologous molecules and 
minimises end-to-end ligations of cDNA.
Pilot ligations were set up using 10 ng of Hae Ill-restricted 
(flush-ended) BPV4 DNA with 100 ng of phosphatased vector to 
check reagents. The following control reactions were also 
performed: 100 ng phosphatased vector plus T4-DNA ligase;
100ng vector without enzyme; 1 ng of non-restricted vector 
without ligase. The amount of phosphatased vector required to 
give a 5 molar excess over cDNA molecules was calculated
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using the data from 2.2.7.(ii).
Ligations were carried out according to the method described 
by Maniatis et al. (1982). The DNA to be ligated was mixed in 
the smallest possible volume of 50 mM Tris-HCl (pH 7.4), 10
mM MgCl^ , 10 mM dithiothreitol, 1 mM spermidine, 1 mM ATP
and 100 pg ml BSA. 10 units of T4-DNA ligase were added per
pg of vector and the reaction was incubated at 4 °C
overnight. Ligated DNA was phenol/chloroform and ether 
extracted and ethanol precipitated.
2.2.9. Preparation and transformation of competent 
bacterial cells.
2.2.9*(i). Preparation of competent E. coli strain JM83.
Plasmid DNA may be introduced into EL coli cells which have 
been treated with ice-cold calcium chloride solution. This 
competence increases with up to 24 hr. of such treatment 
(Dagert and Erlich, 1979).
A variation of the method of Dagert and Erlich was used, 
incorporating some aspects of the simple transformation 
procedure of Hanahan (1985) (A. Sproul, Beatson Institute, 
pers. comm.)
E. coli strain JM83 (Messing, 1979)> the host bacterium for 
pUC plasmids, was grown from glycerol stock in L-Broth 
overnight. 1 ml of this culture was then inoculated into 100 
ml of SOB medium: 2% (w/v) bacto tryptone, 0.5% bacto yeast
extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgCl2, 10 mM MgSO^
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(Hanahan, 1985). This culture was incubated at 37 °C until it 
reached an 0-D*55onm of between °-3 and 0.5. 50 ml of this
culture was then cooled on ice and centrifuged at 1000 x g^ 
in the MSE 4L centrifuge for 7.5 min. at 4 °C. The 
supernatant was discarded and the sedimented bacteria 
carefully resuspended by swirling in 10 ml of ice-cold 
10 mM MgSOjj. This, and all other steps, was carried out on 
ice or at 4 °C. The resuspended bacteria were left for 20 
min., then sedimented by centrifugation at 1000 x g^ for 
5 min. The sedimented bacteria were resuspended in 10 ml of 
ice-cold 50 mM CaCl^ , again as gently as possible. After one 
hour they were again centrifuged for 5 min. and this time 
resuspended in 4 ml of ice-cold 50 mM CaCl^ . The competent 
cells were then stored at 4 °C to await transformation.
2.2.9.(ii). Transformation of competent E. coli strain JM83.
DNA may be introduced into competent bacterial cells by
incubation with the cells on ice followed by heat-shocking 
the cells. The simple transformation procedure of Hanahan 
(1985) was used.
Ligated recombinant plasmids and control samples were 
resuspended in water to a concentration of 1 ng pi and 10
pi placed in plastic bijoux (Sterilin) on ice. 200 pi of
competent cells was added, mixed thoroughly and left on ice 
for 40 min. The cells were then heat-shocked by placing the 
bijoux in a 42 °C waterbath for 90 s., and immediately
returned to ice. 800 pi of SOB median containing 20 mM
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glucose was added to the heat-shocked cells which were then 
incubated at 37 °C for a ’’recovery period" of 1 hr. The
recovery period allowed the expression of antibiotic
resistance before exposing the cells to ampicillin, and the 
presence of glucose enhanced the recovery of cells from
heat-shock.
Since prolonged calcium chloride treatment increases 
competence of E. coli, pilot transformations were carried out 
on fresh competent cells, which could then be used the next 
day at greater efficiency if the competence was indicated.
2.2.10. cDNA library screening.
2.2.10.(i). Selection of recombinants.
pUC13 contains two selection markers (Figure 10): the
ampicillin resistance gene 6-lactamase, and a modified
R-galactosidase gene, which complements a defective gene in 
the host cell, JM83. Ampicillin resistance is used to select 
for transformants. Active R-galactosidase cleaves 
5-bromo-4-chloro-3-indolyl-B-D-galactoside (X-gal) to give a 
blue colour. Since insertions in the multiple cloning site of 
the pUC plasmids convert them to lac , transformants 
containing recombinant plasmid produce white colonies when 
grown on medium with the chromogenic substrate, while intact 
pUC containing transformants are blue.
Transformed cells were spread onto 14 cm L-Agar plates
1 —1containing 50 pg ml ampicillin and 0.2 pg ml X-gal and
150
grown overnight at 37 °C.
2.2.10.(ii). Screening of recombinants bv Grunstein-Hogness 
colonv-lift analysis.
A replica of the colony distribution on an agar plate may be 
made on a disc of transfer membrane by layering a sterile 
disc onto the plate and carefully peeling it off. The 
transferred colonies are then lysed _in situ and their DNA 
baked onto the membrane for Southern hybridisation analysis 
(Grunstein and Hogness, 1975).
PALL nylon membrane filter discs were used to analyse pUC 
transformants. Dry, sterile discs were carefully layered onto 
the plates. Alignment marks were made for later 
identification of clones before peeling off the membranes. It 
was found that colonies were apparently transferred to the 
membrane in their entirety, but a few hours’ incubation of 
the plates at 37 °C resulted in satisfactory regrowth from 
remaining cells. Transferred colonies were lysed by placing 
the dies, colony-side up, on Whatman 3MM paper saturated with
1.5 M NaCl, 0.5 M NaOH for 5 min. The discs were then 
neutralised on 3 M sodium acetate in the same fashion, air 
dried and baked at 80 °C for 1 hr.
The membranes were then analysed by hybridisation to 
radiolabelled BPV4 DNA as described in 2.2.6.(iii) and
2.2.6.(v). Alignment markers were radioactively labelled, and 
recombinants containing BPV4 sequences were identified by 
realigning autoradiographs of hybridised discs with the
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original plates. BPV4-positive colonies were inoculated into 
5 ml L-Broth + ampicillin using sterile toothpicks and 
cultured overnight for glycerol stocks and mini-preps.
2.2.11. Sequencing of DNA and RNA.
2.2.11.(i). DNA sequencing in bacteriophage M13 vectors.
The principles of "dideoxy” sequencing (Sanger et al., 1977)
and methods for cloning and sequencing DNA in Ml 3 vectors are 
clearly described in the M13 cloning and sequencing manual 
supplied by Amersham International. These protocols were 
strictly adhered to.
2.2.11.Cii). DNA sequencing in pUC plasmids.
An application of the dideoxy sequencing technique to 
double-stranded plasmid DNA (Chen and Seeburg, 1985) was used 
to sequence BPV4-positive cDNA inserts in pUC13. M13 
universal primer or reverse sequencing primer is added to 
plasmid DNA denatured by treatment with alkali; it anneals to 
the complementary sites in the plasmid DNA on acidification, 
while the two strands of plasmid DNA ranain denatured. After 
a precipitation step, the insert is sequenced in the normal 
way.
152
2.2.11.(iii). RNA sequencing.
•22
5’- P labelled specific oligonucleotide primers were used to
sequence BPV4 transcripts in poly(A)+RNA isolated from
papillomas. The method entailed dideoxy chain termination of
first-strand cDNA synthesis (Geliebter, 1987).
325 ng of a 5'- P labelled oligonucleotide was annealed to 
10 jig of poly(A)+RNA in 10 pi of 10 mM Tris-HCl (pH 8.3), 
250 mM KC1. The specificity of this annealing was optimised 
by denaturing the RNA at 80 °C then incubating for 45 min. at 
a temperature dependent upon the composition of the 17 
3*-most bases of the oligonucleotide. Effective annealing 
temperatures, T , were calculated using the following 
"rule-of-thumb" equation:
T = 4(G + C) + 2(A + T) - 5 °C, a
where G, C, A and T are numbers of guanosine, cytosine, 
adenosine and thymidine residues, respectively, in the 17mer. 
2 pi aliquots of annealed primer/RNA were added to 3»3 Pi of 
24 mM Tris-HCl (pH 8.3), 16 mM MgCl^ , 8 mM dithiothreitol,
0.8 mM dGTP and dATP, dCTP, dTTP each at 0.4 mM, containing 
5 units of AMV reverse transcriptase (Pharmacia), in each of 
four microfuge tubes labelled A, C, G and T. 1 pi of 1 mM 
ddATP was added to tube A, 1 pi of 1 mM ddCTP to tube C, 1 pi 
of 1 mM ddGTP to tube G and 1 pi of 2mM ddTTP to tube T. The 
reactions were incubated at 50 °C for 45 min. and stopped by 
the addition of 2 pi of formamide containing marker dyes.
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They were then boiled for 3 min. and run on a sequencing gel 
at 48 W for 2 hr.
2.2.12. Primer extension analysis.
Primer extension analysis is a means of precisely mapping the 
5' end of a transcript by synthesising cDNA onto a 
radiolabelled single-stranded DNA primer specific to that RNA 
(Jones et al., 1985 ).
2.2.12.(i). 5’ end labelling of DNA.
325'-dephosphorylated DNA was K P-phosphate labelled using
T4-polynucleotide kinase (Chaconas and van de Sande, 1981).
This enzyme catalyses the transfer of the )f -phosphate group
of ATP to the dephosphorylated 5’-end of a DNA strand.
32Radiolabelling was acheived using [Of- P] dATP. Transfer to 
recessed 5' ends is poor unless they are partially denatured 
by heating. Since some of the ds DNA fragments used in this 
project as primers had recessed 5’ termini, a two-stage 
buffer system was used in which the heat-labile components 
were added after the denaturation step (based on Maniatis et
al., 1982):
Kinase buffer 1 Kinase buffer,2
20 mM Tris-HCl (pH 9-5) 0.5 M Tris-HCl (pH 9-5)
1 mM spermidine 0.1 M MgCl2
0.1 mM EDTA 50 mM dithiothreitol
50% (v/v) glycerol
154
5*-dephosphorylated DNA (2.2.8(i)) was resuspended in 2.5 pi 
of 10 mM Tris-HCl (pH 8.0). The quantity of ds DNA used was 
varied according to its size, e.g. 0.1 pg of 0.1 kbp, 0.2 pg 
of 0.2 kbp, etc. 0.1 pg of oligonucleotides was used. The use 
of excessive amounts led to low specific activity labelling 
as labelled nucleotide was converted to the diphosphate.
17.5 pi of Kinase buffer 1 was added to the resuspended DNA 
which was then heated at 90 °C for 2 mins and promptly
immersed in ice/water. 2.5 pi of Kinase buffer 2 and
4.625 MBq of ['t^P]-dATP in a volume of 2.5 pi. 20 units of
T4-polynucleotide kinase were then added and mixed, and the
reaction was incubated at 37 °C for 30 min. The reaction was 
terminated by the addition of EDTA to 25 mM. If the labelled 
DNA was to be strand-separated, 25 Pg of yeast tRNA was added 
as carrier and the solution was ethanol precipitated, 
resuspended in 80% (v/v) formamide and run on a strand
separating gel (2.2.4.(vii)). For use as a hybridisation 
probe, it was separated from radioactive nucleotide in an 
Elutip-d column.
2.2.12.(ii). Annealing of primers and RNA.
Hybridisation of single-stranded (ss) DNA primers to 
poly(A)+RNA was carried out in 0.4 M NaCl in the presence of 
80% formamide. Formamide has the effect of lowering Tm of 
nucleic acid duplexes, allowing the use of lower temperatures 
which have a less damaging effect on RNA, and RNA:DNA hybrids 
are more stable in the presence of formamide (Casey and
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Davidson, 1977) The of such hybrids is higher than that 
of the corresponding DNA duplex, Tmf, which is related to 
formamide concentration and nucleotide frequency by the 
following formula:
Traf = Tm - (0.5 x mol f ^ C  + 0.75 x mol frnAT) x Jformamide,
(Thomas et al., 1976) where mol frnAT/GC is the mole
fraction of dG, dC or dA, dT in the DNA molecule, and T is’ m
dependent on salt concentration [2.2.6.(iii)]. Therefore if
f
hybridisations are carried out at the T of the DNA primer, 
RNA:DNA hybrids should predominate over intrastrand duplexes 
and ds DNA duplexes formed with any contaminating 
complementary strand.
Approximately 2000 cpm or 5 ng of radiolabelled, 
single-stranded DNA primer was lyophilised with 5 Pg of 
poly(A)+RNA and 20 pg of yeast tRNA. This was resuspended in 
10 pi of 40 mM PIPES (pH 6.4), 1 mM EDTA, 80% (v/v) formamide 
(Ghosh et al., 1981) and sealed in glass capillaries. A
control reaction was carried out in the same buffer with 
primer and tRNA only. The sealed capillaries were heated to 
90 °C for 7 min. to denature the DNA and RNA, then 
immediately submerged in labelled test tubes in a water bath 
at the predetermined hybridisation temperature. After 
incubation, the capillaries were carefully broken and their 
contents flushed out with 200 pi of 0.2 M sodium acetate 
and ethanol precipitated.
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2.2.12.(iii). Synthesis and analysis of primer extended cDNA.
First-strand cDNA was synthesised from the annealed primers 
using 200 units of cloned MMTV-reverse transcriptase at 42 °C 
(d’Alessio et al., 1987) in the reaction buffer supplied by
BRL, with dNTP's at 0.5 mM. In order to increase full-length 
synthesis products, reactions times were extended up to 2 hr 
and reactions were chased every 30 min. with 200 units of 
fresh enzyme. The reaction was terminated by the addition of 
EDTA to 50 mM, and the solution was phenol/chloroform and 
ether extracted and ethanol precipitated in the presence of 
yeast tRNA. Primer extension products were then resuspended 
in formamide containing dye markers and run on a sequencing 
gel next to radiolabelled size markers. Gels were analysed by 
autoradiography in the usual way.
2.2.13* S1-nuclease protection analysis.
Primer extension and S1-mapping complement one another in the
fine mapping of 51 ends of RNA transcripts. In S1-nuclease
32protection analysis (Berk and Sharp, 1977), a 5f- P labelled 
genomic restriction fragment from the region of interest is 
strand-separated and the individual strands hybridised to 
poly(A)+RNA. The heteroduplexes are then digested with 
S1 -nuclease, which degrades ss DNA but not ds DNA or RNA:DNA 
hybrids. Analysis of the reaction products enables 51 ends of
RNA to be mapped according to the length of the protected
fragments.
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2.2.13.(i). Hybridisation of ss probes and RNA.
5f end labelled single-stranded probes were hybridised to 
poly(A)+RNA or control tRNA as described in 2.2.12.(ii). 
Optimum hybridisation temperatures could be more accurately 
calculated if primer extension had previously been used to 
map the transcript.
2.2.13.(ii). S1-nuclease digestion.
Capillaries containing the annealed probe or appropriate 
control were flushed out with 235 pi of ice-cold 250 mM NaCl, 
30 mM sodium acetate (pH 4.6), 1 mM ZnSO^  and 200 pg ml”*
sonicated salmon sperm DNA. 100 units of S1-nuclease were 
added per reaction, and the digests incubated at 37 °C for 1 
hr. In the case of highly A/T-rich probes, this temperature 
was reduced to 18 °C. This reduces "breathing" and hence 
inappropriate degradation of the A/T-rich regions (Pelham, 
1982).
Reactions were terminated by phenol/chloroform extraction, 
then ether extracted and ethanol precipitated. Reaction 
products were run on a sequencing gel next to radioactive 
size markers and analysed by autoradiography as previously 
described.
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Figure 10, The multiple cloning site of pUC13«
The pUC13 vector, showing the positions of cIKA’s blunt—end ligated 
into the Smal restriction site.
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3. RESULTS AND DISCUSSION.
In this section, results obtained in this project are 
described in appropriate subsections and a discussion of each 
result included under the same subsection. A summary of 
results and a concluding discussion are presented at the end 
of the section.
3*1. Isolation and analysis of DNA and RNA from papillomas.
3-1.1. Collection and selection of bovine upper alimentary 
papillomas.
Bovine upper alimentary papillomas were supplied by Glasgow 
Veterinary School Pathology Department. Bovines with multiple 
upper alimentary papillomatosis from farms around the Glasgow 
area were slaughtered at the Veterinary School. Papillomas 
were excised and plunged into liquid nitrogen, care being 
taken to include the peduncle of the papilloma while 
minimising the amount of surrounding normal tissue. This 
ensured maximum recovery of the full range of viral 
transcripts expressed in each differential layer of the 
epithelium.
For the purposes of isolating DNA and RNA, papillomas from 
each affected site were subdivided according to size: those
$6 mm in diameter (0.4 g) were kept separate from those 
>6 mm (Fig. 11). These distinctions were made because it had 
been found previously that smaller papillomas yielded
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proportionally more BPV4-specific RNA (M. S. Campo, pers. 
comm.). This may be due to an increased proportion among the 
larger papillomas of regressing tumours containing reduced 
quantities, or no BPV4 DNA, in which viral transcriptional 
levels are low or absent (Jarrett, 1985). Larger papillomas 
also have a larger proportion of keratinised fronds over the 
solid core, and hence a smaller proportion of the less 
differentiated tissue in which viral transcription takes 
place.
A single case with multiple site infection was supplied; this 
was designated AOP 298. This animal had multiple papillomas 
on the tongue, oesophageal wall and cardiac area of the 
rumen. Papillomas from different sites were stored and 
processed separately in order to detect any possible 
variation in the viral DNA content and transcriptional 
pattern at the different sites of infection. They were 
labelled AOP 298tong, AOP 298oes and AOP 298rum, 
respectively.
In most cases, papillomatosis was confined to the upper 
oesophagus (Table 3-1), and it was usual to collect up to 200 
papillomas from this site. Oesophageal papillomas had a 
typical ’’onion" shape, the main body of the tumour having a 
larger girth than the basal peduncle, tapering into long, 
keratinised fronds. Papillomas from this site extended an 
average 1 cm from the basal peduncle into the oesophagus and 
were usually arranged in straight, longitudinal lines. This 
pattern may be due to viral infection occurring in lines of 
scarified epithelium caused by the passage of abrasive
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material ingested by the animal.
Papillomas at other sites (tongue, cardiac area of rumen) 
were less abundant in case AOP 298 at 20 to 50 per site; 
tongue papillomas were flatter and more rounded in 
appearance, having no keratinised fronds, presumably due to 
mechanical abrasion. Papillomas from the rumen were in 
general larger and often the tubules appeared loosely bunched 
and could easily be separated. It was considered that these 
were at a more advanced stage of BPV4 infection and may have 
been regressing.
3*1*2. Isolation of DNA and RNA from papillomas.
It was important for the purposes of this project to obtain a 
preparation of papilloma RNA of the highest possible quality. 
It was often difficult to obtain tumour samples immediately 
after the slaughter of the animal, and in addition, papilloma 
tissue is exceptionally tough and difficult to break up, and 
took some time to homogenise in guanidinium isothiocyanate 
buffer. These factors resulted in the inevitable degradation 
of some or all of the RNA in wart samples.
RNA was extracted from papillomas of seven different cases; 
with the AOP 298 samples, this was a total of nine 
extractions. DNA was recovered from cases AOP 30/10, A0P3/11, 
AOP 298 and AOP A.
The guanidinium isothiocyanate/ caesium chloride density 
gradient centrifugation technique (Chirgwin et al., 1979) 
yielded between 0.22 and 0.66 mg of DNA and between 0.47 and
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1.2 mg of RNA per g of papilloma tissue (Table 3.1.).
3.1.3. Southern blot hybridisation analysis of papilloma DNA
Papilloma DNA was subjected to Southern blot hybridisation 
analysis in order to demonstrate the presence and integrity 
of the BPV4 episome. 10 ug samples of AOP A DNA were run on a 
1% agarose gel either undigested (Fig. 12(1), lane A), or 
digested with restriction endonucleases (lanes B, C, D). 
After Southern transfer, a radiolabelled BPV4 genomic DNA 
probe was hybridised to the blot. This was isolated from 
plasmid pBV4 (Fig. 13). An autoradiograph of the blot is 
shown next to the gel in Figure 12(1); sizes of the 
hybridisation bands were calculated using a computer analysis 
program (Chuck Buckler Programs, Bethesda).
The autoradiograph showed the typical restriction pattern of 
BPV4 DNA (Campo et al., 1980). In the undigested sample, the 
most intense band corresponds to supercoiled Form I viral DNA 
(Fig 12(1), lane a). The faint band of lower mobility 
represents relaxed Form II DNA and an even fainter band 
between the two, linearised Form III DNA. Digestion with 
restriction endonuclease BamHI. in this case a partial 
digest, resulted in the 7.2 kb band of increased intensity in 
lane (c). Digestion with EcoRI and Hindlll resulted in the 
typical hybridisation pattern (Campo et al.. 1980) seen in
lanes (b) and (d).
10 pg samples of the other DNA preparations were also run on 
a 1% agarose gel , transferred to nylon membrane and
168
hybridised to the BPV4 DNA probe (Fig. 12(2)). These were run 
undigested (Fig. 12(2), lanes 1), or after digestion with 
restriction enzymes BamHI (lanes 2) and EcoRI (lanes 3). In
each case, the results showed that no major deletions or
rearrangements had occurred in the BPV4 DNA contained in the 
papillomas, and little variation was seen in viral DNA
content between cases, except for AOP 298tong which had an
increased content (Fig. 12(2), lanes c).
3.1.4. Northern blot hybridisation analysis of papilloma RNA
20 pg of each RNA preparation was electrophoresed on a 
agarose gel containing 2.2 M formaldehyde and transferred to 
nylon membrane. A nick-translated probe of BPV4 genomic DNA 
was then hybridised to the immobilised RNA. Autoradiographs 
of the resulting Northern blots are presented in Figure 14, 
and the calculated sizes of the hybridisation bands in each 
lane are tabulated in Table 3.1.
The highest quality RNA preparation was from AOP A 
papillomas (Fig. 14, lane e). Nine distinct hybridisation 
bands can be seen , of 6.4, 5.4, 4.3, 3.6, 2.8, 2.3, 2.0, 1.6 
and 1.2 kb, respectively. Some of the bands are quite broad, 
indicating that more than one transcript size is represented, 
particularly the 1.2 kb band.
The major transcripts, indicated by the more intense bands, 
are represented by the 6.4, 5.4, 4.3, 2^ 8, 2.0 and 1.2 kb
size classes. The last four of these were considered to 
correspond to the 4.2, 2.8, 1.9 and 1.0 kb transcripts
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reported previously (Smith et al., 1986). The 3.6 and 1.6 kb 
minor transcripts have also been identified previously. The 
larger 6.4 and 5.4 kb size classes have not been reported. 
They may represent further mRNA’s of BPV4 or may just be 
unspliced nuclear intermediates. No previous report of the 
2.3 kb major size class has been made, although the high 
intensity of this hybridisation band indicates that it is a 
mature mRNA.
Variations in the overall intensity of autoradiographic bands 
occur for different RNA samples in Figure 14. In some cases, 
such as AOP 30/10 and AOP 3/11, this was due to degradation 
of the RNA, giving diffuse bands with high background. 
Preparation AOP X contained no BPV4-specific RNA (Fig. 14, 
lane d) ; since only 290 pg of total RNA was recoverd from 1g
of tissue in this instance, this may have been due to a
failure in the preparative technique.
In preparations AOP 298tong, AOP 298rum and AOP 299, there 
are marked reductions in the relative intensity of the 6.4,
5.4, 4.3 and 2.8 kb bands. The 4.3 and 2.8 kb size classes
contain late transcripts (Smith et al., 1986) and the size of 
the 6.4 and 5.4 kb species indicates that they must contain 
sequences from the late region of BPV4. The papillomas used
for these preparations were predominantly of the larger size
gradation in AOP 298tong and AOP 299 and exclusively large in 
AOP 298rum. Therefore a larger proportion of older papillomas 
may have been present in these cases, and the reduction in 
late transcripts may relate to the decrease in virion 
production seen in older, regressing papillomas (Jarrett,
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1985). Low virion production may also be a feature of the 
site of infection in the tongue and rumenal papillomas. The 
late transcripts of HPV's 1, 6b and 11 were found to be 
extremely rare in warts and condylomata, and this was 
similarly taken to correlate with low virion productivity in 
these lesions (Chow et al., 1987a,b).
The larger number of viral transcript size classes found in 
this study is similar to that of other papillomaviruses in 
vivo. BPV1-specific transcripts in fibropapilloma RNA occupy 
eight size classes (Engel et al., 1983) and a large number of 
differentially spliced mRNA’s have been found (Baker and 
Howley, 1987; Ahola et al.. 1987); fourteen different viral 
transcripts have been mapped in condylomata containing HPV6b 
and HPV11 (Chow et al., 1987a).
The main objective of screening the papilloma RNA 
preparations in this manner was to select RNA suitable for 
cDNA synthesis and transcript mapping. Preparation AOP A was 
considered the most suitable and a further 2 g of papilloma 
tissue was processed, giving an accumulated yield of 3072 jig 
of total RNA.
3.1.5. Isolation of polvadenvlated RNA.
Poly(A)+RNA was separated from total AOP A RNA using an 
oligo(dT) cellulose column. Measurement of optical density at 
260nm showed that 120 jig of poly(A)+RNA was recovered (Table 
3.1). This was 3*9% by weight of total RNA, close to the 
value of 3% obtained by Aviv and Leder (1972) for poly(A)+RNA
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from rabbit reticulocyte total RNA. This was taken as an 
indication that the papilloma mRNA had been purified 
sufficiently for further analysis.
1 pg of the polyadenylated RNA was subjected to Northern blot 
hybridisation analysis, using the BPV4 genomic probe, to 
confirm the integrity of the isolated transcripts (Fig. 43, 
lane A; Table 3*1). The results of this analysis show a 
dramatic reduction in the relative intensities of the 6.4,
5.4, 4.3 and 2.0 kb size classes, while those of the 3.6,
2.8, 1.6 and 1.2 kb are maintained. The 2.3 kb size class is
no longer present. This is somewhat surprising when the 
Northern blot of total AOP A RNA is compared. It is unlikely 
that selective degradation of certain transcripts occurred, 
so the apparent variation in their abundance may have been 
due to poor transfer onto the membrane in the Northern blot, 
or low retention in the oligo(dT) column due to short or 
fully degraded poly(A) tails.
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Figure 11, Bovine oesophageal papillomas
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Figure 12. Southern blot hybridisation of papilloma IRA.
1). LEFT: Ethidium bromide stained 1 f0 agarose gel containing AOP A IRA -
A: undigested; B; EcoRI-digested; C: BamHI-digested; D: Hindlll-digested. 
M: size markers- Hindlll-digested K OJA.
RIGHT: RNA was transferred to nylon membrane and probed with BPV4 IRA.
The hybridised blot was autoradiographed for 1.5 hr* (lanes a-d).
2). Southern blot of papilloma IRA hybridised to BFV4 IRA and autoradiographed 
for 1.5 hr: Lanes 1: undigested; Lanes 2: BamHI-digested;
Lanes 3: EcoRI—digested. IRA was extracted form papillomas of cases- 
(a): AOP 30/10; (b): AOP 3/11; (c): AOP 298tong; (d): AOP 298oes;
(e): AOP 298rum.
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Figure 14. northern blot hybridisation of T^pilloma
o 9 M formaldehyde. agarose golf 20 ug Total RNA from papillomas was run on a 2.2 wa  exposed
transferred to nylon membrane and probed with BFV4 IMA*
to X-Ray film for 48 hr*
Lanes M: RNA size markers (BRL). (*). aqp X: (e): AOP A;
fa): AOP 298tong; (b): AOP 298oeS; (o): AOP 298rum, (d). AOP A,
(f): AOP B; (g): AOP 299
2). A: AOP 30/10; B: AOP 3/11•
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Table 3*1« Analysis of ERA from papillomas.
Fig.13,
lane:
Sample No. Site Size of 
pap./mm
RNA/pg* RNA size classes/kb Rel. amt. 
RNA
Rel. amt. 
ENA
a AOP 298 
tong
tongue all 880 6.4; 4.3; 2.8; 2.0; 
2.1
+ ++
b AOP 298 
oes
oesophagus ^6 470 6.4; 5-4 ; 4.3; 3.6; 
2.8; 2.0; 1.6; 1.2
++ +
c AOP 298 
rum
rumen >6 665 4 .3 ; 3.6; 2.0; 1.2 + +
d AOP X oesophagus >6 290 - -* nd
e AOP A oesophagus s6 30751 6.4 ; 5 .4 ; 4 .3 ; 3.6 ; 
2.8; 2.3; 2.0; 1.6; 
1.2
+++ +
f AOP B oesophagus k6
2
320 6.4; 5 .4 ; 4.3; 3.6; 
2.8; 2.3; 1.6; 1.2
+++ +
C AOP 299 oesophagus all 480 5.4; 4 .3 ; 3.6; 2.8; 
1.6; 1.2
++ nd
A AOP 30 /10 oesophagus *6 1260 7.9; 5.4; 3.6; 3 .1; 
1.8; 0.8
+ +
B AOP 3/11 oesophagus =s6 830 7.9; 5.4; 3.6; 3.1; 
1.8 ; 0 .8
+ +
AOP A 
poly (a )+
- - 120 6.4; 5*4 ; 4 *3 ; 3.6; 
2 .5 ; 2 .0 ; 1.6 ; 1.1
nd — not determined 
*
recovered from 1 g of tissue
recovered from 3 g of tissue 
recovered from 0 .5 g of tissue
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3-2. Construction and screening of a cDNA library.
Mapping of BPV4-specific transcripts by Northern blot 
hybridisation and S1-nuclease protection analyses provided 
information on the organisation of transcriptional exons and 
the orf’s contained in their sequences (Smith et al., 1986).
The transcriptional organisation of BPV4 was shown to be 
complex, with differential splicing producing polycistronic 
transcripts containing potential fusions between different 
orf’s. A number of possible transcriptional initiation sites 
were also identified (Fig. 9). This work made it clear that 
the expression jin vitro of subgenomic fragments containing 
separate orf’s would in many cases not constitute a 
functional appraisal of BPV4 genes and that the only way to 
dissect the functions of in vivo gene products would be to 
synthesise cDNA’s from viral transcripts from papilloma RNA 
and express these in an .in vitro system. A cDNA library would 
also provide precise information on the positions of splice 
junctions and could be used in the fine mapping of 
transcriptional initiation sites.
3.2.1. Synthesis of cDNA.
cDNA was synthesised from oligo(dT) ^ -primed poly(A) RNA 
isolated from total AOP A RNA. The method of Gubler and 
Hoffmann was chosen as it ensures better representation of 
5’ terminal sequences of mRNA’s in the ds cDNA than do 
previous techniques relying on the action of S1-nuclease to
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degrade "turn around" loops arising in first-strand synthesis 
(Fig. 15).
Aliquots of first and second strand synthesis reactions of 
the globin mRNA pilot experiment and of AOP A mRNA were 
electrophoresed on 1.4% alkaline agarose gels. 
Autoradiographs of the gels are shown in Figure 16.
In the globin mRNA pilot experiment, it can be seen that 
full-length products of approximately 600 nucleotides were 
obtained in both the first and second strand reactions and 
that these accounted for the vast majority of reaction 
products (Fig. 16(a)). Similar intensities are seen for bands
in both lanes as equivalent fractions of the original mRNA 
input were loaded onto each. Incorporation of radioisotope 
into TCA-precipitable material was measured by scintillation 
counting and it was calculated from this that approximately 
50% of the globin mRNA had been reverse transcribed into 
single stranded cDNA, and that virtually all of this had been 
converted into double stranded (ds) DNA in the second strand 
reaction. Since this represented optimum efficiency for this 
protocol (A. Hall, Chester Beatty Institute, London, personal 
communication), cDNA was synthesised from 10 pg of AOP A 
poly(A)+RNA using the same reagents.
Calculations based on radiolabel incorporation data gave an 
estimate of only 20% conversion of mRNA into ds cDNA. The 
reduction in conversion efficiency occurred mainly in the
first strand reaction, as second strand synthesis was
approximately 90% efficient. The reasons for failure to
reverse transcribe efficiently may have been:
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1). the presence of biological and chemical contaminants in 
the mRNA sample inhibiting reverse transcriptase activity, 
such as RNA-binding proteins and traces of SDS remaining from 
the column chromatography step;
2). premature termination of first strand synthesis on a 
proportion of transcripts due to RNA secondary structure. 
Alkaline agarose gel analyses of first and second strand
reaction products are shown in Figure 16. According to these 
autoradiographs, the majority of first strand reaction 
products were between 150 and 2000 nucleotides in length, the 
greatest intensity of the radioactive signal being between
500 and 1200 nucleotides (Fig. 16(b)). The ds cDNA had much 
the same distribution, although an increase in higher 
molecular weight species was seen (Fig. 16(c)). Gubler and 
Hoffmann (1983) noted that a small percentage of globin cDNA 
molecules of twice the normal size appeared after second 
strand synthesis using their method; this was thought to be 
due to priming of DNA pol-1 by the hairpin-loop structure 
produced in first strand synthesis, leading to slightly
reduced cloning efficiency as the hairpin is not degraded in 
this protocol.
Since the conversion of AOP A mRNA to ds cDNA appeared to 
cover a size range which would include at least seme viral 
transcripts, and was satisfactory according to radiolabel 
incorporation data, the second strand reaction products were 
"blunt-ended" for cloning using T4-DNA polymerase.
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3.2.2. Preparation of the vector.
Plasmid vector pUC13 was linearised with restriction 
endonuclease Smal and treated with phosphatase to prevent 
religation. Test ligation reactions were set up using blunt 
ended Haelll fragments of BPV4 DNA with appropriate controls 
as described in Section 2.2.8.(ii). The ligated DNA was used 
to transform newly prepared competent E. coli JM83 cells 
which were then spread onto 1.5% L-agar plates containing 
ampicillin and X-gal, and incubated overnight at 37 °C. Blue 
and white colonies on each plate were counted; results are 
presented in Table 3.2(a)
A minimal number of colonies grew on the cut vector control 
plates, showing that the vector had been efficiently 
prepared. According to the colony count on the uncut vector 
control plate , the transformation efficiency was calculated
fl
at 2.19 x 10 transformants per pg of vector, an order of 
magnitude below the maximum efficiency reported by Dagert and 
Ehrlich (1979). 20% of the test ligation colonies were blue,
but since the ligation control plate produced only 15 blue 
colonies, this was thought to be due to the expression of 
fusion proteins from orf’s cloned in frame with 
B-galactosidase in the vector. This preparation of competent 
JM83 cells was therefore considered suitable for 
transformation by pUC13-cloned cDNA.
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3-2.3. Transformation of E. coli cells with cloned cDNA.
Blunt ended cDNA was ligated to the phosphatased pUC13 vector 
and used to transform the competent cells approximately 24 
hours after their preparation. The entire cDNA preparation 
was resuspended in 100 pi of water and three ligation 
reactions were set up containing 0.5, 1.0 and 2.5 pi of this 
solution and 50 ng of vector; each of these ligations was 
used to transform 200 pi of competent cells. The 
transformations were spread onto selective medium plates as 
above in aliquots of one-fifth of the total volume, and 
incubated overnight.
Results are shown in Table 3.2(b). The transformation
efficiency of the cells was increased, at 3.49 x 10 colonies
per pg of pUC13. Optimum ligation efficiency was obtained
when 1 pi of the cDNA solution was used in the ligation
5
reaction , giving a predicted library size of 1.47 x 10 
recombinants. The remainder of the cDNA was ligated to pUC13 
and introduced into competent cells at an average 
transformation efficiency of 2 x 10 colonies per pg of 
vector. 14 cm L-Agar plates were dried for 30 mins. under a 
Category I hood and the whole of each transformation spread 
onto a single plate. Between 2500 and 3000 colonies grew on 
each plate, and a total of approximately 107000 colonies were 
obtained, representing 10700 recombinants per pg of input 
mRNA. This was considerably less than the cloning efficiency 
of 300000 clones per pg of mRNA reported by Gubler and 
Hoffmann; the lowered transformation efficiency of the
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bacterial cells prepared in this project, and the reduced 
conversion efficiency of the cDNA synthesis account for this 
low yield. Also, blunt end cloning, while it was chosen to 
reduce the number of manipulations carried out from RNA 
isolation to recombinant transformation, is less efficient 
than other more elaborate methods such as polynucleotide 
tailing. Nevertheless, a cDNA library of over 10^  clones is 
of a useful size and should be representative of rare 
transcripts such as those of BPV4.
In addition, glycerol stocks of JM83 cells transformed by 
pUC8-cloned cDNA produced from bovine oesophageal papilloma 
mRNA were plated out. These constituted the remaining part of 
a cDNA library synthesised by A. Sproul (Beatson Institute) 
to provide the cDNA’s used in mapping the 3’ ends of viral 
transcripts (Smith et al., 1986). The viability of these
stocks was considerably reduced and a total of only 2670 
colonies was obtained.
3.2.4. Screening of the cDNA library.
The two cDNA libraries were screened by the "colony-1 iftn 
method of Grunstein and Hogness (1975). Membrane discs were 
hybridised to nick-translated BPV4 genomic DNA, using
_-j
unlabelled pUC DNA at a concentration of 20 ug ml in the 
prehybridisation to block non-specific hybridisation to 
vector sequences and thus reduce the number of false 
positives obtained. The use of calf thymus DNA in the 
pre-hybridisation solution also minimised non-specific
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hybridisation to cDNA inserts containing bovine sequences. 
The washed membrane discs were autoradiographed: a typical
autoradiograph is shown in Figure 17.
Two BPV4-positive colonies were found in the cDNA library 
supplied by A. Sproul. These were designated 10-1 and 7E11. 
Hybridisation of BPV4 was observed to 19 colonies in the cDNA 
library produced from AOP A mRNA: these were designated A to 
S. Autoradiographs were matched up to corresponding plates 
and the positive colonies picked and grown up in mini-prep 
cultures. All of these were white colonies, indicating that 
no orf's were cloned in frame with the R-galactosidase gene. 
Part of each mini-prep was used to make glycerol stocks and 
plasmid DNA was isolated from the remainder.
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Lgure 15« Alternative schemes for cUJA synthesis and cloning.
’reparation of cIRA by ENaseH method Preparation of cIRA by S1 nuclease raetl
AAAA poly(A)4 RNA
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Figure 17. Grunstein-Hogness colony lift hybridised to BFV4 IMA.
Competent E. eoli JM83 cells transformed with cloned cUTA's were spread on 
14 cm selective medium plates, and the resulting colonies analysed by the 
Grunstein-Hogness colony lift technique. An autoradiograph of a typical filter 
disc probed with BFV4 USTA is shown. A positive colony is indicated by a 
snail arrow.
M: radioactive alignment markers.
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Table 3-2.(a) Pilot transformations.
Plate T LC CC UC
Blue
colonies
110 15 7 217
White
colonies
420 1 0 2
TOTAL 530 16 7 219
T: 5 ng linearised, phosphatased pUC13 plus 1 ng Haelll-cut BPV4 INA. 
LC: Ligation control, 5 ng linearised, phosphatased vector plus ligase. 
CC: linear vector control, 5 ng linearised, phosphatased vector,
UC: uncut vector control, 0.1 ng intact pUC13 INA*
Table 3.2. (b) cUlA transformations.
Plate 1 2 3 UC
Blue
colonies (ave) 37 43 78 345
White
colonies (ave) 110 265 647 4
TOTAL* 132 293 710 349
1: 0.5 ill cUlA in ligation reaction.
2: 1.0 pi cUTA in ligation reaction .
3: 2.5 pi cMA in ligation reaction.
UC: 0.1 ng intact pUC13.
Totals corrected for ligation control (Table 3.4*(a))«
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3*3. Analysis of cDNA1 a.
cDNA’s were hybridised to BPV4 DNA in a Southern blot
analysis to confirm that they contained BPV4 sequences. A
selection were then mapped to regions of the viral genome by 
hybridisation to restriction fragments of BPV4 DNA. The 
cDNA’s were then sequenced, and their sequences analysed 
using the Microgenie computer analysis program (Queen and 
Korn, 1984).
3*3.1. Southern blot hybridisation analysis.
3.3.1.(i). Hybridisation to total BPV4 DNA.
Plasmid DNA from each of the colonies A to S was digested
with restriction endonucleases BamHI and EcoRI to separate 
cDNA inserts from vector sequences (see pUC multiple cloning 
site, Fig. 10). cDNA inserts were given the same designation 
as the colonies from which they were isolated (A to S; 7E11; 
10-1); the corresponding plasmid recombinants were 
distinguished by the prefix "p" (pA to pS; p7E11; p10—1). The 
digests were run out on a 1% agarose gel, visualised by 
ethidium bromide staining and U.V. transillunination and 
photographed (Fig. 18(a)). The DNA was then transferred to 
nylon membrane and hybridised to the BPV4 DNA probe (Fig. 
18(b)).
One plasmid, pS, contained no cDNA insert. On reexamination 
of the plate from which it had been picked, no other colonies
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were found near enough to have caused any error in picking 
colony S. It was therefore considered either that 
hybridisation to the colony had been spurious and that the 
failure to produce P—galactosidase was due to inappropriate 
religation of the vector causing a frameshift within the 
multiple cloning site, or that the cDNA insert was so small 
as to have run off the gel.
Strong hybridisation to all the inserts was seen except for 
the smaller fragment of cDNA P (Fig. 18(b), lane p). It was 
therefore thought that pP contained two cDNA's ligated end to 
end, one containing BPV4 sequences and the other, cellular 
sequences. In sane lanes hybridisation was observed with 
bands of higher molecular weight than the inserts. The larger 
of these bands had the same mobility as linear pUC DNA, and 
probably represented hybridisation of contaminating plasmid 
DNA in the probe. The smaller band in most cases had no 
detectable counterpart in the gel photograph and probably 
represented small quantities of undigested, supercoiled 
plasmid.
3.3.1.(ii). Mapping of cDNA1s on the viral genome^
Southern blot hybridisation experiments were carried out to 
localise cDNA's to subgenomic fragments of BPV4 DNA. Five 
cloned subgenomic restriction fragments of BPV4 were already 
available; these were: EcoRI - BarpHI (nt1142 -nt2601), BamHI- 
Hindlll (nt2602 - nt3705); HindHI - HindHI (nt3706- 
nt5954); Hindlll - EcoRI (nt5955 - nt904) and EcoRI - EcoRI
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(nt905 nt1142). However, on the basis of known positions of 
transcriptional exons (Smith et al., 1986) and orf’s of BPV4 
(Patel et al., 1987), it was considered that these fragments
did not reflect the transcriptional and genetic subdivisions 
of the viral genome. It was decided that the use of PstI 
fragments of BPV4 would enable more accurate localisation of 
cDNA's (Fig. 20).
Rather than clone the 9 PstI fragments into plasmids, it was
reasoned that the longer cDNA inserts could be classified by
hybridising their respective plasmids to a Southern blot of
PstI digested BPV4 DNA. Each cDNA class could then be
hybridised back onto the Southern blot containing all the
cDNA inserts. This was carried out on the assumption that
BPV4 cDNA’s could only have one of two 3' termini with
respect to the original mRNA, based on the transcriptional
organisation.
>
cDNA’s of £300 bp were chosen for classification: these were
cDNA's G, J, L, M, N, and Q. cDNA's 7E11 and 10-1 were also 
included. To ensure efficient nick translation, the 
appropriate plasmid DNA's were used. 10 pg aliquots of AOP A 
papilloma DNA were digested with PstI, run on a 156 agarose 
gel and transferred onto nylon membrane. Papilloma DNA was 
used as it eliminated the problems caused by plasmid 
contamination in the previous experiment and provided a 
plentiful supply of immediately available BPV4 DNA.
The plasmid recombinant DNA's were radiolabelled by 
nick-translation and hybridised to the Southern blots. Some 
of the resulting autoradiographs are presented in Figure 19.,
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and the results are summarised in the table in Figure 20. 
Autoradiographs of blots probed with pG, pj, PL and pM were 
all identical to that obtained using pQ (Fig. 19, lane D). 
These cDNA's hybridised to the 1317 bp PstI fragment (nt3017- 
nt4334) which contains the early polyadenylation signal at 
nt4009 and the splice acceptor of the 31 terminal exon of the 
early region at nt3376. Since the 1.0 kb major transcript was 
mapped to this region (Smith et al., 1986), it was not
surprising that the majority of cDNA's hybridised to this
PstI fragment.
Plasmid p7E11 hybridised to the 1317 bp fragment, but also to 
the 230 bp band (Fig. 19, lane B). The 230 bp PstI fragment
extends from nt917 - nt1147, far upstream of the 1317 bp
fragment; it was therefore considered either that the p7E11 
insert consisted of two cDNA's ligated end to end, or that it 
represented a previously unidentified cDNA.
Plasmid pN (Fig. 19, lane C) hybridised to the double band 
containing the PstI fragments from nt7126 - nt917 containing 
the E8 orf, most of the E6 orf and the late polyadenylation 
site at nt45 (Smith et al., 1986), and from nt4334 to nt5403,
containing most of the L2 orf. Since cDNA N was 300 bp in
length, it seemed unlikely that it derived from a late
transcript as the 3* terminus of these is only 190
nucleotides downsteam of the PstI site at nt7126, and the 
cDNA did not hybridise to the adjacent 1723 bp PstI- fragment. 
Since no other polyadenylation consensus signals could be 
found in the sequences of either of the 1 kb fragments, it 
was concluded that cDNA N was a truncated cDNA.
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Plasmid p10 1 (Fig. 19, lane D) hybridised to the 450 bp band 
representing two adjacent PstI fragments from nt1147 -nt1578 
and from nt1579 to nt2051. The region encompassed by these 
two fragments includes the 3 * end of the E7 orf and the 5 * 
one third of the E1 orf.
As the two fragments lie across two overlapping exons 
representing different transcriptional interpretations of the 
E1 orf (Fig. 20), it was important to map cDNA 10-1 more 
precisely. A pAT153-derived plasmid containing the EcoRI - 
BamHI subgenomic fragment (nt1142 - nt2601) was digested with 
these two enzymes in one reaction, and in a triple digest 
with Xhol in another. Restriction endonuclease Xhol cuts BPV4 
at ntl624 (Fig. 21). These digests were run on a 1$ agarose 
gel (Fig. 21, lanes A and B), transferred to nylon membrane 
and hybridised first to pUC DNA (Fig. 21, lanes 2(a) and 
(b)). The radiolabelled plasmid DNA hybridised only to the 
3.4 kb band representing pAT153> showing that results would 
not be confused by other plasmid bands. Radiolabelled p10—1 
was then hybridised to the same blot. Hybridisation was 
observed to the 1.45 kb EcoRI - BamHI fragment (Fig. 21, lane 
1(a)), but only to the 0.97 kb Xhol - BamHI fragment (Fig. 21 
lane 1(b)). These results led to the conclusion that cDNA 
10-1 represented sequences between ntl624 and nt2051 at the 
5* end of the E1 orf, and that it was another truncated cDNA, 
as no polyadenylation signals are found in this region of 
BPV4.
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3-3.2. Sizing of cDNA inserts.
Plasmids p7E11, pN, pQ and p10-1 were digested with BamHI and 
EcoRI and run on 1.5% agarose gels next to size markers to 
obtain more accurate calculations of their insert sizes (Fig. 
22). The results confirmed that the 231 bp cDNA N could not 
represent a late transcript as it did not hybridise to the 
1732 bp PstI fragment of BPV4, and also indicated that the 
775 bp cDNA 7E11 could represent sequences extending upstream 
of a putative splice junction at nt3376.
The existence of truncated species meant that cDNA’s would 
not fall into two simple categories defined by the early and 
late polyadenylation sites, and it was evident that the most 
practical way of analysing the cDNA’s was by sequencing.
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Figure 18. Southern blot hybridisation analysis of BFV4~Posi'kive cDNA inserts,
(a) Ethidiura bromide stained agarose gel containing BamHI + EcoRI digested 
plasmid IS7A isolated from BFV4—positive recombinant bacterial clones.
Lanes Mr: size markers (Haelll-digested (DX174 LNA);
Lanes A — S: pAtopS DNA
(i>) Southern blot of the above gel* hybridised to a BFV4 LNA probe and
autoradiographed for 16 hours. Lanes (a - s) correspond to lanes A - S.
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Figure 19* Mapping of cUJA inserts by Southern blot hybridisation.
10 tig aliquots of Pstl-digested AOP A UJA were run on a agarose gel 
and transferred onto nylon membrane. The Southern blots were hybridised 
to the following probes:
A: BPV4 ENA (control)
B: p7E11 
C: pN 
D: pQ 
E: p10-1
Lane M: size markers in ethidium bromide stained gel (Haelll-digested
CBX174 H7A).
196
<o
T— “
r-
c n
_I 04
O -
LO
UJ
ao
•H
-P
cd
O  CO
i t0) U
iiO O
m
NO
sO
JD nOm
04
CO «oCO
UJ NOvt
UJ
CM
UJ
CO
o
in
Tfco
COTt
< -
r—
5
CO
CO
CM
CM
in
o
CM
oo
r—m
r—
CD
<-4
<of 
c m '
cn
UD
o
r-
co
c n
c o
<T
c n
U K
04
LO
O
-p p< 
£
CD
I)CL)a n
h -H
<+h CO
i—I
cd
£ uoo £•H CO -H
-P CD *■ CD
P< S -H
•H O 
£-( « S 2
O  CD o £co
£ >S
n) ,£U
-p
o
CD
o
Io
113/.
197
Nu
mb
er
s 
ab
ov
e 
th
e 
ta
bl
e 
re
fe
r 
to 
nu
cl
eo
ti
de
 
po
si
ti
on
s 
in 
th
e 
BF
V4
 
ge
no
me
 
A 
- 
po
ly
ad
en
yl
at
io
n 
si
te
 
 
po
ly
ad
en
yl
at
ed
 
RN
A 
3
’ 
te
rm
in
us
A B a b a b
Eco R1 Xho1 Bam HI
1 Jf ^
01nt 11U2 162U 26
Figure 21. Mapping of cINA 10-1 by Southern blot hybridisation.
1 |ig aliquots of a pAT153“derived plasmid containing the EcoRI - BamHI 
subgenomic fragnent were digested with:-
A: EcoRI and BamHI 
B: EcoRI| BamHI and Xhol.
These digest were run on a 1^ agarose gel, transferred to nylon membrane 
and hybridised to:- , .
1). p10—1; and 2). pUC13 INA. Lanes (a) and (b) correspond 
to lanes A and B in the gel.
The subgencmic fragment of BFV4 used in this analysis and the nucleotide 
positions of the relevant restriction sites are shown below the photograph.
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Figure 22* Sizing of d3NA,s 10-1, 7E11« N and Q.
Ethidium bromide stained 1*5$ agarose gels of reoombinant 
plasmid INA digested with EcoRI and BamHI:
(a) 1: p10—1; K: size markers (HinfI—digested pAT153 HJA)
STD LEN DIST PRED LEN DEVIATION
1. 63 50.500 1 . A3 —0.001
0. 52 79.000 0. 52 0. 004
0. 4 0 84.500 0. 39 0. 003
0. 29 89.500 0. 30 —0.010
0. 2 2 94.000 0.22 —0.000
0. 15 98.500 0. 15 0. 003
UNKNOWN FRAGMENTS:
FRAGMENT DISTANCE PREDICTED LENGTH
1 ■ i ) 38. 00 2. ?’55
1 < i i ) 88. 75 0. 3 1. 1
A: p7E11; B: pN; C: pQ; M: size markers (Haelll—digested
0X174 hja).
STD LEN DIST PRED LEN DEV T ATION
1. - *j>5 15.500 1 . 36 -0.01 1
1 . 09 1.7. 500 1 . 10 -0.006
0. 87 20.000 O. S 5> 0 - 0 1 7
0 - 60 2.4. 000 0. 59 0. 0 1 5
0. 3 1 30. <300 0. 33 -0.022
0. 27 32.000 0. 27 -0.OO1
0. 23 33.750 0. 23 0 „ 004
0. 1 9 35.250 0. 1.9 0. ooo
o. 12 38.750 0. 12 0. 007
Mi i!-rMCWN FRAGMENTS r
FRAGMENT DISTANCE PREDICTED LENGTH 
A 21.00 0.775
(a)
1 M
M
y 1630
(b)
520 
398 
287 
221/0 
154
A B C M
bp
, y
1353
1078
872
603
310
281
271
234
bp
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3-3.3. Sequencing of cDNA's.
At this time a simple method of sequencing ds plasmid DNA 
inserts became available, based on the ’’dideoxy” sequencing 
protocol (Chen and Seeburg, 1985).
This method is somewhat more prone to problems such as 
premature termination artifacts than is M13 sequencing and in 
addition only yields 150 - 250 nucleotides of sequence. 
However, the fact that mini-prep DNA may be used and that ^ P  
is incorporated into the sequencing strand enables the rapid 
screening of inserts while providing precise details of their 
genomic location. Plasmid DNA could be isolated from 
bacterial cultures, sequenced, run on a sequencing gel and 
autoradiographed in a single day.
This system was ideally suited to the rapid analysis of the 
21 BPV4-positive cDNA’s. Those less than 400 bp in length 
could be sequenced end to end by this method, but the larger 
inserts were cloned into M13 vectors for full sequencing. 
Sequences were recorded and compared to BPV4 genomic sequence 
on the Microgenie computer program (Queen and Korn, 1984). 
The results of these analyses are summarised in Table 3-3.
3.3-3*Ci)- General: abundance of cDNA's and representation of 
viral transcripts.
The sequences of all of the cDNA’s except cDNA P were >90% 
homologous to particular regions of the BPV4 genome. The 
sequence autoradiograph and homology comparison of cDNA I are
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shown in Figure 23. The sequence of cDNA P contained no 
significant homologies to BPV4 or plasmid DNA, so the strong 
hybridisation of the viral genomic probe to this insert could 
not be explained. The different classes of cDNA obtained will 
be discussed separately.
In the AOP A cDNA library, therefore, a total of 17 BPV4 cDNA 
clones were isolated from 107000 clones, representing only 
0.016%. Of these, 14 contained sequences exclusively from the 
3* terminal exon of the early region, representing the 3’ 
ends of the early mRNA’s, confirming Southern hybridisation 
data for cDNA’s G, J, L and M. cDNA N contained sequences 
from the leader exons of the 4.2, 2.8 and 3.0 kb transcripts, 
and cDNA Q represented an unspliced transcript, not 
previously mapped, from the E2/E4/E5 region. The 3’ ends of 
the late transcripts were not represented, and this reflected 
the low abundance of these species in the Northern 
hybridisation analysis of the poly(A)+RNA (Figure 43). These 
rarer transcripts may not have been represented in the cDNA 
library due to the low transformation efficiency of the 
bacterial cells used, and the decreased cloning efficiency 
resulting from blunt end ligation.
cDNA libraries of papillomavirus mRNA in general yield low 
numbers of cDNA’s. A figure of 0.02% was obtained for ID 13 
cells (Yang et al., 1985a), although for fibropapilloma RNA, 
the yield of BPV1 cDNA’s was 1.3%. These reflect the low 
level of viral transcription.
The BPV4 cDNA’s were in general short (100 - 200 bp) and most 
were 3* truncated, having no poly (A) tail. This may have been
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due to a combination of incomplete second strand synthesis 
and degradation by the exonucleolytic activities of T4-DNA 
polymerase. In addition, the colony-lift screening method, 
while indispensible for the screening of large numbers of 
recombinants, is subject to the limitation that not all 
positive clones may be detected.
While the figure of 0.016% is by no means an accurate one for 
the abundance of BPV4 transcripts in papilloma mRNA, it does 
reflect the low abundance of viral transcripts common to 
infections of cells with all papillomaviruses so far 
characterised.
3-3-3«(ii). Identification of the early polvadenvlation site 
of BPV4.
The majority of cDNA’s (18 out of 20) contained sequences 
from the 3’ terminal exon of the early region (Table 3-3). 
None of these contained splice junctions except cDNA 7E11; 
this will be discussed in detail under subsequent headings. 
Nearly all had 3’ ends (with respect to the original 
transcript) near the polyadenylation signal, ATTAAA, at 
nt4009. However, only three, cDNA’s 7E11, G and J, had 
poly (A) tails. The sequence of the 3' end of cDNA 7E11 is 
shown in Figure 24, demonstrating the polyadenylation signal 
and the poly(A) attachment site. Sequence homology with BPV4 
breaks down at nt4038 at the end of a run of four adenosine 
residues preceded by a G and followed by a cluster of G and T 
residues. This polyadenylation site configuration is compared
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to the known polyadenylation sites of other papillomaviruses 
in Figure 25.
Eukaryotic RNA polyadenylation is usually directed by the 
motif AAUAAA at a CA dinucleotide 10 to 25 nucleotides 
downstream followed by a G/U cluster (Fitzgerald and Shenk, 
1981).
This rule applies to the two early polyadenylation signals of 
CRPV (Giri et al., 1985; Danos et al., 1985), but in BPV1,
the early poly(A) attachment site is a G residue directly 
following a CA dinucleotide (Yang et al., 1985a), and in
HPV11, the early polyadenylation signal is AGUAAA and two 
polyadenylation sites are used, both being G residues within 
the G/U cluster, rather than tha CA dinucleotide upstream 
(Dartmann et al., 1986; Nasseri et al., 1987). The
polyadenylation signal for the early transcripts of BPV4 is
AUUAAA (Smith et al., 1986), known to substitute for the
canonical sequence (Birnsteil et al., 1985) and the poly(A)
addition site, as shown by cDNA's 7E11, G and J, is the G 
residue at nt4034, 25 nucleotides downstream of the first A
of the polyadenylation signal at nt4009.
This polyadenylation site is unusual in that the G residue at 
nt4034 is chosen rather than the CA dinucleotide 5* adjacent 
to it. cDNA’s H and I end at nt4029 and cDNA B at nt4028
(Table 3*3); this may indicate that a second site at nt 4028,
the CA dinucleotide, may be polyadenylated, but no poly(A) 
tails have been found attached at this site.
S1-nuclease protection mapping placed the 31 end of BPV4 
early region transcripts at nt4030, but the sequence of
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cDNA's produced in this project allows the precise assignment 
of the early polyadenylation site to nt4034. The spatial 
arrangement of this site 25 nucleotides downstream of the 
polyadenylation signal is consistent with canonical 
eukaryotic RNA polyadenylation signalling, as is the position 
of the G/T cluster on the genome.
With this study, the early polyadenylation site of four 
papillomaviruses have been identified. These appear to 
conform to the eukaryotic pattern of mRNA precursor 
polyadenylation and cleavage at sites directed by signals 
contained in the sequence. However, it is also apparent that 
utilisation of the late viral polyadenylation site occurs 
only in differentiated host epithelial cells. In BPV1, this 
appears to be linked to the activation of a specific 
promoter, (Baker and Howley, 1987). It is not known
whether this is due to transcriptional termination upstream 
of the late polyadenylation signal in the early transcripts, 
or to an attenuated mechanism determining the site of 
polyadenylation and cleavage of RNA continuously transcribed 
all the way round the circular genome.
Nevins and Darnell (1978) in their analysis of the nuclear 
processing of adenovirus type 2 transcripts, showed that 
transcription extended well beyond the polyadenylation sites 
and that concerted polyadenylation and cleavage at a single 
site determined the 3* end of each mature mRNA. It was also 
shown that polyadenylation preceded splicing. This has been 
taken to indicate that polyadenylation site selection may 
influence the subsequent splicing pattern of mRNA precursors.
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In the case of differential expression of irrmunoglobulin type 
M p-heavy chain genes in maturing lymphocytes, the same 
transcript is polyadenylated at different sites, leading to 
differential splicing which gives rise to two different 
mRNA’s expressing membrane-bound and secreted forms of the 
IgM heavy chain (Early et al., 1980; Kemp et al., 1983).
Tissue-specific expression of calcitonin and calcitonin 
gene-related peptide also occurs from the same 
transcriptional unit by differential polyadenylation and 
splicing (Amara et al.. 1984). In both of these instances,
differential expression is brought about by splicing to exons 
downstream of the first polyadenylation site, which is 
spliced out. This appears to be the case in the late region 
transcripts of BPV1 (Fig. 2; Baker and Hcwley, 1987), HPV1 
(Fig. 4; Chow et al., 1987b) and BPV4 (Fig. 9; Smith et al., 
1986), so it may be that polyadenylation occurring at the 
late polyadenylation site directs the splicing out of the 
early site, thus preventing cleavage at this site. Only about 
20 % of P^-directed transcripts extend beyond the early 
polyadenylation site; this may be related to a mechanism 
influencing choice of polyadenylation site on nascent 
transcripts. The leader sequence of the late transcripts may 
be involved in differential polyadenylation since transcripts 
from all other BPV1 promoters terminate at the early 
polyadenylation site.
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3*3-3-(iii)- Sequence analysis of cDNA 10-1.
Parts of the plasmid sequencing autoradiographs of cDNA 10-1 
are shown in Figure 26, and the sequence analysis in Figure 
27.
cDNA 10-1 is 288 bp in length and, according to plasmid 
sequencing, 100% homologous to BPV4 from nt1158 to ntl845, 
placing it at the 5* end of the E1 orf (Table 3.3). The 5» 
end of cDNA 10-1 is 7 nucleotides downstream of the acceptor 
site at nt1553 which is utilised in the 4.2 and 3.0 kb 
transcripts. It also coincides with the 5* end of the 1.9 kb 
transcript, indicated by minor 5’ termini a few nucleotides 
downstream of the 5’ terminus of the exon in the S1-nuclease 
protection assays of Smith et al. (1986). cDNA 10-1 may 
therefore represent the 5* end of a full length cDNA which is 
3’ truncated, since there is no polyadenylation consensus 
sequence in this region.
A possible TATA homology, (G)TATTAG (Breathnach and Chambon, 
1981) occurs in an A/T-rich region at nt 1529, 29 nucleotides 
upstream of the 5’ end of cDNA 10-1, although no other known 
promoter/enhancer sequences can be found in this region.
A splice donor site consensus sequence (Nevins, 1983) occurs 
at nt1779 which is not utilised in this cDNA, nor in any BPV4 
transcript mapped so far.
Putative translation products of cDNA 10-1 in all three 
reading frames of the coding strand are shown beneath the 
sequence in Figure 27. The cDNA encodes the first 90 amino 
acids of the E1 orf, from the first methionine. The presence
206
of an A residue three nucleotides upstream of this ATG codon 
makes this a strong translational initiator (Kozak, 1986). 
Assuming that the E1 orf is functionally divided in the same 
way as that of BPV1 (Bergetal., 1986), cDNA 10-1 may 
therefore encode part of the replication modulator.
The E1 orf is encoded in the 4.2, 3.0 and 1.9 kb transcripts
of BPV4; the splice junction of the 1.6 kb transcript removes 
the 3' end of E1. This suggests that the functional division 
of this orf is effected by the presence or absence of the 31
end, in the same way as the E1a gene of adenovirus (Lillie et
al., 1987). If the 3' truncated E1 orf gene product does
indeed modulate replication, then the paucity of the 1.6 kb 
transcript in papilloma RNA extracts may indicate that it is 
not produced in the more differentiated cell layers where 
viral DNA replication occurs in an apparently uncontrolled 
fashion. Testing of this function could be carried out using 
cDNA 10-1 in a suitable expression vector, but appropriate 
replication mutants of BPV4 would first have to be
constructed. The fact that pBV4 (Fig. 13) exists in stably
transformed NIH 3T3 cells at a copy number of only 3 to 30 
episomes per cell (Campo and Spandidos, 1983) suggests that 
the replication factor has been disabled by the effective 
deletion of the E1 orf downstream of the BamHI cloning site 
at nt2601, and that the 5’ end of E1 encodes a replication 
modulator controlling copy number in these cells. Present 
theories regarding papillomavirus replication relate only to 
cultured fibroblasts, however, and meaningful functional 
analyses await the development of an in vitro differentiating
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epithelial system supporting vegetative propagation of 
papillomaviruses.
3.3.3•(iv) Sequence analysis of cDNA N.
Parts of the plasmid sequencing autoradiographs of cDNA N are 
shown in Figure 28; analysis of the full sequence is 
presented in Figure 29.
cDNA N is 205 bp in length and has perfect homology with BPV4 
DNA from nt633 to nt837 (Table 3-3). It is a 3’ truncated 
cDNA, since no polyadenylation signals exist in this region 
of the genome. The 5’ end of cDNA N does not map close to any 
previously defined mRNA 5T termini, but a TATA consensus 
signal, (G)TAAATAG (Breathnach and Chambon, 1981), occurs 51 
nucleotides upstream at nt582, so it could be part of a near 
full-length cDNA.
The putative translation products of cDNA N are shown beneath 
the sequence in Figure 29. It encodes the first 41 codons of 
the E6 orf, from the first methionine codon at nt715. The 5’ 
flanking sequences of the A7G codon, from nt703 to nt715, 
constitute an almost perfect palindrome, capable of forming a 
hairpin-loop structure which could conceivably interfere with 
translation of the mRNA. Experiments on mutants of the 
preproinsulin gene showed that the translational efficiency 
of eukaryotic ribosomes was not affected by the presence of a 
stable hairpin structure constructed around the ATG codon 
(Kozak, 1986), and it appears that translational initiation 
is modulated only by nucleotides at certain key positions
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around the initiator codon (Kozak, 1986), with the sequence 
ACCATGG being the most efficient initiator. The A residue 
three nucleotides upstream of the E6 ATG codon makes this a 
strong initiator.
The E6 orf is contained in the leader exons of tha 4.2, 3.0
and 2.8 kb transcripts, and it was thought at first that the 
expression of the downstream orf’s would be strongly 
inhibited by this. However, it has been shown that the 
eukaryotic ribosome is capable of reinitiating translation in 
downstream orf's of polycistronic transcripts. The efficiency 
of each initiation event is affected only by the sequence 
context of the respective ATG codons (Kozak, 1986). The 
polycistronic transcriptional organisation is a feature of 
the papillomaviruses and may be a result of economical 
transcriptional control packaging in a discrete region of the 
viral genome.
The E6 region of BPV4 DNA has few restriction sites, making 
the cloning of the E6 orf difficult. cDNA N, although 
truncated at the 3' end, could be useful for the synthesis of 
E6 peptides for antiserum production.
3«3»3.(v). Sequence analysis of cDNA 7E11.
(a). Plasmid sequencing.
cDNA 7E11 was too long to be sequenced by the plasmid 
sequencing method. Nevertheless, initial plasmid sequencing 
analyses provided a good deal of information on the cDNA 
insert. Sequence autoradiographs showing part of the 5’ end
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of cDNA 7E11 are shown in Figure 30(2) and (3); clearer
sequencing of the 3’ end was obtained by Ml3 sequencing,
which is shown in Figure 24.
Sequencing of the 3’ end defined the early polyadenylation 
site of BPV4 (3-3-3-(ii))- Sequencing of the 51 end confirmed 
the Southern hybridisation data (Fig. 20): a stretch of DNA
with perfect homology to nt943 to nt 1016 at the 3’ end of 
the E6 region was joined to sequences from the E2/E4/E5 
region, starting at nt 3376. The true length of the insert 
was therefore 754 bp, including the 21-nucleotide poly(A)
tail (Table 3*3).
Since a transcriptional 5' terminus had been mapped around nt 
3375 (Smith et al., 1986), and since many of the cDNA’s
sequenced were truncated at both ends, it was considered 
possible that the insert of p7E11 was a cloning artifact
consisting of two cDNA’s ligated end to end. However, three 
lines of evidence argued in favour of this being a single 
cDNA:
1). a similar E6/E4 splice junction was seen in BPV1 cDNA’s 
produced from ID13 cell mRNA (Fig. 2;Yang et al., 1985a), and 
splice junctions from the E6/E7 region to the E2/E4 region 
had been mapped in CRPV transcripts (Nasseri and Wettstein, 
1984);
2). a splice donor site was known to exist at nt10l6, and an 
acceptor site at nt3376; the sequence of cDNA 7E11 across the 
junction conformed to that of a canonical splice junction 
(Fig. 31; Nevins, 1983);
3). electron microscopy (e.m.) of R-loops formed by
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poly(A)+RNA from bovine oesophageal papillomas annealed to 
pBV4 DNA (Fig. 13), presented several examples of mRNA 
species which hybridised to two widely separated regions of 
the BPV4 genome. The larger of the two loops mapped between 
nt3700 and nt4100, and the smaller loop around nt1000. 
Because of the position of the cloning site in the early
region of the viral DNA, the position of this exon was
actually downstream of the larger R-loop, and this 
complicated interpretation of the e.m. data (by kind
permission of L. Coggins, Beatson Institute).
Although evidence was circumstantial in the first two 
instances, it was strongly supported by the e.m. data and it 
was therefore considered that cDNA 7E11 represented a single 
transcript. This was confirmed beyond doubt by subsequent 
experiments and supported by studies of papillomavirus
transcriptional organisations published later.
The positions on the viral genome of the exons represented by 
cDNA 7E11 are shown in Figure 33*
No promoter/enhancer sequences exist in the vicinity of the 
51 end of cDNA 7E11 on the viral genome and it was therefore 
considered that the cDNA was not full-length. Preliminary 
analysis of the plasmid squencing data showed that putative 
translation products 3' to the splice junction included the
3* ends of the E2, E4 and E5a orf's. Sequences upstream of
the splice junction contained the 22 carboxy-terminal codons 
of the E6 orf, terminating just before the junction, and the
junction created two fusion orf’s. One of these contained no
ATG codons, but the other was a fusion of four codons
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including an ATG at nt1004 to the 3’ end of the E5b orf. The 
translation product of this orf would have been only 23 amino 
acids, according to the sequence of BPV4. The first ATG of 
the E2 reading frame of cDNA 7E11 would have been at nt3443, 
downstream of the sequenced region.
The coding potential of this cDNA therefore consisted of a 23 
amino acid protein encoded by a fusion orf, and the 3* half 
of the E2 orf. Since the cDNA apparently did not represent 
the full length of a transcript, it was thought that the E6 
orf might also be encoded by this mRNA as the nearest known
transcriptional start site was at nt654.
The cDNA was sequenced along its entire length by M13
sequencing to confirm that it consisted solely of the two
exons of BPV4.
(b). M13 sequencing.
cDNA 7E11 was isolated from pUC8 vector sequences using 
restriction endonucleases EcoRI and Sail. The insert was 
separated from the vector on a 1% LMP agarose gel, purified 
and cloned into bacteriophage M13mpl8 and mp19, which contain 
these cloning sites in opposite orientations relative to the 
universal primer sequence (Norrander et al., 1983). Due to
the length of the cDNA insert, it was subcloned in two 
fragments using the Hindlll site corresponding to nt3705 in 
the BPV4 genome; this enabled overlapping sequences of both 
strands to be obtained over the entire length of the cDNA 
(see Fig. 31(a) for sequencing strategy). Parts of the 
sequencing autoradiographs of cDNA 7E11 are shown in Figure 
30; analysis of the full sequence is shown in Figure 32.
The full sequence of cDNA 7E11 was compared to the genomic 
sequence of BPV4 (Patel et al., 1987)- The splice junction
was confirmed by the sequence of the antisense strand (Fig. 
31(b)), and the sequence of cDNA 7E11 was 100% homologous to 
that of BPV4 from nt3460 to the polyadenylation site at
nt4034; however, eight mismatches were found between nt3412 
and nt3460 (Fig. 31(b)). These were confirmed by repeated 
sequencing in both directions, showing that the mismatched 
sequence was not an artifact caused by secondary structure in 
the sequencing reaction products. They are indicated by boxes 
next to the sequence autoradiographs (Fig. 30) and by
asterisks in the computer analysis (Fig. 31(b)). They consist 
of :
1). a point deletion at nt3413;
2). inversion of the CA dinucleotide at nt3430;
3). inversion of the TA dinucleotide at nt3443;
4). inversion of the AC dinucleotide at nt3446 and
5). a point insertion after nt3459, of a G residue.
It was at first uncertain whether these mismatches
represented reading errors made by the reverse transcriptase 
or DNA pol-1 in the first or second strand synthesis of the 
cDNA, or whether they represented faithful transcripts of the 
viral DNA resident in the papilloma cells. The implications 
of such alterations to the published sequence and genome
organisation and to the coding potential of the transcript 
represented by cDNA 7E11 are far-reaching and will therefore 
be discussed under a subsequent heading (3.5).
3*3.3.(vi). Sequence analysis of cDNA 0.
(a). Plasmid sequencing.
cDNA Q was again too long to be sequenced along its entire 
length by plasmid sequencing, which located the 5’ and 31 
ends at nt3235 and nt3788, respectively (Figs. 33; 34; Table 
3.3). Although it was truncated at the 3f end, this 553 bp 
cDNA was of immediate interest as it contained contiguous 
sequences crossing the splice acceptor site at nt3376 and 
extending 150 nucleotides upstream. The 5’ end was also 
positioned 50 nucleotides downstream of a consensus TATA 
sequence, (G)TATTAT (Breathnach and Chambon, 1981), at 
nt3l85, and a CAAT sequence (McKnight and Tjian, 1986), was 
found at nt3156. However, the CAAT - TATA promoter system is 
not an absolute requirement for transcriptional initiation 
(Nevins, 1983), as evidenced by the late promoter of SV40 
(Brady et al., 1982) and by recent work on BPV1 transcription 
(Ahola et al., 1987; Baker and Howley, 1987), so the
possibility that the transcript represented by cDNA Q 
initiated much further upstream was not ruled out. The coding 
potential of the cDNA sequences (Fig. 36) was restricted to 
the E5a orf.
(b). M13 sequencing
cDNA Q was sequenced along its entire length in the M13mpl8 
and mp19 vectors. According to the genomic sequence, a Kp.nl 
site was conveniently positioned, at nt3411, for subcloning 
cDNA Q in two fragments. The cDNA was, however, resistant to 
digestion by this enzyme and was therefore cloned intact into
the M13 vectors using the EcoRI and Sail cloning sites.
Parts of a sequencing autoradiograph showing the sense
sequence is shown in Figure 35(1). It emerged from the 
sequence data thus obtained that cDNA Q contained the same 
mismatched sequences as cDNA 7E11 when compared with the 
genomic sequence.
(c) M13 sequencing using a synthetic oligonucleotide primer. 
Since the region of mismatched sequences was over 300 
nucleotides into the antisense sequence, difficulty was 
experienced in obtaining clear sequencing autoradiographs. It 
was therefore decided to use an oligonucleotide to prime the 
sequencing reaction from a point closer to the mismatched 
region. The primer sequence was chosen from nt3551 to nt3535 
of the non-coding strand of BPV4 DNA. This was designated
primer 140 (Table 3*6). The sequence was chosen as it had
minimal complementarity to all other parts of the genome and 
was rich in G+C residues (65%) which form stronger 
interstrand bonds than A and T, but did not contain 
palindromic sequences which would inhibit annealing to the 
template due to the formation of secondary structure. These 
factors ensured specific annealing of the primer to its 
complementary sequence in the single stranded template.
Primer 140 was used in place of the M13 universal primer in 
the sequencing reaction. The resulting antisense sequencing
autoradiograph is shown in Figure 35(2). The mismatched 
sequences were confirmed. The point deletion at nt3413 
destroys the Kpnl site GGTACC by removing the T residue, 
explaining the failure of this enzyme to cut cDNA Q. Primer
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140 was also used to confirm the sequence of the 
corresponding region in cDNA 7E11.
The isolation of two cDNA’s from separate libraries which 
presented the same variations on the published genomic 
sequence strongly suggested that the variations were at the 
genomic level. As was previously mentioned (3.3.3.(v).), 
these apparent changes caused major alterations to the 
genomic organisation of BPV4, so a further experiment was 
performed to confirm the altered sequence.
3.4. RNA sequence analysis using primer 140.
In order to demonstrate that the sequences of cDNA’s 7E11 and 
Q were faithful copies of BPV4 mRNA sequences, sequencing of 
poly(A)+RNA from AOP A papillomas was performed according to 
the protocol of Geliebter (1987). This method is identical in 
principle to Sanger ’’dideoxy” sequencing (Sanger et al. T 
1977): purified mRNA template is annealed to a radioactively
labelled DNA primer with exact specificity for the point from 
which sequence is required. First strand cDNA is then 
synthesised in the presence of each of the four 
dideoxynucleotide triphosphate (ddNTP) analogues in separate 
reactions; the reaction temperature of 50°C minimises RNA 
secondary structure. When run out on a sequencing gel, these 
give a radioactive sequencing ladder complementary to the 
original RNA template.
The sequence of primer 140 and its annealing temperature for 
RNA sequencing (Geliebter, 1987; section 2.2.11.(iii)) are
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shown in Table 3.6.
Synthetic oligonucleotides do not possess a 5' phosphate 
group, so primer 140 was 5’ 32P labelled to high specific
activity using polynucleotide kinase. It was then annealed to 
AOP A poly(A)+RNA, the sequencing reaction performed, and 
reaction products run out on a sequencing gel. It was found 
that the recommended ddNTP concentrations only gave readable 
sequence information up to about 100 nucleotides upstream of 
the primer. These concentrations were halved in subsequent 
experiments, and the autoradiograph of such a sequence is 
shown in Figure 37.
The sequence clearly shows the alterations to the BPV4 DNA 
sequence found in cDNA’s Q and 7E11. The implications of 
these alterations to the viral genome organisation and the 
expression of its encoded genes is discussed in the next 
subsection.
The RNA sequence was readable up to the splice acceptor site 
at nt3376, where bands in the C track become faint and 
finally disappear. This phenomenon was not overcome by 
reducing the ddCTP concentration in the C reaction and 
therefore represents the limit of the technique. The sequence 
was therefore impossible to read accurately beyond this 
point, but by interpolating C residues in the appropriate 
places, it was found that the sequence of the first 12 
nucleotides 5* to the splice acceptor site matched that in 
cDNA 7E11 more closely than the corresponding contiguous 
sequence in the genome. This sequence did not match the 
upstream sequence of any other splice donor site in the BPV4
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genome. This confirmed the splice junction of cDNA 7E11 and 
moreover suggested that it represents a transcript which is 
many times more abundant than any other transcript containing 
the early region 3? terminal exon.
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Table 3 ® 3 Sequence analysis of BPV4 cfliA’s.
c MA Length/bp
*
Position on genome ORE's
A 275 3709 - 3983 3 * end E2
B 201 3828 - 3983 it
C 26? 3729 - 3995 M
D 122 3851 - 3972 tt
IE 113 3761 - 3873 tt
T 76 3916 - 3991 tt
G 323 3745 - 4034 + (a) 33 tf
:h 109 3921 - 4029 If
i 103 3927 - 4029 It
j 285 3755 -  4034 + (A) It
:k 152 3843 - 3994 II
l 243 3781 - 4023 IT
M 487 3523 - 4009 3 1 end..E5at E4, 7E2
“N 205 633 -  837 5 * end E6
0 188 3830 - 4017 3 * end E2
P -375 - -
Q 554 3235 - 3788 E4, E5af E5bf
3 1 end E2
R 190 3805 - 3994 3* end E2
'TfEU 754 943 -.1016; 3* end E6t E2, E4,
3376 - 4034 + (a) 91 E5a; whol e E5b;
C - \ E5a fusion
t0“ 1 288 1558 - 1845 5* end E1
-«•
numbers indicate nucleotide positions on the BFV4 genome.
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Figure 23. Sequence of cINA I
cUTA I was sequenced "by plasmid sequencing from either 
end of the multiple cloning site of pUC13*
(a) Sequencing autoradiographs of pi. Parts of the 
sequence are shown next to the photograph. Vector 
sequences are boxed. Numbers refer to nucleotide 
positions in BPV4*
1). Plasmid sequencing using universal primer;
2). Plasmid sequencing using reverse sequencing 
primer.
The overlapping regions of sequence are shown near the 
top of the sequencing gel.
(b) Comparison of the cBNA sequence with BFV4 INA:
1). Antisense strand
2). Sense strand.
(Q)
3969
3979
4019
4029
(b)
1 2
A C G T  A C G T
: iE
*
fe~«r
3989
i  ■  = g g g g
■ ” fflrAAA—
23- =1"° r-
tG C tG
= g 3— — —
3979
3969
3959
3999
w ~  "
4009 —  2
— A—  •
c- ,
A — * 
C -  
G -  
T -  
C -  
G -  
- T  —
C 
C 
C 
G
C 
T
C
T— 3939
— G 3927
bpv4
4031 4021  4011 4001 3991 3981 3971 3961
TTTCGTC TTGCTQCACG AACCATTTTA ATAGCATTTG CTATAACCCG TCAAGAGCCC CTTTCACAGC ACTGACACCT
[CTCGCC CfTGCTQCACG AACCATtTTA ATAGCATTTG CTATAACCCG TCAAGAGCCC CTTTCACAGC AC----
* * * I____ ^
cINA insert
2) 39 2 9  3 939  3 9 4 9  3 9 5 9  3969  3 979  3989 3999
GAGCAAAGGA ACTGCTTTTT GGCTTCTGTT CGATTACCAA AAGGTGTCAG TGCTGTGAAA GGGGCTCTTG ACGGGTTATA
fclfigAGGATCCCClGGA ACTGCTTTTT GGCTTCTGTT CGATTACCAA AAGGTGTCAG TGCTGTGAAA GGGGCTCTTG 
t *** II___
cINA insert
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ACGT
■u „ , r/1 4 0 4  1 4 0 3 1  4 0 2 1  4 0 1 1  4 0 0 1
D PV 4 CTCAGACGCA CGVTT1CGTC TTGCTGCACG AACCATTTTA AT|AGCATTTG
7e11 T FTT FT TCGTC TTGCTGCACG AACCATTTTA ATAG
***
Figure 24- The early polyadenylation site of BFV4«
M13 sequencing of cENA 7^11, showing the poly(A) tail and polyadenylation 
site. The early polyadenylation signal, ATTAAA, is boxed. A comparison of 
the cUTA sequence with that of BFV4» antisense strand, is shown below the 
photograph.
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Figure 25. Early polyadenylation sites of papillomaviruses.
4348
CRFV AAUAAA----- 13----- CAAAAGGUGUCAUG
4468 *
AAUAAA----- 13----- CAAUUGCAGAU
T
4371
HFV11 AGUAAA---- 11---- CAGUGUGUG
t  t
4180
BFV1 AAUAAA------- 18------- CAGAGUAAAACGUG
f
7156
BFV1 (late) AAUAAA----- 13----- CAAUGUGCUGUG
t
4009 4034
BFV4 AUUAAAUGGUUGGUGCAGGAAGACGAAAACGUGCGUCUG
t
Numbers refer to nucleotide positions on the BFY4 genome. 
Poly(A) addition sites are indicated by vertical arrows.
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Figure 26* Sequencing of cjDEJA 10—1.
(a) p10—1 was sequenced in both directions using the plasmid 
sequencing method with:
^) universal primer;
2) reverse sequencing primer.
(b) Comparison of the sequence of cUJA 10—1 with the genomic 
sequence of BPV4.
Figure 27* Sequence and putative translation products of cH7A 10—1,
E H
1558 156B 1578 1588 1598 1608
TTAAAA£YrG|ACAAAACATTGCTGCAGAAACTGGGTGGGAACTGTATATAGA 
L_ K M T K H C C R N M V G T V Y R  
U K U Q N I A A E T G W E L Y I E  
K N D l< T L L Q K L G G N C I U
1618 1628 1638 1648 1658 1668
GCCAGAGAAGAATTGCTCGAGGCTTCAAAAACAATTTTGCAAAAATGCTGTGATTTT ATT 
A R E E L L E A S  K T I L Q K C C D F I  
P E K N C S R L Q K G F C K N A V I L F 
B Q R R I A R G F  K N N F A K I'l L. U F Y
1678 1688 1698 1708 1718 1728
CT ATTGTTAACGCACACTTGTAAATATGGTTTCCTGGCATTGTTTTTGCTGGAATTT AAG 
L L L T H T G K Y G F L A L F L L E F K 
Y C U R T L V N M 9 S W H C F C W N L R  
S I V N A H L U I W F P G  I V F A G I U
1738 1748 1758 1768 1778 1788
ACTGCTAAAAGTAGAGAGACTGTGCAGCGCTTGTTTGAGCATAT ATTGCAGGTGGAAAAA 
T A K S R E T V Q R I.. F E H I L Q V E K 
L L \< V E R L C S A C L. S I Y C R W l< K 
D C U l< LI R D C A A L V U A Y I. A G G K
1798 1808 1818 1828 1838
G A A G A T A T G C T G T T A G A A CCTCCTAAGT7 AAAAAG T TT ACCGGCGGCAACCTT T TGG 
E D M L L E P P l< L K S L P A A I F W 
K I C C IJ N L L S U l< V Y P R Q P F G 
R R Y A V R T S  U V K K F "I" R G N L L
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Figure 28* Sequencing of cQTA U.
(a) pN was sequenced in both directions using the plasmid 
sequencing method with:
1) universal primer;
2) reverse sequencing primer#
(b) Comparison of the sequences of the 5* and. 3f ends of 
cUTA with the genomic sequence of BFV4*
* = mismatched sequence
(a)
1A C G T 2 ACGT
(b)
bp  v 4
1)
8 3 1  0 2 1  8 1  1 8 0 1  7 91  7 8 1  7 7 1
TGCAAAAGGG TTAGGGGTG7 CCACCTCCTC AGTTTCAATC TCCTCTTCAC AATGCAAGTT AATTGGACTA
----- G TTAGGGGTGT CCACCTCCTC AGTTTXAATC TCCTCTTCAC AATGCAAGTT AATTGGACTA
cdnaN -#
bpvA ,
6 4 2  6 5 2  6 6 2  6 7 2  6 3 2  6 9 2^ GGC ATTTAAAAGC TGACCTTCCA GTCTTAATTG CAGTAGGCGC CTAAGAGGGT GGTGGTGGTA TAAGTTC
ATTTAAAAGC TGACCTTCCA GTCTTAATTG CAGTAGGCGC CTAAGAGGGT GGTGGTGGTA
cdnaN
:T7G
iTTG
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Figure 29 Sequence and putative translation products of cH?A IT.
639 649 659 669 679 689
ATTTAAAAGCTGACCTTCCAGTCTTAATTGCAGTAGGCGCCTAAGAGGGTGGTGGTGGTA 
S U P S S L N C S R R L R G W W W Y  
A D L P V L  I A V G A U E G G G G  
L T F G S U L Q U A P K R V V V V
E6 —^
699 709 719 729 739 749
t a a g t t c a a g t t t t t c a a g a a a ^ T gIa a g g g g c a g a a c g t g a c a t t a c a g g a c a t t g c a a t
k f k f f k k m k g q n v t l q d i a i
I S S S F S R K U R G R T U H Y R T L Q  
U V Q V F Q E N E G A E  R D  I T G H C N
759 769 779 789 799 809
AGAATT A GAGGAT ACAATT AGTCCAATT AACTT GCATTGTGAAGAGGAGATTGAAACTG 
E L E D T I S P I N L H C E E E I E T  
U N U R I Q L V Q L T C I V K R R L K L  
R I R G Y N U S N U L A L U R G D U N U
819 829
GGAGGTG GACACCCCT AACCCTTTT 
E V D T P N P F 
R R W T P L T L 
G G g H P U P F
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Figure 30* Sequencing of cDNA 7E11.
cDNA was cloned into M13 vectors and sequenced along its 
entire length. For sequencing strategy, see Figure 31* 
Selected autoradiographs are shown. Numbers refer to 
nucleotide positions in BFV4*
1) Sequencing of antisense strand of cUTA 7E11, cloned 
into M13 phage mpl8, using primer 140 (Table 3*6).
Sequence mismatches with the BFV4 genanic sequence 
are boxed. The splice junction is shown (nt 1016/3375)
2) Sequencing of the sense strand of c W A  7E11, cloned 
into M13mp19* Mismatched sequences are boxed.
3) Sequencing of the sense strand of cDNA 7E11 across 
the splice junction.
Figure 31* (overleaf).
(a) Sequencing strategy of cH7A 7B11 in M13 vectors.
The bold line represents plasmid UTA; boxes indicate 
the multiple cloning site and all numbers refer to the 
nucleotide sequence of BFV4. Diagonal lines show the 
position of the splice junction.
(b) Homology between cDNA 7E11 sequences and BFV4 
genomic sequence.
Mismatches are indicated by asterisks.
1008- 
337V1016- 
3388-
3407-
3421-
3440-
3464-
1
ACGT
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G G A t t  i •» r a ATTt^
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c a a  =
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Gr r =
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I *“ I -:■■<’ 
■ ■'
* /a
TGci
g g ^ c a-| ~
^ a "G1 
ga a - a
yf-
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GT -3387
G1 1016/3375
-1005
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ACGT
-3 4 6 5
Figure 31*
(a) Sequencing strategy of cHTA 7E11 in M13 vectors.
->h
EcoRl Sail
^ -------------- 1-------------pb—
943 Hind III 4034
3705
(b) Homology between cDNA 7E11 and BFV4 sequences,
1) Antisense orientation.
3461 3451 3441 3431 3421 3411
b p v 4  CTCTGGAAGA T GGGGGGACG GTCGTCATCG TCCTCGGGC r GGGTCCCCGG TTTGGGTACC CGCG
7 e 1 1  CTCTGGAAGA TCGGGGGGACG GTCTGCTACG TCCTCGGGCG TGGTCCCCGG TTTGGGT CC CGCG
* ** ** * * *
3381 3371 3361
AACACGAA GC-GAACTGGT AACAGAGGGA
1021 1011 1001  
AAGCACGGTA GTACCTTTAG GGTCCATTTC
CTTTAG GGTAACACGAA GCGAA
2) Sense orientation: exon 2.
3 4 0 9  3 4 1 9  3 4 2 9  3 439  3449 3459  3 4 6 -
b p v 4  AGGACAACGC GGGTACCCAA ACCGGGGACC CAGCCCGAGG ACGATGACGA CCGTCCCCCC ATCVTCCAGA
7e11  CGC GGG ACCCAA ACCGGGGACC ACGCCCGAGG ACGTAGCAGA CCGTCCCCCCG ATCTT--------------
* * * ' * * * *  *
3) Sense orientation: splice .junction.
, 101.2 1022 1032
DPV4 AATGGACCC7 AAAGGTACTA CCGTGC7 TGA  - j h
7® 11 a a t g g a c c c t  aaag
3369  3379 3389
CTCCCTCTGT TACCAGTTCG CTTCGTGTTG
TTCG CTTCGTGTTG
EXON
A | A
AGGT AGT 
C G
DONOR SPLICE SITE
INTRON- EXON
C | G 
pYpyPyPyPyPyX A GG  
T T
ACCEPTOR SPLICE SITE
Consensus splice site sequences (Breathnach and Chambon, 1981). 
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Figure 32. The nucleotide sequence of cDNA 7E11.
9 5 2  9 6 2  9 7 2  9 8 2  9 9 2  1 0 0 2
CTTTCTATCT GTGTGCAGCT TGCTTCCAAA CAAGTGTTCT GTAACCGCAG ACCCGAGCGA
AATGGACCCT AAAG^
3415 . 3425 3435
ACGCGGggCC CAAACCGGGG ACCfi(3GCCCG
3475 3485 3495
CAGAGACGCC CGGGGCCGGC AGCAGAGGGC
*7* cr -r* i“* cr n rr rr cr cr crO J O J  O  J * t  J  o  u  *_> u
ACGATCACGA TCGCCTACGA AGGG6CCGCA
3595 3605 3615
TCCCGGGAGA CCCCCGGGAG GAAGACGAAG
3655 3665 3675
AACACCGACT CCGCCAACTC CTGACCAAGT
3715 3725 3735
AGCTTCGTCT AGACTTGCTC AGCTTATAGA
3775 3785 3795
ACAAGGTGCT GCAAACACTT TAAAATGCTT
3835 3845 3855
CAAATTTCTG TGCATGAGCA CAAGCTGGAC
3895 3905 3915
GGGACATAGA ATGCTGATTG CATTTTCGAA
3955 3965 3975
TGTTCGATTA CCAAAAGGTG TCAGTGCTGT
4015 4025 4035
GCTATTAAAA TGGTTCGTGC AGCAAGACGA
TTCGCTTCGT GTTGGGAGAT CCGGAGGACA
3445 3455 3465
AGGACGjTAGC flGACCGTCCC CCCgATCTTC
3505 3515 3525
GCAGTCGTCT TCGCGATCGC GATCACGGTC
3565 3575 3585
CTCCAGTGGA CGAGACACGC GGCTACCGAG
3625 3635 3645
GGGCACCCCC GAACGGGAAC GATGCCCTGG
3685 3695 3705
GGGAGGACGA TCTTCAACGC CTAAGAGACA
3745 3755 3765
CGCGGCATAC GACCCTCCAG TACTCCTGCT
3805 3815 3825
TAGGCGCAGG GCAACGCAGG CTCATCCTCA
3865 3875 3885
ATGGGTTAGC AAAACTTCCC CTTTGAAATC
3925 3935 3945
CTCTGAGCAA AGGAACTGCT TTTTGGCTTC
3985 3995 4005
GAAAGGGGCT CTTGACGGGT TATAGCAAAT
AAAAAAAAAA AAAAAAAAAA
Numbers r e f e r  to  n u c le o tid e  p o s it io n s  on th e  BPV4 genome. D iagonal l in e s  
in d ica te  th e  s p lic e  ju n c t io n . Boxed sequences a re  mismatches w ith  the  
published BPV4 sequence (P a te l e t  a l . f 1987)*
Underlined sequences:
ATG — m eth io n in e  codon;
ATTAAA -  p o ly a d e n y la tio n  s ig n a l.
Figure 33. oi^rvl—  of cIgTA>s relative to the genomic and transcriptional
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TTCGCTTCGT tattaaaatggttcgtgcagcaagacc(a). ct)MA
•CTTACCAG TTCGCTTCGT • BFV< a«qu<nc«
A A flT T C A Aa TTTTTCAAGA AA^ T Q VAGGG GCAGAACGTG cD K A  • « q u « 1 C «
! I ; i i
cIKA 10-1
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Figure 34* Plasmid sequencing of cUTA Q.
(a) Plasmid sequencing of pQ, using:
1) universal primer;
2) reverse sequencing primer;
•the sequence of cINA Q at the cloning site is shown 
next to the photograph.
(b) Comparison of the 3* and 5* ends of cUTA Q, to the 
genomic sequence of BFV4*
(a) 1 a c g t 2a c g t
(b)
1) bPv4 3781 3771 3761 3751 374 1 3731 3721 3711
ttttaaagtg t t t g c a g c a c c t t g t a g c a g g a g t a c t g g a g g g t c g t a t g ccgcgtctat aagctgagca a g t c t a g a c g----
TTAAAGTG TTTGCAGCAC CTTGTAGCAG GAGTACTGGA GGGTCGTATG CCGCGTCTAT AAGCTGAGCA AGTCTAGACG----
3701 3691 368 1
— aagcttgtct CTTAGGCGTT GAAGATCGTC
-- AAGCTTGTCT CTTAGGCGTT GAAGA----
2)
b(JV/’ 3239 3249 3259 3269 3279 3289 3299 3309 3319
TTGGATTATG at g gaatatt t t a t a t t g a t a a t c a g g g g a ACAAGATATA TTATGTGAAC TTTCAGGACG ATGCAGCATT GTATTCTAAT
TTATG ATGGAATATT TTATATTGAT AATCAGGGGA ACAAGATATA TTATGTGAAC TTTCAGGACG ATGCAGCATT GTATT----
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Figure 35* M13 sequencing of cltfA Q.
(a) Sequencing gel autoradiographs containing the region of 
mismatched sequences are shown:
1) Sequencing of the sense strand of cUNA Q in M13mp19«
2) Sequencing of the antisense strand of cINA Q in 
M13mpl8, using primer 140 (Tahle 3*6).
Sequence mismatches with the genomic sequence are boxed,
(b) Comparison of the sequences of cUtfA Q with the BFV4 
genomic sequence. Sequence mismatches are denoted 
by asterisks.
to
D
ACGT
a <n i  L tGg t aaC'3368
.. - L aG C G A ^
-3388
z-GC -3407
-3421
■3440
#
3464«»
3369 3379 3309 3399
DPV4 TCCCTCTGT TACCAGTTCG CTTCGTGTTG GGAGATCCGG
Q TCCCTCTGT TACCAGTTCG CTTCG------------------
3409 34 19 3429 34 39 34 49 3459
AGGACAACGC GGGTACCCAA ACCGGGGACC CAGCCCGAGG ACGATGACGA CCGTCCCCCC
   --CGC GGG ACCCAA ACCGGGGACC ACGCCCGAGG ACGTAGCAGA C C - --
* * * * * * *
2)
3461 3451 3441 3431 3421 3411
Dpv4 CTCTGGAAGA T GGGGGGACG GTCGTCATCG TCCTCGGGCT GGGTCCCCGG TTTGGGTACC CGCG
Q    AAGA TCGGGGGGACG GTCTGCTACG TCCTCGGGCG TGGTCCCCGG TTTGGGT CC CGCG
* ** t* * * *
3 3 0 1  3 3 7  1 3 3 6 1
  CCAACACGAA GCGAACTGGT AACAGAGGGA
------  AACACGAA GCGAACTGGT AAC -----
ACGT
22
02
Figure 36. The nucleotide sequence of cDKA. Q.
3244 3254 3264 3274 3284 3294
TTATGATGGA ATATTTTATA TTGATAATCA GGGGAACAAG ATATATTATG TGAACTTTCA
3304 3314 3324 3334 3344 3354
GGACGATGCA GCATTGTATT CTAATTCTGG CATGGGGCAA GTGCATTTTG AAAGCAAAGT
3364 3374 3384 3394 3404 3414
TCTTTCTCCC TCTGTTACCA GTTCGCTTCG TGTTGGGAGA TCCGGAGGAC AACGCGGgAjc
3424 3434 3444 3454 3464 3474
CCAAACCGGG g ac cTOg c c c. GAGGACGlTAG CffcACCGTCC CCCC0ATCTT CCAGAGACGC
3484 3494 3504 3514 3524 3534
CCGGGGCCGG CAGCAGAGGG CGCAGTCGTC TTCGCGATCG CGATCACGGT CACGATCACG
3544 3554 3564 3574 3584 3594
ATC6CCTACG AAGGGGCCGC ACTCCAGTGG ACGAGACACG CGGCT ACCGA GTCCCGGGAG
3604 36 1 4 3624 3634 3644 3654
ACCCCCGGGA GGAAGACGAA GGGGCACCCC CGAACGGGAA CGATGCCCTG GAACACCGAC
3664 3674 3684 3694 3704 3714
TCCGCCAACT CCTGACCAAG TGGGAGGACG ATCTTCAACG CCT AAGAGAC AAGCTTCGTC
3724 3734 3744 3754 3764 3774
TAGACTTGCT CAGCTTATAG ACGCGGCATA CGACCCTCCA GT ACTCCTGC TACAAGGTGC
3784 
TGCAAACACT TTAA
Numbers refer to nucleotide positions on the BFV4- genome. 
Boxed sequences are mismatched with the genomic sequence.
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Figure 37. KNA sequencing using primer 140*
(a) Sequencing autoradiograph of BFV4 transcripts in 
the region of mismatched sequence. These are shown 
boxed alongside the photograph.
(b) The ENA sequence is compared to the genomic 
sequence. Mismatched sequences are indicated by 
asterisks. The sequence of cENA 7^ 11 across the 
splice junction is also compared.
(a> ACGT
-3375
-3388
-3407
-3421
-3440
-3462
(b)
bpv4
346! 3451 34 4 1 3431 3421 3411 3401 3391
CTCTGGAAGA T GGGGGGACG GTCGTCATCG TCCTCGGGCT GGGTCCCCGG TTTGGGTACC CGCGTTGTC.C TCL'GGATCTC
GA TCGGGGGGACG GTCTGCTACG TCCTCGGGCG TGGTCCCCG G TTTGGGT CC CGCGTTGTCC TCCGGATCTC 
* * * # +  * * *
3381 3371 3361
CCAACACGAA GCGAACTGGT AACAGAGGGA
CCAACACGAA GCGAACTTTA (d)GGT AT----
** ********
7e11 CTTTA GGGTCCATT'i
234
3*5. Proposed amendment to the nucleotide sequence and 
genome organisation of BPV4.
The evidence in favour of alterations in the sequence and 
changes in the nomenclature of the E4 and E5 orf’s of BPV4 
will be presented and discussed in this subsection.
3.5.1. Comparison of the putative translation products of the 
genomic and cDNA/RNA sequences of BPV4.
The sequencing experiments analysed in the previous two 
subsections revealed a consistent variation on the sequence 
of BPV4 DNA between nt3412 and nt3460 in two cDNA clones from 
independent cDNA libraries, and in polyadenylated RNA 
transcribed from this region jln vivo.
The described sequence variations are shown in the coding 
strand in Figure 38(b) beneath the previously defined BPV4 
sequence in this region (Patel et al., 1987). Putative
translation products and orf's of all three reading frames 
are shown with each sequence.
Reading from 5’ to 3* (left to right), the first mismatch 
between the sequences is a point deletion corresponding to 
nt3413. The absence of a T residue causes a frameshift such 
that reading frame 1 (rf1) reads into rf2, rf2 into rf3 and 
rf3 into rf1. The joining of rf1 with rf2 results in the loss 
of a valine codon in rf1 and a tyrosine codon in rf2, and 
their replacement by an aspartate codon. The result of the 
frameshift is that the E4 orf reads into the E2 orf at this
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point, E2 reads into E5a and E5a into E4.
Inversion of the CA dinucleotide at nt3430 causes codon 
changes in all three rf’s. A glutamine codon in rf1 of the 
genomic sequence is changed to a threonine in rf3 of the 
cDNA/RNA sequence; similarly a serine of rf2 is changed to 
arginine in rf1 and a proline in rf3 to histidine in rf2.
The most extensive mismatch occurs from nt3443 to nt3447: the 
sequence ATGAC in the genomic sequence is changed to TAGCA in 
the cDNA/RNA sequence. The effect of these changes on the 
coding capacity of this region is considerable, since a 
methionine codon of the E2 orf in rf2 of the genomic sequence 
is changed to a translation termination codon, TAG, in rf1 of 
the cDNA/RNA sequence, and a termination codon, TGA, in rf3 
at the end of the E5a orf is changed to a serine codon in 
rf2. In addition, a threonine codon in rf2 in the genomic 
sequence is changed to glutamine in rf 1, next to the 
termination codon, and two aspartate codons in rf1 are 
changed to valine and alanine in rf3.
Finally, the point insertion after nt3459 causes another 
frameshift in reverse orientation to the first, restoring the 
rf’s of the cDNA/RNA sequence to their original context. The 
insertion of a G residue alters a histidine codon in rf3 to 
arginine in rf2, before the frameshift, and creates an extra 
aspartate codon in rf3*
The overall effects of these changes on the genome 
organisation are as follows: the three orf's encoded in this
region change frame over a stretch of 16 codons. The E4 orf 
is divided by a stop codon at nt3443 into two short orf’s of
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32 and 74 codons, respectively, of which the smaller, 5' orf 
has no AID codon and the larger only has one at codon 65. The 
E5 orf is no longer split by the stop codon at nt3444 and is 
now 148 codons in length, having an ATG at codon 5. The E2 
orf remains continuous with alterations in the 16 codon 
frameshift region.
The altered coding potential of the cDNA/RNA sequence 
therefore represents a considerable divergence from the 
genome organisation of Patel et al. (1987). Agreement between 
sequences of two cDNA clones produced from RNA from 
papillomas of two different cases of bovine oesophageal 
papillomatosis suggested that these represented at least a 
common variant of BPV4. However, these changes affect the E4 
orf, the translation products of which are thought to have a 
central role in virion production in benign tumours (Doorbar 
et al., 1986; Breitburd et al., 19 87)- Since this orf in the
cDNA/RNA sequence was split and could not be expressed by any 
known transcript of BPV4, it was considered that a 
reappraisal of the nomenclature of the E4 and E5 orf’s might 
be required. Further evidence for this was provided by an 
analysis of the coding capacity of cDNA 7E11 and comparisons 
between this cDNA and those obtained from the transcripts of 
other papillomaviruses. It was therefore decided to suspend 
the original judgement on the nomenclature of these orf’s and 
to temporarily designate the new continuous E5 orf, X, and 
the split E4 orf, Y (Figure 38)*
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3-5.2. The coding capacity of cDNA 7E1 1.
Neither of the short Y orf’s encoded by the cDNA/RNA sequence 
contains an ATG codon in a suitable position for the 
translation of more than 10 amino acids, while the X orf 
could potentially be translated into a 143 amino acid 
protein. In HPV1a-induced papillomas the E4 translation 
product is the most abundant viral protein (Doorbar et al.,
1986). It may therefore be encoded by the major transcript of 
HPV1 (Fig. 4; Chow et al., 1987b) in which a short leader 
exon mapping to the 3’ end of the EJ orf is spliced onto the 
3* terminal exon of the early region. Similarly spliced major 
transcripts have been mapped in HPV11- and HPV6-induced 
condylomata (Chow et al., 1987). cDNA’s of the major 
transcript of HPV11 show that the E4 orf is expressed as a 
fusion with a four codon orf from the 5* end of the E1 region 
(Fig. 39(b); Nasseri et al., 1987). In BPV1-induced
fibropapillomas, the major viral transcript in the epithelial 
part of the tumour encodes an E4 fusion orf in which the 
first two amino acids are encoded by sequences from the ncr 
(Fig. 2; Baker and Howley, 1987).
The coding capacity of cDNA 7E11 is shown in Figure 39(a). 
The X orf is fused to a short orf in the 5’ exon, which has 
an ATG codon at nt1004; thus it encodes a 123 codon fusion 
orf consisting of the 3* 119 codons of the X orf attached to
4 codons from the end of the E6 region, from the first ATG. 
The 3’ half of the E2 orf cannot be expressed, as was thought 
earlier (3-3.3.(v)), as there is no methionine codon at
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position 3443 in the cDNA, although a 53 codon polypeptide 
corresponding to the 3' end of the E2 orf could be translated 
from a very weak initiator codon at nt3839, downstream of the 
X orf. No other ATG-containing orf’s are encoded by cDNA 
7E11, but the possibility of the E6 orf being encoded in the 
transcript represented by cDNA 7E11 had not at this stage 
been excluded.
The splicing and putative translational organisations of cDNA 
7E11 therefore have very convincing similarities to those of 
the major transcripts of BPV1, HPV11 and probably HPV's 6 and 
11, suggesting that the encoded fusion orf is the BPV4 
homologue of those found in the other viruses. This appears 
likely in view of the highly conserved genomic and 
transcriptional organisations of the papillomaviruses.
On the basis of this evidence, it was considered that the X 
orf specified by the cDNA/RNA sequence was similar to the E4 
orf of other papillomaviruses. The assignment of orf numbers 
in this part of the genome is difficult due to low homology 
at both the nucleic acid and protein level between the E4 and 
E5 orf’s of papillomaviruses (Danos et al., 1984). The E5a
and E5b orf’s of BPV4 were named by their similarity to the 
split E5 orf’s of HPV’s 6 and 11, and the E4 orf due to its 
length of approximately 100 codons and lack of an ATG codon, 
as in HPV’s 16 and 33. In view of the changes specified by 
the cDNA/RNA sequence, it seems likely that these orf's were 
inappropriately assigned.
This conjecture was examined by analysing the degree of 
homology between the putative translation products of the X
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and Y orf’s and the E4 and E5 orf’s of other 
papillomaviruses.
3.5.3. .Reassignment of the EM and E5 orf’s of BPV4 hy
homology and alignment with those of other 
papillomav iruses.
3.5.3. (i) Homology of X and Y with E4 and E5 orf’s of other
papillomav iruses.
Putative translation products of the X and the larger Y orf’s 
defined by the cDNA/RNA sequence were compared to the E4 and 
E5 orf’s of other papillomaviruses by amino acid sequence 
homology and alignment, using the function ’’Protein alignment 
by similarity” in the Microgenie computer analysis program 
(Queen and Korn, 1984). This function calculates the
alignment of two amino acid sequences giving the maximum 
number of of identical or similar matched residues, e.g
arginine to arginine, histidine or lysine. Homology is given 
as a percentage of the length of the longer sequence in the 
analysis. The results of the homology comparisons are 
presented in Table 3.5.
As has already been mentioned, the E2/E4 region of 
papillomaviruses is poorly conserved between different types 
(Danos et al., 1984). This was reflected in the low
percentage homology values obtained for both the X and Y 
orf’s.
For orf X, the highest homology was found with the E4 orf of
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HPV8. This was surprising in view of the exceptional nature 
of the HPV8 E4 orf which at 229 codons is more than twice the 
average length of 90 codons. The E4 orf of HPV8 encodes
protein sequences homologous to the Epstein-Barr virus
nuclear antigen 2, primarily as a result of the high (22%)
proline content (Fuchs et al., 1986). The alignment of the
two orf's is, however, poor throughout their entire length 
(not shown) and the higher homology may be due to the larger 
size of the HPV8 sequence increasing the possibility of 
similar amino acids being encoded. The degree of homology
between the E4 orf of HPV8 and those of other 
papillomaviruses is extremely low (Fuchs et al., 1986).
Of greater interest are the homology data resulting from 
comparisons between the BPV4 X orf and the E4 orf’s of HPV16 
(Seedorf et al., 1985), HPV18 (0. Danos, pers. comm.) and
HPV33 (Cole and Streeck, 1986), and between the X fusion orf 
of cDNA 7E11 and the E1-E4 fusion orf of the major transcript 
of HPV11 (Nasseri et al., 1987). These homologies were 22.1%, 
22.1%, 20.3% and 20.1%, respectively, considerably higher
than the homologies with the E5 orf’s of the same viruses, 
which range from 10.1% to 13-5%. It is significant that, like 
BPV4, all of these viruses infect mucosal epithelium (Campo 
and Jarrett, 1987) and, in common with HPV8, are associated 
with cancer (Gissmann et al., 1984).
Homology between the X fusion orf of cDNA 7E11 and a putative 
E1-E4 fusion orf of HPV6b (Nasseri et al., 1987, based on
Schwarz et al., 1983) was slightly lower at 17-9%; homology
between the BPV4 X orf and the E4 orf's of BPV1 (Chen et al.,
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1982) , CRPV (Giri et al., 1985) and HPV1a (Danos et al.,
1982) was lower at between 17.6% and 16.1%; nevertheless, 
homologies with the E5 orf's of these skin-specific 
papillomaviruses was again lower than with their E4 orf's at 
10.1 % to 14.2 %.
Comparisons of the larger of the two Y orf's of the cDNA/RNA
sequence with the E4 and E5 orf’s of the other
papillomaviruses in general gave very low percentage homology 
values. The highest values were obtained with the E4 orf's of 
BPV1, CRPV and HPV1 at 17.5%, 14.6% and 17.4%. However,
comparisons of the values obtained with the E4 and E5 orf's 
of each papillomavirus did not yield a consistent pattern: 
for instance, homology between the BPV4 Y orf and the HPV16 
E4 and E5 orf's was 7.3% and 11.3%, respectively, while for 
the HPV33 these figures were 12.9% and 8.5%, respectively. 
For CRPV, the two figures were identical at 14.6%.
Therefore the X orf specified by the cDNA/RNA sequence of
BPV4 is , with the exception of HPV1, more homologous to the
E4 orf's of other papillomaviruses than to their E5 orf's.
The larger Y orf of BPV4 in general shares slightly higher 
homology with the E5 orf's of other papillomaviruses than 
with their E4 orf's, but homology values are low and no clear 
pattern emerges. This and the lack of suitable translational 
initiation codons may indicate that the split Y orf is not 
expressed.
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3.5.3.(ii). Comparison of the X orf of BPV4 with the E4 
orf's of HPV's bv alignment.
The protein alignments calculated for the X orf of BPV4 and 
the E4 orf’s of HPV's 16, 18, 33 and 1a, and the E1-E4 fusion 
orf's of HPV's 6b and 11 were used to construct the alignment 
plot in Figure 40. Alignments of similar or identical amino 
acids across four or more of the seven sequences are boxed. 
Although few continuous regions of homology are found, the 
sequence divergence of this region of the genome may have led 
to the conservation of only a few positions essential to 
structure and/or function of the encoded polypeptide. The 
most conserved region of the X orf is in the carboxy-terminal 
end, consisting of alternating hydrophobic and hydrophilic 
residues, but small blocks of conserved sequences occur 
throughout most of the orf.
The most highly conserved amino acids are arginine, proline 
and leucine. Presumably the leucine residues of X would form 
part of the hydrophobic interior of this cytoplasmic and 
nuclear protein (Doorbar et al., 1986; Breitburd et al.,
1987). The proline residues are probably structural. The 
charged arginine groups may have functional significance. Out 
of 148 amino acids, 24 are either arginine or lysine, but the 
26 glutamate and aspartate residues indicate that the protein 
may have an overall negative charge. This balance is the same 
for the X fusion orf of cDNA 7E11. In addition, the X protein 
could be phosphorylated at the three serine residues found in 
the more conserved middle to carboxy-terminal region, and at
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a conserved tyrosine residue. Although the alignment of the 
E4 orf’s is somewhat disjointed, the conservation of specific 
regions, particularly of potential structurally and 
functionally important amino acids, suggests that the X orf 
of BPV 4 may encode a similar protein to the E4 orf of other 
pa pil 1 oma v i ru ses.
3.5.3.(iii). The BPV4 X orf corresponds to the E4 orf of 
other papillomaviruses: discussion.
The E4 protein encoded by HPV1a has been characterised and 
its expression in papilloma cells analysed (Doorbar et al., 
1986; Breitburd et al., 1987). A number of proteins were
found which were antigenic to antisera raised against E4 
epitopes. These proteins were all acidic, and up to seven 
phosphorylated isoelectric variants were found for one of the 
larger monomeric proteins, correlating with the seven 
potential phosphorylation sites encoded by the full E4 orf. 
The several forms of the HPV1 E4 protein are considered to be 
derived from two monomeric polypeptides of 10 or 11 kD and 16 
or 17 kD. The larger is regarded as the translation product 
of the full E4 orf on the basis of amino acid quantitation 
(Doorbar et al., 1986), and is expressed in the basal layers
of papillomas (Breitburd et al.. 1987) i.e. at an early stage 
in the viral infective cycle. The 11 kD protein, arising 
later in differentiation of papilloma cells, is thought 
either to be a cleavage product of the 17 kD protein, or the 
product of a spliced transcript. The latter interpretation is
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strongly supported by amino acid analysis of the smaller 
protein which diverges slightly from that of potentially 
corresponding fragments of the larger E4 protein, by the 
failure of some antisera to recognise both proteins (Doorbar 
et al., 1986) and by the transcriptional map of HPV1 (Chow et 
al., 1987b), which shows that the major transcript may be
spliced to express the smaller E4 protein. The cDNA 
representing the major transcript of BPV1 also encodes just 
such a fusion orf, and it is interesting to note that this 
transcript initiates in the late promoter region of BPV1, 
indicating that it is expressed only in the more 
differentiated layers of the epithelium. The similarity 
between cDNA 7E11 and the major, E4-encoding transcripts 
suggests that it may encode the BPV4 homologue of the smaller 
E4 protein.
The X orf specified by the cDNA/RNA sequence of BPV4 shows 
greatest homology to the E4 orf's of papillomaviruses 
infecting mucosal epithelium, suggesting that the function of 
the encoded protein relates to tissue specificity. This has 
already been suggested as a reason for the poor conservation 
of this region of the genome. The function of the E4 proteins 
is as yet unknown, but it is exclusively associated with the 
virion-productive cells of HPV1-induced papillomas (Breitburd 
et al., 1987) and accounts for 20% of wart protein content.
Productively infected wart cells do not produce keratins 
normally associated with terminally differentiating 
epithelial cells, and it has therefore been suggested that 
the E4 protein is involved in the subversion of cellular
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differentiation mechanisms to favour virion replication and 
maturation. The differentiation pathway of mucosal epithelial 
cells differs from that of skin epithelium and a different 
set of keratins are expressed; if the hypothesised function 
of the E4 orf is in fact the case, the E4 orf’s of
mucosa-specific papillomaviruses would be expected to show
specialised adaptations to their host tissue type. Therefore 
the closer homology of the X orf of BPV4 to the E4 orf’s of 
these viruses may reflect conservation of these specialised 
sequences. The E4 orf’s of HPV’s 16, 18 and 33 are all
around 40% homologous to one another, so the decreased
homology of the BPV4 orf relative to this may be due to the
differences in the mucosal cells between host species.
The X orf of BPV4 shows less homology to the E5 orf’s of 
other papillomaviruses. Of these, only the E5 orf of BPV1 has 
been characterised (Schiller et al., 1985; Schlegel and 
Wade-Glass, 1987). The amino acid sequence of this 
transforming orf is widely divergent from those of other 
papillomaviruses. It expresses a 7 kD, 44 amino acid protein 
from an ATG codon well within the orf: this protein is highly 
hydrophobic, consisting of 33% leucine, and is localised in 
cell membranes. It also contains a Cys-X-Cys motif, conserved 
only in other fibropapillomavirus E5 orf’s.
None of these features is shared by the X orf of BPV4, and 
the 14% homology with the E5 orf of BPV1 is confined mainly 
to the untranslated 5' codons of the latter. Homology to the 
E5 orf’s of other papillomaviruses is also consistently lew 
(Table 3-5).
246
3.5.3. (iv) Amendment to the sequence and genome organisation 
of BPV4.
On the basis of the above data and arguments stemming 
therefrom, I propose to amend the sequence of BPV4 DNA in the 
E2/E4/E5 coding region to that represented by the sequences 
of cDNA’s 7E11 and Q and of BPV4 transcripts from this 
region. In addition, the temporarily assigned X orf should be 
redesignated E4. The absence of translational initiator 
codons in the split Y orf, and of potential splice acceptor 
sequences within the orf which could lead to its expression 
as a fusion orf encoded by a spliced transcript, suggest that 
these short orf’s are not expressed. However, until further 
analysis can be carried out, these orf’s are renamed E5a and 
E5b.
The proposed changes to the new E4 and E5 orf’s are detailed 
in Figure 38; the amended genome organisation is presented 
beneath the published map in Figure 41.
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Figure 38. .Comparison of the BPV4 cH7A/HNA sequence and its putative
translation products with those of the published sequence.
(a) Published sequence,
L E4
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E5a E5b
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Arginine Arg R
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Aspartic acid Asp D
Cysteine Cys C
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Glycine Gly G
Histidine His H
Isoleucine lie I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
Termination End U
LEGEND.
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Figure 39* (a) The coding capacity of cUfA 7E11.
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Figure 39* O3) Analysis of a cINA clone of the major transcript of HFV11
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Table 3*5 Homology between putative translation prpducts of orf Vs
X and Y of BPV4 and the E4 and B5 orf«s of other papillomaviruses*
PV Type & orf BPV4 X BFV4 Y
Number of 
amino acids 148 74
1st Met 5 65
HPV8 E4 229 none 25.9 1o 12.7 %
HPV16 E4 96 none 22.1 % 7-3 $
HPV16 E5 79 none 13.5 io 11.3 %
HPV18 E4 91 4 22.1 fo 9.9 %
HPV18 E5 78 15 11 .4 $ 13.6 %
HPV33 E4 83 none 20.3 1o 12.9 %
HPV33 E5 80 6 10.7 % 8.5 %
HPV 11 E1^E41 90 1 20.2 $  2 13.9 $
HPV11 E5a 94 4 10.1 % 13.7 1o
HFV11 E5b 127 55 10.7 % 13.4 %
HPV 6 E1^E41 91 1 17.9 /o2 14.8 i?
HPV6 E5a 103 13 10.1 f 10.7 1=
HPV6 E5b 132 60 12.4 % 14.4 1o
BFV1 E4 126 7 17.4 1o 17.5 1o
BPV1 E5 99 56 14.1 1o 8 .9 %
CPJPV E4 212 1 16.5 fo 14.6 %
CRPV E5 103 1 14.1 % 14.6 fo
HPV1 E4 91 9 16.1 $ 17.4 %
HPV1 E5 92 51 14.2 fo 15.1 1*
fusion orf created by splice junction of major transcript.
2
Homology with X fusion orf of cINA TE11.
Homology between BFV4 Y and HPV E4.
Homologies calculated using protein alignment function of "Microgenie” 
computer analysis program (Queen and Korn, 1984)*
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3.6. Mapping of. the transcript(s) represented bv cDNA 7E11.
The data presented above on cDNA 7E11 show that it encodes a 
fusion orf of what will from now on be referred to as the E4 
orf of BPV4. The splicing of distal exons of the BPV4 early 
region represented by this cDNA was at first thought to be a 
cloning artifact formed by the ligation of two cDNA’s. 
However, the existence of a BPV4 transcript with the same 
splicing arrangement has been proven by R-loop mapping (L. 
Coggins, Beatson Institute), and RNA sequencing of 
transcripts in the 3’ terminal exon of the early region 
suggested that the cDNA may represent the major 1kb mRNA. The 
suggestion that this encodes the E4 orf of BPV4 is supported 
by similarities of the splicing arrangement and coding 
capacity of cDNA 7E11 to the E4 fusion orf encoding major 
transcripts of BPV1, HPV11 and probably HPV's 6b and 1a.
It was therefore surprising that this transcript had not been 
mapped in the transcriptional analysis of BPV4 (Smith et al., 
1986). However, these analyses were carried out by Northern 
blot hybridisation and S1-nuclease protection of subgenomic 
restriction fragments chosen without the benefit of genomic 
sequence information, as a result of which the small EcoRI 
fragment from nt905 to nt1142, encompassing the 5’ exon of 
cDNA 7E11, was not included in the analyses. The S1 nuclease 
mapping probe for this region was the HindiII - EcoRI 
fragment from nt6l06 to nt904, which would not have been 
protected by a short leader exon utilising the splice donor 
site at nt10l6.
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It was therefore undertaken to map the 51 end of the 
transcript represented by cDNA 7E11. This was carried out by 
Northern blot hybridisation analysis, primer extension and S1 
nuclease protection mapping.
3.6.1. Northern blot hybridisation analysis.
Four different DNA fragments were used to map the transcript 
represented by cDNA 7E11 by hybridisation to Northern blots. 
20 pg aliquots of total RNA from AOP 298 oesophageal
papillomas were run on a \% agarose gel containing 2.2 M 
formaldehyde and transferred onto nylon membrane. The 
membrane was cut into strips corresponding to the
RNA-containing lanes of the gel, and radioactive DNA probes 
were hybridised to each strip under stringent hybridisation 
conditions. The results of these experiments are presented 
and discussed below.
3.6.1.(i). Hybridisation of pG to papilloma RNA.
cDNA G represents nt3745 to nt4034 of the BPV4 genome (Table 
3.3) and was therefore used as a probe representing the 3T 
exon of cDNA 7E11. The same experiment had been carried out 
previously using a cDNA probe of similar length and sequence 
(Smith et al., 1986), and identical results were obtained. In
the present study, 1 pg of pG DNA was nick-translated and
hybridised to one of the Northern blot strips described 
above. Plasmid DNA was used as it would be nick-translated
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more efficiently than the cDNA insert which was only 323 bp 
long, compared to the average single stranded length of 
nick-translated DNA of 400 nucleotides (Rigby et al., 1977),
but would not interfere with hybridisation under stringent 
conditions.
An autoradiograph of the hybridised Northern blot is shown in 
Figure 42. The strongest hybridisation band was in the 1 kb 
size class and, as expected from the transcriptional map, 
weak hybridisation was seen to the 1.6, 1.9 and 3.0 kb
transcripts. Weak hybridisation could also be detected to the 
4.2 kb size class; this also came up in the same experiment 
performed by Smith et al. (1986). No significant homologies 
are found between the sequences of the 3' terminal exon of 
the early region and the exons of the 4.2 kb transcript, so 
this hybridisation band may represent a second 4.2 kb 
transcript or an unspliced mRNA intermediate.
3-6.1.(ii). Hybridisation of p7E11 to papilloma DNA.
1 pg of nick-translated p7E11 DNA was hybridised to a 
Northern blot. An autoradiograph of the blot is shown in 
Figure 43, lane B. Hybridisation to the 1 kb band was 
particularly intense and there appeared to be another, 0.8 kb 
band directly beneath it. In addition, hybridisation occurred 
to the 1.6, 2.0, 2.7, 3.6 and 4.3 kb bands presumably
corresponding to the 1.6, 1.9, 2.8, 3*6 and 4.2 kb
transcripts. Hybridisation to the 2.7 and 4.2 kb transcripts
would have been through the 3’ axon of cDNA 7E11. The 5.4 kb
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band could also be detected: this experiment therefore
indicated that transcripts represented by the 5.4 and 3.6 kb 
size classes must contain sequences found in cDNA 7E11. It 
was also an indication that more than one transcript may be 
represented by the 1 kb size class.
3.6.1.(iii). Hybridisation of the 5f exon of cDNA 7E11 to 
papilloma RNA.
The hybridisation pattern of intact cDNA 7E11 to BPV4 
transcripts was as expected from the cDNA sequence and viral 
transcriptional organisation. The hybridisation pattern of 
the 31 exon was also shown using cDNA G.
In order to establish which transcripts contained sequences 
from the 5T exon of cDNA 7E11, it was separated from the 3’ 
exon and used to probe a Northern blot.
The strategy used to separate the 5’ exon from the cDNA is 
shown in Figure 44. The restriction enzyme SinI cuts cDNA 
7E11 at the position corresponding to nt1007 on the genome, 9 
nucleotides upstream of the splice junction. By digesting
p7E11 with this enzyme and EcoRI, which cuts at the adjacent
vector cloning site, a 73 bp fragment consisting of the 5’
exon of cDNA 7E11 could be isolated. Unfortunately, however, 
two other SinI fragments of 58 bp and 53 bp from the 
downstream part of cDNA 7E11 were also produced by this 
digestion. To circumvent ambiguities produced by possible 
contamination of the 5’ exon probe by these fragments, the 
SinI digest was carried out first and the small fragments
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separated on a 4% LMP agarose gel, leaving the 5' exon probe 
still attached to higher molecular weight plasmid sequences 
(Fig. 44(a)). The higher molecular weight fragments were then 
isolated from the gel and digested with EcoRI to separate the 
cDNA 5’ exon. This was isolated from a further 4% LMP agarose 
gel (Fig. 44(b)).
As the 73 bp fragment was too small to be nick-translated, it 
was then phosphatased and 5'-^2P labelled (2.2.12.(i)). The 
radioactive probe was separated from free nucleotide using a 
Pharmacia "Nick-Column" and hybridised to one of the Northern 
blot strips.
An autoradiograph of the hybridised blot is shown in Figure 
43, lane C. The probe hybridised to the 1.0 kb RNA size 
class, producing an intense band on the autoradiograph. Faint 
hybridisation bands could also be seen corresponding to the 
2.8 and 4.2 kb size classes.
This was a pivotal experiment in the analysis of the 
transcript represented by cDNA 7E11 as it showed that:
1). the exons represented by cDNA 7E11 were part of the major 
transcript(s) of BPV4;
2). the 5f exon hybridised to transcripts of only 1 kb; and
3). since no polyadenylation signals occur between the 5’ 
exon of cDNA 7E11 and the early polyadenylation signal at 
nt4034, this exon is part of a 1 kb transcript containing a 
splice junction which joins sequences separated by at least 2 
kb in the viral genome.
Taken together with the exon mapping experiments of Smith et 
al. f 1986), the results of these experiments led to the
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conclusion that cDNA 7E11 represented the 1kb major 
transcript of BPV4.
A further Northern blot hybridisation experiment was 
performed to map approximately the 5* terminus of the 1 kb 
mRNA.
3.6.1.(iv). Hybridisation of pN to papilloma RNA.
The 3’ exon represented by cDNA 7E11 is 659 nucleotides in 
length. With the addition of a poly (A) tail of up to 200 
nucleotides, this leaves approximately 150 nucleotides 
unaccounted for in a 1 kb mRNA. Similarities between cDNA 
7E11 and maps of the major transcripts of BPV1 in 
fibropapillomas (Baker and Howley, 1987), HPV11 in 
condylomata (Nasseri et al., 1987) and HPV’s 6b and 1a in
benign tumours (Chow et al., 1987a,b), also indicated that
the leader exon of the 1 kb transcript of BPV4 would be 
short.
As a preliminary experiment to map the 5’ end of the 1 kb 
transcript, hybridisation of subgenomic restriction fragments 
lying upstream of the position of cDNA 7E11 was considered. 
However, computer analysis of this region revealed few 
restriction enzyme sites, so this approach was not practical. 
cDNA N contains sequences from nt633 to nt837 of BPV4; 
failure of this DNA to hybridise to the 1 kb band in a 
Northern blot would therefore indicate that the 5' end of the 
1 kb transcript was downstream of nt837.
pN was radiolabelled by nick-translation and hybridised to a
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Northern blot strip. The resulting autoradiograph is shown in 
Figure 43, lane E. A discrete hybridisation band of 1.1 kb 
appears in this autoradiograph which is of much lower 
intensity than the 1 kb bands produced by the cDNA 7E11 
probes. Hybridisation to other E6-containing transcripts was 
weak but did not differ from that obtained with the 73 bp 5* 
exon probe (lane C).
This experiment showed that the 1 kb size class of BPV4 
transcripts contained sequences upstream of nt837. Since 
hybridisation of cDNA N occurred in a discrete 
autoradiographic band representing transcripts slightly
longer than 1 kb, it was concluded that only a proportion of 
a heterogeneous 1 kb size class of transcripts contained
sequences upstream of nt837* The low intensity of the 
hybridisation band indicated that this proportion was small. 
More precise information on the 5* ends of the 1 kb 
transcripts was sought using the more sensitive mapping 
techniques of primer extension and S1 nuclease protection 
analysis.
3.6.2. Primer extension of probes derived from cDNA7E11._
The distance of the 5' terminus of a RNA transcript from a 
specific nucleotide position on the transcript can be 
determined by reverse transcribing the RNA from a
radiolabelled specific antisense primer and running the 
resulting single stranded cDNA on a sequencing gel. The
position of the RNA 5 ’ terminus may then be calculated by
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subtracting the size of the extension product from the 
nucleotide position of the 5’ end of the primer.
The 5’ end of the 1 kb mRNA represented by cDNA 7E11 was 
mapped using two such primers.
3.6.2.(i). Primer extension using the 168 bp Bbvl fragment of 
cDNA 7E11.
Mapping of the transcripts of BPV4 poses the obvious problem 
that with the differential splicing pattern, a single primer 
may be specific to more than one transcript. Advantage was 
therefore taken of the splice junction in cDNA 7E11 to 
produce a primer specific to transcripts containing the same 
splicing arrangement. The restriction enzyme Bbvl cuts BPV4 
DNA at nt957 and nt3484. The same sites in cDNA 7E11 are 60 
nucleotides 5’ and 108 nucleotides 3’ to the splice junction, 
respectively, producing a restriction fragment ideally suited 
to primer extension mapping of the 1 kb transcript (Fig. 45). 
In selecting this primer, it was taken into consideration
that sequences upstream of the splice junction could also 
hybridise to other transcripts, e.g the 4.2, 3*0 and 2.8 kb
mRNA’s, containing the same sequences (Smith et al., 1987),
leading to the erroneous assignment of 5’ termini. The 
nucleotide composition of the Bbvl primer was such that 
sequences 3’ to the splice junction were G+C-rich, while
those 5' to it tended to contain more A+T residues. The
preponderance of 3’ sequences increased the theoretical
optimum annealing temperature of the primer to RNA in 80%
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formamide (Table 3-6), favouring hybridisation of the 3'
sequences. This meant that nucleation steps in the annealing 
process would be more likely to take place in the downstream 
region, allowing subsequent annealing in the 5’ exon, while 
non-specific annealing of the 5’ sequences would be
minimised.
p7E11 DNA was digested with Bbvl to produce a 168 bp fragment
spanning the splice junction. This was separated from the
other digestion products on a 2% LMP agarose gel (Fig. 45(b))
and purified. Approximately 0.1 pg of the primer was then 
32phosphatased, 5* P labelled and run on a 6% polyacrylamide 
strand separating gel (Fig. 45(c)). Three bands were seen on 
autoradiography of the gel, designated primers 1, 2 and 3. A 
high percentage of reannealing of the two strands normally 
occurs in strand separating gels, and the ds DNA usually has 
a higher mobility than the single strands which are 
presumably irregular in topology due to intrastrand duplex
formation and therefore retarded to greater degrees by the
gel matrix (Maniatis et al., 1982). The ds DNA then appears
as a more intense band below the single strand bands. With 
the Bbvl fragment, however, no such distinction could be made 
and all three bands were isolated.
An estimated 5 ng of each primer was annealed to AOP A 
poly(A)+RNA. Paucity of RNA stocks necessitated a further 
refinement to the method. Where an abundant supply of RNA is 
available, primers are annealed to poly(A)+RNA at a range of 
five to ten different temperatures and the optimum annealing 
temperature defined empirically for each primer according to
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the quality of primer extension products obtained. To carry 
out such a titration with the three Bbvl primers would have 
expended a considerable amount of poly(A)+RNA, so instead the 
optimum annealing temperature in 80% formamide and 0.4 M NaCl 
was calculated according to the equations in Section 2.2.6. 
and 2.2.12. (Marmur and Doty, 1962; Thomas et al., 1976),
using the base composition indicated by the cDNA sequence 
(Table 3.6). Due to the high (63-7%) G+C content of this 
primer, the theoretical annealing temperature was 
approximately 54°C. Annealing was carried out at three 
temperatures to check the accuracy of the calculation: these
were 56.5°C, 54°C and 49°C. Control reactions containing the
appropriate probe with tRNA were set up.
Primer extension was carried out using the annealed probes 
and the reaction products fractionated on a sequencing gel 
next to a sequencing T track of M13 DNA. An autoradiograph of
this gel is shown in Figure 46.
The autoradiographic exposure time of 5 days was an indicator 
of the low abundance of viral RNA relative to cellular 
mRNA*s. Extension products were seen above each primer;
however, those of primers 2 and 3 (Fig. 46, lanes 2+ and 3+)
may have been non-specific as bands were also seen in the 
control reactions (lanes 2- and 3-)* Those of primer 1 (lanes 
1+) extended well beyond the non-specific tRNA extension 
products (lane 1-). Of the test reactions , best results were 
obtained with the pre-calculated annealing temperature. This 
finding was also reported by other workers (N. Lowndes; J. 
Chester, Beatson Institute). In order to conserve poly(A) RNA
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stocks, all further experiments involving the annealing of a 
primer to RNA were carried out at the calculated optimum 
annealing temperature.
The length of the major primer extension products obtained 
for primer 1 was used to calculate their position on the 
genomic sequence. These positions are shown in Figure 47. The 
large number of extension products at first suggested that 
premature terminations had occurred due to RNA secondary 
structure. However, it had already been shown through 
Northern blot hybridisation analysis that more than one 
transcript existed in the 1 kb size range, so these 
termination bands were mapped. It was found that the most 
intense bands, i.e. the majority of primer extension 
products, mapped between nt869 and nt905 on the BPV4 genome, 
with the most intense band corresponding to nt870. Bands 
representing shorter primer extension products were also 
found in the control lane. Fainter bands mapped to positions 
between nt845 and nt847 and the longest primer extension 
product to nt793.
Examination of the genomic sequence in this region revealed 
no promoter/enhancer sequences of known type. The palindromic 
sequence CTTGCGAGCAAG around nt870 could have formed a 
hairpin stucture by intrastrand base pairing in the RNA 
molecule, preventing readthrough by the reverse transcriptase 
and hence forcing a premature termination at this point. 
However, palindromes of this length in the multiple cloning 
site of pUC13 were read through easily using the same enzyme 
in the plasmid sequencing method, and no such sequences were
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found around the other termini in this experiment. The
absence of a TATA box has been demonstrated for
transcriptional start sites in SV40 (Brady et al., 1982) and
adenovirus type 2 (Baker et al., 1979), in each of which the 
RNA 5' end is heterogeneous. Moreover, it has been shown that 
deletion of the TATA box of the SV40 early promoter does not 
prevent transcriptional initiation but causes it to occur at 
multiple specific sites, i.e. the TATA sequence is only 
required for precisely directed transcriptional initiation 
(Benoist and Chambon, 1981; Mathis and Chambon, 1981).
These primer extension data corroborated the results of
Northern blot hybridisation in that a small proportion of 
reaction products extended beyond nt837, the 3* end of the 
cDNA N probe. These were predominantly confined to the single 
band mapping to nt792 at the furthest extent of primer
extension.
The transcriptional initiation site at nt654 was not 
represented by any bands in this autoradiograph or in a 
longer exposure, affirming the specificity of the primer.
3.6.2.(ii). Primer extension and RNA sequencing using a 
synthetic oligonucleotide primer.
Although continued experimentation with the Bbvl primer may 
have led to finer mapping of the 1 kb transcript represented 
by cDNA 7E11, the low yield of primer did not justify the 
exceptional cost of this enzyme. Instead, a synthetic 
oligonucleotide was obtained, designated primer 142 (Table
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3.6), which consisted of 24 nucleotides centred on the splice 
junction of cDNA 7E11, from the antisense strand. The use of 
a synthetic oligonucleotide had the advantage that high 
labelling efficiency was acheived, reducing autoradiographic 
exposure times and therefore background.
pp
Primer 142 was 5’ P labelled and annealed to AOP A 
poly(A)+RNA at a calculated optimum temperature of 45.5°C. A 
control reaction was included. The annealed primer was then 
extended with reverse transcriptase, and at the same time a 
RNA sequencing reaction was set up using the same primer. The 
two sets of reactions were run side by side on a sequencing 
gel next to radioactive size markers. An autoradiograph of 
the gel, at 36 hrs exposure, is shown in Figure 48, and the 
sequencing ladder has been expanded in Figure 49.
The primer extension products in this autoradiograph map to 
positions shown on the genomic sequence in Figure 47, in 
which the proportional intensity of each of the major 
autoradiographic bands is indicated by the size of the arrow 
under the corresponding nucleotide position. These results 
concurred with those of the Bbvl primer extension, and there 
were in addition three faint bands mapping to nt606, nt690
and nt722. This may have been due to lowered specificity of 
the oligonucleotide primer for the 1 kb mRNA, resulting in 
priming of cDNA synthesis from other transcripts. The results 
of all the primer extension experiments described in this 
subsection will be discussed under a subsequent heading.
The RNA sequence allowed direct determination of the 
nucleotide positions of the 5’ ends of mRNA’s and confirmed
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that these transcripts were not spliced. The major 
termination site was shown to be nt870; upstream of this 
site, the RNA sequence becomes faint and was only readable on 
a longer autoradiographic exposure, which again showed that 
no splice junctions occurred for at least another 30 
nucleotides upstream. The reaction temperature of 50°C in 
this protocol was selected to reduce RNA secondary structure 
without compromising the efficiency of the reaction 
(Geliebter, 1987). The RNA sequencing experiment therefore 
provided good evidence that the termination band at nt870 
represents a genuine RNA 5' terminus, and the major 
transcriptional start site of the heterogeneous 1 kb class of 
BPV4 mRNA’s. Other transcriptional start sites identified by 
RNA sequencing were at nt882, nt886, and nt898-nt901.
3.6.2.(iii). Primer extension using primer 142 at higher 
reaction temperatures.
Steps were taken which would increase the number of 
full-length primer extensions if premature terminations were 
being mapped in the experiments described above. It was 
considered that the use of higher temperature incubations in 
the reverse transcription reaction would reduce any RNA 
secondary structure inhibiting the reaction and allow a 
greater degree of full-length primer extension.
Radioactive primer 142 was annealed to BPV4 mRNA as before 
and the reverse transcription reaction initiated at 42°C. A 
second aliquot of reverse transcriptase was added after 30
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min. and the incubation temperature increased to 50°C. After 
a further 30 min., another aliquot of enzyme was added and 
the temperature increased to 55°C. The reaction was 
terminated after another 30 min., and the reaction products 
fractionated on a sequencing gel. An autoradiograph of this 
gel is shown in Figure 50, and the sizes of the major bands 
are shown beneath the figure legend.
The genomic positions of the major termini were no different 
to those in the previous experiment, and the relative 
intensities of the bands representing them appeared 
unchanged. The results of the RNA sequencing experiment 
indicated that primer extension products mapping 5’ to nt870 
were produced by reverse transcription through the 
palindromic sequence around this position; if secondary 
structure in this region were responsible for the low level 
of readthrough products, this level would be expected to 
increase at the higher reaction temperature due to a 
reduction in secondary structure. Since this was not the 
case, it was concluded that nt870 represented a genuine mRNA 
5’ terminus.
3.6.3. S1 nuclease protection mapping of the E6 region 
of BPV4.
Primer extension experiments have the limitation that they do 
not map splice junctions and may produce spurious 5’ ends due 
to internal termination of reverse transcription. The 
presence of splice junctions downstream of nt870 was ruled
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out by RNA sequencing, but the existence of the 51 termini 
mapped in the primer extension experiments required 
confirmation using an alternative approach.
Protection of single stranded DNA from S1 nuclease digestion 
is afforded by hybridisation of the DNA to its complementary 
RNA strand. S1 nuclease protection of 5’ end labelled, single 
stranded antisense DNA from the region mapped by primer 
extension is a complementary experimental system by which 
the positions of mRNA 5’ termini may be confirmed. Protected 
fragments are resolved on a sequencing gel and mapped in the 
same way as primer extension products.
Previous S1 nuclease mapping of the E6 region was carried out
using a probe extending upstream from the EcoRI site at nt904 
(Smith et al., 1986); the greater proportion of protected
fragments representing the major 1 kb transcript would 
therefore have been <35 nucleotides in length, leading to 
considerable losses in the precipitation step after S1 
nuclease digestion and confusion with non-specific
degradation products at the bottom of the sequencing gel.
3.6.3.(i). Isolation of a single stranded antisense DNA probe
A S1 nuclease protection assay for the E6 region of BPV4 was 
set up. The DNA probe was a SspI - Sau96I restriction 
fragment from nt592 to nt1007. The 5* end of the antisense 
strand was at nt1009» only seven nucleotides upstream of the 
splice donor site utilised in cDNA 7E11, ensuring protection 
of the labelled 5' end in an RNA hybrid duplex while
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maximising the length of the shortest protected fragments. 
The strategy used to isolate the probe is shown in Figure 51. 
pBV4 DNA was digested with restriction endonucleases SspI and 
_Sau96_I and the 418 bp fragment separated from other digestion 
products by fractionation on a 2% LMP agarose gel (Fig. 
51(b)). This was extracted from the gel and approximately 0.4 
jig of the fragment phosphatased and 5' end labelled with ^2P. 
The two strands were separated on a polyacrylamide strand 
separating gel . The position of the separated strands in the 
gels was identified by autoradiography (Fig. 51(c)); they 
were extracted and designated probe 1 and 2.
Probes 1 and 2 were annealed to 5 Ug AOP A poly(A)+RNA in 80% 
formamide, 0.4 M NaCl. The optimum annealing temperature was 
calculated to be 42°C using the base composition of nt654 to 
nt1009, representing the sequence from the 5’ end of the 
antisense probe to the previously mapped transcriptional 
start site at nt654 (Smith et al., 1986). Control reactions
containing only probe plus tRNA carrier were also set up.
3.6.3«(ii) S1 nuclease mapping of annealed probes.
Annealed probes were subjected to S1 nuclease digestion and 
the reaction products fractionated on a sequencing gel. An 
autoradiograph of the gel is shown in Figure 52.
Protected fragments were found for the reaction containing 
probe 1 plus mRNA only (Fig. 52, lane 1+). A small proportion 
of the probe was fully protected, confirming that transcripts 
initiate at positions upstream of nt592. A small amount of
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full length probe appeared in the control reaction in 
lane 1-, but this band was of much lower intensity than that 
in lane 1 + . Similarly, a faint band representing fully 
protected probe was seen in lane 2+, but this was thought to 
be due to contamination with probe 1. No protected bands were 
apparent in the control lane for probe 2 (not shown).
The sizes of the major protected fragments in lane 1+ are 
tabulated in the legend to Figure 52. The genomic positions 
of the 5' ends of these fragments are shown in Figure 53. 
These positions confirm the primer extension map of this 
region, except for the terminations at nt606 and nt690.
The most intense bands on the autoradiograph mapped to 
nt871/872, and within the error limits of the technique, 
corresponded to the major 5’end at nt870. The S1 assay has 
the advantage that RNA secondary structure is minimised by 
annealing the entire length of the transcript to a DNA strand 
under conditions favouring RNA:DNA interactions. This 
experiment therefore provided convincing evidence that the 
major 5 ’ terminus of the 1 kb mRNA represented by cDNA 7E11 
is at nt870.
The relative intensities of the other S1 bands also reflect 
those of the primer extension autoradiographs.
S1 nuclease protection assays sometimes produce spurious 
bands mapping to A+T-rich regions of the genomic sequence. 
This is thought to be due to "breathing” of the weaker A-T 
hydrogen bonding at the reaction temperature, allowing S1 
nuclease attack on momentarily single stranded DNA (Pelham, 
1982). However, examination of the genomic sequence in the
270
region of the 5 ’ ends mapped by S1 nuclease protection 
revealed no A+T-rich regions (Fig. 47) and the precise 
correlation with primer extension data confirms the 
heterogeneous nature of the 5’ end of the 1 kb major 
transcript.
3.6.4. Discussion: Mapping .of the 1 kb maior transcript of 
BPV4.
Primer extension and S1 nuclease protection data are shown 
relative to the orf’s encoded by the mapped region in Figure 
53.
The two exons represented by cDNA 7E11 were mapped by 
Northern blot hybridisation analysis to the 1 kb major size 
class of BPV4 transcripts. Two primers specific to the cDNA 
sequence were used to map the multiple 5T ends of the 
transcript, and a single stranded probe specific to the 
region delineated by the primer extension data confirmed 
these sites by S1 nuclease protection. The exact nucleotide 
position of some of the 5* termini was found by RNA 
sequencing. The major transcript of BPV4 therefore has a 
heterogeneous start site between nt777 and nt901. The number 
of nucleotides of genomic sequence represented in the 1 kb 
transcripts is between 775 and 900.
The termini mapped by primer extension at nt606 and by primer 
extension and S1 nuclease mapping at nt 722 both have TATA 
homologies 24 and 32 nucleotides upstream, respectively. 
These may represent other transcripts as they were not mapped
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by the Bbyl primer. A promoter at nt582 would direct the 
synthesis of an E6-encoding transcript, and may be
represented by cDNA N, of which the 5' end is at nt633. The
potential TATA promoter at nt691, directing transcription 
from nt722, would give rise to an RNA encoding all but the 
first three codons of the E6 orf from the ATG, and therefore
incapable of expressing E6. The splicing pattern of
transcript(s) initiating from this minor start site is not 
known, but the existence of an apparently TATA controlled 
minor transcriptional start site slightly upstream of a 
heterogeneous major start site is reminiscent of the 
arrangement of the late promoter region of BPV1 (Baker and 
Howley, 1987). Failure to map the RNA start site at nt654 
(Smith et al., 1986) by either of the methods was unexpected; 
even autoradiographic exposures of 5 days did not show any 
bands of the appropriate size.
The majority of 5’ termini mapped by primer extension and S1 
nuclease protection analysis fell between nt776 and nt902, 
the most frequently used initiation site being at nt870. 
Assuming total specificity of the primer for transcripts 
spliced from nt10l6 to nt 3376, the coding potential of all 
of these is the same, as the first ATG codon downstream of 
all of these sites is located in the orf which is fused to E4 
by the splice junction in cDNA 7E11. The apparently haphazard 
distribution of 5' termini is very similar to that of the 
wart-specific promoter, P^ , of BPV1, which extends from 
nt7213 to nt7256 of the ncr, overlapped by a tandemly 
repeated sequence homologous to the late promoter of SV40
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(Brady et al., 1984). The SV40 late promoter homology in BPV4
is at nt213 (Table 5; Patel et al., 1987); however,
comparison of the late promoter region of BPV1 with the major
transcriptional initiation site of BPV4 revealed a homologous
motif. Two similar sequences from the BPV4 E6 region and
their three homologous motifs in the BPV1 P^ .or- and Pr
71o5 L
regions are shown in Figure 47. These sequences have the
general form: TTGPyPuNTGPyG. A similar repeated sequence is
found in the ncr’s of HPV’s 16, 18 and 33- The repetition of 
this motif in the heterogeneous major transcriptional start 
sites of BPV1 and BPV4, its confinement to this region of .the 
genome and the existence of similar motifs in the
transcriptional control regions of other papillomaviruses, 
suggest that it may be an alternative promoter. Moreover,
this may indicate that the multiple start site of BPV4 is the 
late promoter. The transcriptional organisation of BPV4 is 
such that the E6 orf is not spliced out of transcripts
initiating in the ncr, while the "cassette" system of gene
expression through differential splicing common to BPV1 and 
HPV11 (Baker and Howley, 1987; Nasseri et al., 1987) could
operate through the short orf containing an A1G four codons 
upstream of the universally utilised splice donor site at 
nt10l6.
The fact that the major transcript of BPV4, represented by 
cDNA 7E11, encodes an E4 fusion orf thought to be associated 
with the expression of the small E4 proteins, supports the 
idea that this may be the late promoter, as these proteins 
are only expressed late in the viral infective cycle (Doorbar
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et al., 1987; Breitburd et al., 1987).
The transcriptional initiation site of the 4.2 kb late 
transcript of BPV4, previously mapped at nt654, was not found 
in any of the mapping experiments described in this 
subsection. If the multiple initiation site is in fact the 
late promoter region of BPV4, the 4.2 kb transcript may 
actually be transcribed from here.
The discovery of a major multiple initiation site with a 
secondary TATA-controlled site a short distance upstream 
suggests that the transcriptional organisation of BPV4 in 
benign tumours is more similar to that of other 
papillomaviruses than was previously thought. It parallels 
the transcriptional organisation of BPV1 late in the viral 
infective cycle in epithelial cells (Baker and Howley, 1987). 
The splicing pattern of the major transcript, which allows 
for the translation of one of the forms of the E4 protein 
from a fusion orf, is identical to that of BPV1 transcribed 
from the late promoter, and that of HPV11 (Nasseri et al.. 
1987), and probably HPV’s 1, 6 and-H' (Chow et al., 1987a,b). 
In all of these viruses, the transcript encoding the L1 orf 
is also transcribed from the major promoter region; although 
purely speculative at this time, it is possible that the L1 
encoding transcript of BPV4 is transcribed from the major 
promoter.
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Figure 42. Mapping of the 3* exon of cINA rJE^  ^ by Northern blot hybridisation.
20 pg of total AOP 298oes RNA was electrophoresed on a 2.2M formaldehyde,
1% agarose gel, transferred to nylon membrane and hybridised to 
radioactively labelled pG RNA. The hybridised blot was autoradiographed 
for 48 br.
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Figure 43* Mapping of the ma.ior transcript of BPV4 by 
northern blot hybridisation analysis.
Northern blot strips were prepared containing 20 pg of 
total AOP 298oes RNA (B - E) and one of 1 pg AOP A 
poly (A)+RNA (A)• These were hybridised to the 
following radioactive DNA probes:
A: BPV4;
B: p7E11;
C j the 5* exon of cDNA 7E11;
D: BFV4 (control);
E: pN.
The hybridised blots were autoradiographed for 
48 hr (A,B,D) or 5 days (C,E).
M: RNA size markers (BRL).
M A B C
M D
kb 0-3
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Table 3.6 Primers and S1 probes used to map BPV4 transcripts.
Primer Position^ S1 probe Position Size
(nt)
2Base
composition
T (RNA 
seq)
Optimum T 
(80$ fomw)
140 below 17 51°C
142 below 24 GC 50Jo 
AT 50$
47°c 45-4°C
156 below 17 41 °C 36.4°C
Bbvl '3484-3376;
1016-957
168 GC 63.7% 
AT 36.3$
53.75°C
7E11 1009-592 418 GC 43.9$ 
AT 56.1$
41.7°C
Q 3244-2842 406 GC 35.2$ 
AT 64.8$
36.4°C
numbers refer to nucleotide positions on the BFV4 genome (antisense strand), 
antisense strand.
Oligonucleotide primers.
3551 3535
Primer 140 5’“GCCCCTTCGTAGGCGAT—31
3387 3376^_—- — _^J1016 1005
Primer 142 51 -ACACGAAGCGAA ^^'CTTTAGGGTGCA-3f
3269 3253
Primer 156 5 *-TCCCCTGATTATCAATA-3’
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Figure 46* Primer extension using the 168 nt Bbvl primer*
Primers 1, 2 and 3 (fig* 45 (c)) were each annealed to 5 Ug 
AOP A poly(A)+ENA at three different temperatures and 
extended with reverse transcriptase. tRRA controls were 
included. The reaction products were fractionated on a 
sequencing gel. An autoradiograph of 5 days’ exposure is 
shown.
Lane M: T-track of M13 ENA;
1- control reaction,primer 1
2- control reaction,primer 2
3- control reaction,primer 3
Lanes 1+ test reactions, primer 1
2+ test reactions, primer 2
3+ test reactions, primer 3
Annealing reactions were performed at:
(a )
oo5
(*>) 54°C
(c) 56.5°C
1- 2- 3-
i ;  i ^
a be abc abc
1+  2+  3+
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Figure 47 • mHNA 5* ends mapped in the E6 region of BFV4 by primer extension 
and S1 nuclease protection*
559 569 579  589 599
bpv4. CTTTGCTAGA TGAATTAGAA CAGGAGGAAC AGfrAAATdGA ATATTGCTGT
609 619 629 639 649 659
GCTTTTACAT TTGAGAAGGA TTGTAGTGTG GGCATTTAAA AGCTGACCTT CCAGTCTTAA
t
669 679 689 699 709 719
TTGCAGTAGG CGCCTAAGAG GGTGGTGGTG GlTATAAGlrTC AAGTTTTTCA AGAAAEyTgIAA
t  E 6 - *
729 739 749 759 769 779
GGGGCAGAAC GTGACATTAC AGGACATTGC AATAGAATTA GAGGATACAA TTAGTCCAA1
t T
789 799 809 819 829 839
TAACTTGCAT TGTGAAGAGG AGATTGAAAC TGAGGAGGTG GACACCCCTA ACCCTTTTGC
t t  t
849 859 869 879 889 899
AATAACAGCA ACTTGTTATG CTTGCGAGCA AGTCCTTCGT TTAGCTGTTG TAACGTCAACtftttt ftt t tt
909 919 929 939 949 959
AGAAGAATTC ATCTCAACTG CAGCAACTGC TGTTCGACAA CCTCTTTCTA TCTGTGTGCA
969 979 989 999
GCTTGCTTCC AAACAAGTGT TCTGTAACCG CAGACCCGAG C
TATA box and mENA start site consensus sequences (Breathnach and Chambon, 1981)
mRNA start site
A A
G - g T A T A  A - g - - g
T T
9 t o 17 BP
PY - - * PY A P Y P Y P Y P Y P Y
Potential TATA boxes and the ATG codon of the E6 orf are boxed. RNA 5* ends 
are signified by vertical arrows: size of arrow is proportional to the 
intensity of primer extension and S1 nuclease protection bands mapping to 
each site. A repeated sequence motif, conserved in the late promoter region 
of BPV1, is underlined.
_______ CONSERVED SEQUENCE MOTIF.
BFV4
620 t t g t a g t g t g 629
7 84t t g c a t t g t g 793
BFV1
7177a t g t  c tg tg 7185  
7233 ttg c a g tg c g 7242  
7255o t g tg c tc g c 7 2 6 4
CONSENSUS TTGPyPuNTGPyG
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Figure 48« 5* P-labelled primer 142 was* annealed to 5 l*g
mRNA at the theoretical optimunf temperature of 
45*5 C. A control reaction was also set up. 
Primer extension and REA sequencing using primer 142 were 
carried out simultaneously and the products fractionated 
on a sequencing gel. An autoradiograph of 36 hr. 
exposure is shown.
M : size markers (radiolabelled Sau961—digested pAT153 UTA). 
+ : test reaction, primer extension.
— : control reactionf primer extension 
ACGT : sequencing lanes.
The REA sequence is shown alongside the photograph.
Figure 49* (overleaf) The RNA sequencing autoradiograph 
is expanded. The RNA sequence is shown 
alongside the photograph in the region of the 
multiple start site, and at the overlap with 
the cBNA 7E11 5* end.
A comparison of this sequence with the BPV4 
genomic sequence is shown below the photograph.
Figure 4 Primer extension and RNA sequencing using primer 142
M +  A C G T
-8 7 0
-8 9 0
-932
-9 4 9
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Figure 49* Sequencing of the major BFV4 transcript using primer 142.
ACGT
bpv4
m *#; Ar-r'ACT — 870 
_ A A G G ^ r  
■ isCTAAAC
- *  i-ACAACA _ 8 9 0
ag:
L tc g aa
-932
‘T V t T g  agg
=_-|-Ag
AaAg
-949
9 5 1  9 4 1  9 3 1  9 2 1  9 1 1  9 0 1  0 9 1
CTGCACACAG ATAGAAAGAG GTTGTCGAAC AGCAGTTGCT GLAGTTGAGA TGAATTCTTC TGITGACGTT
RNA —  -TAGAAAGAG GTTGfCGAAC AGCAGTTGCT GCAGTTGAGA TGAATTCTTC TGTTGACGTT
BB 1 8 7  1 8 6  1
ACAACAGCT A AACGAAGGAC TTGCTC.GCAA
ACAACAGClA AACGAAGGAC T— I
283
98
Figure 50* Primer extension using primer 142 at elevated 
reaction temperatures*
The primer extension reaction described for Figure 48 
was carried out at gradually increasing temperatures 
up to 55°C. The products were fractionated on a 
sequencing gel and autoradiographed as before,
M : size markers - Sau96l-digested pAT153 INA
plus Hhal—digested pAT153 
ENA,
+# - : as Fig, 48*
Sizes of the major bands in this autoradiograph are 
tabulated below: STD LEN DIST FRED LEN DEVIATION
6 1 6 . 0 0 7 0 . 0 0 0 6 0 8 . 0 9 7 . 9 1 3
3 9 3 .0 0 1 1 3 .5 0 0 4 0 2 .9 1 - 9 . 9 1 0
3 5 2 .0 0 1 2 9 .5 0 0 3 5 5 .86 - 3 . 8 5 7
3 3 7 .0 0 1 3 5 .5 0 0 3 4 0 . 5 8 - 3 . 5 7 9
3 3 2 .0 0 1 3 7 .5 0 0 3 3 5 . 7 3 - 3 . 7 3 2
2 7 5 .0 0 1 6 8 .5 0 0 2 7 3 . 1 8 1 . 8 1 9
2 7 0 .0 0 1 7 1 .0 0 0 2 6 8 .9 8 1 . 0 1 6
2 5 9 .0 0 1 7 9 .0 0 0 2 5 6 . 2 3 2 .  768
2 4 9 .0 0 1 8 5 .5 0 0 2 4 6 .5 7 2 .  427
222.00 2 0 7 .0 0 0 2 1 8 . 4 2 3 .  5 79
2 0 6 .0 0 2 1 9 .5 0 0 2 0 4 . 3 0 1. 7 02
1 9 1 .0 0 2 3 4 .5 0 0 1 8 9 .1 2 1 .8 7 9
1 7 4 .0 0 2 5 2 .5 0 0 1 7 3 .0 5 0 . 9 5 2
1 5 1 .0 0 2 8 2 .5 0 0 1 5 0 .3 9 0 . 6 0 6
1 3 2 .0 0 3 0 9 .0 0 0 1 3 3 .7 3 - 1 . 7 3 3
1 3 1 .0 0 3 1 2 .0 0 0 1 3 2 .01 - 1.010
1 2 4 .0 0 3 2 4 .0 0 0 1 2 5 .4 1 - 1 . 4 1 2
UNKNOWN FRAGMENTS:
FRAGMENT DISTANCE PREDICTED LENGTH
+ 1 1 5 0 .5 0 3 0 6 . 8 6 4
+2 1 7 3 .5 0 2 6 4 .8 9 1
+3 1 8 2 .0 0 2 5 1 . 7 0 0
+•4 I B S . 50 2 4 2 . 3 1 0
+5 1 9 0 .0 0 2 4 0 . 2 2 2
+6 1 9 1 .5 0 2 3 8 . 1 6 3
+7 1 9 2 .2 5 2 3 7 .1 4 4
+8 1 9 3 .5 0 2 3 5 .4 6 1
+9 2 1 2 .5 0 2 1 2 . 0 2 6
+ 10 2 1 9 .5 0 2 0 4 . 2 9 8
+ 1 1 221.00 2 0 2 . 6 9 8
+ 12 2 3 2 .0 0 1 9 1 .5 2 9
+ 13 2 3 3 . OO 1 9 0 .5 6 1
+ 14 2 3 7 .0 0 1 8 6 .7 5 9
+ 15 2 3 8 .0 0 1 8 5 .8 2 6
+ 16 2 4 0 .5 0 1 8 3 .5 2 5
+ 17 2 4 2 .5 0 1 8 1 .7 1 4
+ 18 2 4 3 .5 0 1 8 0 .8 1 9
+ 19 2 7 3 .5 0 1 5 6 .7 1 8
+20 2 7 5 .0 0 1 5 5 .6 3 8
+21 2 7 6 .5 0 1 5 4 .5 6 8
+22 2 7 7 .5 0 1 5 3 .8 6 1
+23 2 8 7 .0 0 1 4 7 .3 6 8
+24 2 9 1 .0 0 1 4 4 .7 4 9
+25 2 9 2 .5 0 1 4 3 .7 8 4
+ 26 2 9 4 .0 0 1 4 2 .8 2 7
+27 2 9 8 .5 0 1 4 0 .01 1
+ 28 3 1 3 .0 0 1 3 1 .4 4 2
+29 3 1 4 .5 0 1 3 0 .5 9 7
+30 3 1 6 .5 0 1 2 9 .4 8 2
+31 3 2 0 .0 0 1 2 7 .5 6 1
+32 3 3 1 .0 0 1 2 1 .7 6 6
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Figure 52. S1 nuclease protection analysis of probe 7E11.
Probes 1 and 2 (Fig 5 0  were each annealed to 5 pg 
AOP A poly(A)+HNA at the precalculated temperature 
of 42°C, with appropriate tKNA controls. The 
annealed probes were then subjected to S1 nuclease 
attack at 37°C for 30 rain., and the digestion 
products fractionated on a sequencing gel which 
was autoradiographed for 48 hr*
M: radioactive size markers (Sau96I—digested 
pAT153 ENA; Hhal—digested pAT153 IKA
1+: test reaction, probe 1 
1-: control reaction, probe 1 
2+: test reaction, probe 2 
1 : undigested probe 1.
The sizes of the principal protected fragnents are 
tabulated below:
STD LEN DIST PRED LEN DEVIA T I O N
616.00 63.000 610.99 5.013
393.00 96.500 400.22 -7.221
352.00 108.500 354.08 -2.082
337.00 112.500 340.74 -3.735
332.00 114.000 335.96 —3.955
275.00 137.500 273.89 1.111
270.00 140.000 268.44 1.558
259.00 145.500 257 . OS 1.918
249.00 151.500 245.58 3. 421
222.00 169.000 216.47 5. 528
206.00 178.500 202.95 3. 048
191.00 190.500 187.72 3. 280
174.00 195.000 182.47 -8.471
151.00 229.000 149.24 1. 760
132.00 250.000 133.08 -1.082
131.00 253.000 130.99 0.014
124.00 263.500 124.01 — 0 . Oil
109.00 287.500 109.93 -0.931
U N KNOWN F R A G M E N T S :
FRAGMENT DISTANCE PREDICTED L E NGTH
1 + 1 132.00 286.554
1+2 160.00 230.687
1+3 169.00 216.472
1+4 193.50 184.194
1+5 203.00 173.691
1+6 210.00 166.535
1+7 216.50 160.290
1+8 220.00 157.074
1+9 242.50 138.542
1 + 10 245.OO 136.686
1 + 11 258.50 127.264
1 + 12 260.00 126.276
1 + 13 261.50 125.298
1 + 14 282.50 112.673
1 + 15 285.00 111.290
M  1 + 1 - 2 +  1
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3-7. Mapping of the transcript(s) represented bv cDNA Q.
Sequence analysis of cDNA Q showed that it was a 554 bp 
truncated cDNA representing nt3235 to nt 3788 of the BPV4 
genome. It therefore represented a previously unmapped 
transcript in which the splice acceptor site at nt3376 is not 
utilised. The presence in the genomic sequence of a TATA box 
homology 50 nucleotides upstream of the 5’ end indicated that 
the cDNA might be nearly full length. Although it was
\k>
truncated at the 3f end,<was assumed that the 3f terminus of 
the original transcript was at the early polyadenylation site 
since no splice junctions had been mapped to this part of the 
early region (Smith et al., 1986). The coding capacity of 
cDNA Q featured the full E4 orf (Fig, 33) and it was thought 
possible that the represented transcript could express the 
larger species of the E4 protein as in HPV1a (Doorbar et al.,
1986). However, studies on the BPV1 E2 orf transcriptional 
enhancer/repressor system suggested that a similar 
transcriptional arrangement for the expression of the E2 orf 
might prevail in BPV4. Two minor transcriptional initiation 
sites exist within the early region of BPV1, one multiple 
site around nt2440 and one at nt3080 (Fig. 2; Ahola et al., 
1987; Stenlund et al., 1985). A small proportion of
transcripts initiating at P2440 are unsPliced and potentially 
express the full E2 orf (Stenlund et al., 1985); transcripts 
directed by P3080 encode the 3’ three Quarters of the E2 orf, 
to which the short-lived E2 repressor protein was mapped 
(Lambert et al., 1987), and could express the repressor
288
protein from an ATG codon at nt3091 (Ahola et al., 1987).
The first methionine codon of the BPV4 E2 orf is at nt2996, 
and two closely spaced ATG sequences are found in this orf at 
nt3049 and nt3158. Transcripts initiating downstream of these 
points would be translated from the ATG codon of the E4 orf 
at nt3300, or a spliced transcript could encode a new fusion 
orf. The multiple translational potential of this region 
prompted the mapping of the transcript(s) represented by 
cDNA Q.
3.7.1. Northern blot hybridisation of pQ to polvadenvlated 
AOP A RNA.
Transcripts containing contiguous genomic sequences upstream 
of the splice acceptor site were mapped by Northern blot 
hybridisation analysis. pQ DNA, used as a probe as higher 
specific activity labelling could be acheived, was 
nick-translated and hybridised to a Northern blot of 
AOP298oes total RNA. This was prehybridised with unlabelled 
cDNA 7E11, separated from vector sequences. This would 
prevent hybridisation of the sequences of the radioactive 
probe shared by cDNA’s 7E11 and Q to the 1 kb major 
transcript. Only sequences of cDNA Q lying upstream of the 
splice acceptor site would hybridise to BPV4 RNA.
After prolonged autoradiographic exposure (5 days), a faint 
hybridisation band of 1 kb was seen. It appeared, therefore, 
that more than one type of transcript was contained in the 1 
kb size class. In an attempt to resolve the different 1 kb
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transcripts, 5 ug of AOP A poly(A)+RNA was run on an extended 
1.5% agarose, 2.2 M formaldehyde gel, 14 cm in length. The 
use of polyadenylated RNA represented an effective 6-fold 
increase in the amount of mRNA in the gel. The hybridisation 
procedure described above was repeated on a Northern blot of 
the gel. An autoradiograph of the hybridised blot is shown in 
Figure 54.
Again, a single hybridisation band appeared, calculated to be 
1.0 kb in size. cDNA Q therefore represented a rare 
transcript of the 1 kb size class. Allowing for a poly(A) 
tail, the 5’ end of the transcript(s), if unspliced, could 
have mapped to between nt3000 and nt3200. Fine mapping of the 
transcript(s) was carried out to establish the positions of 
5' termini.
3*7.2. RNA sequencing using a synthetic oligonucleotide 
primer from cDNA Q 5T sequences.
Primer extension and RNA sequencing experiments were carried 
out to map the 5* ends of the transcripts represented by cDNA 
Q. A synthetic oligonucleotide of complementary sequence to 
nt3235 to nt3269 of the BPV4 coding strand was obtained: this 
was designated primer 156 (Table 3*6). The sequence was 
chosen to optimise specific hybridisation, with its position 
well upstream of the splice acceptor site at nt3376; this 
position was also chosen to be about 100 nucleotides 
downstream of the expected RNA 5f termini so that it would 
also be suitable for RNA sequencing.
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Primer 156 was 5’ labelled and hybridised to AOP A 
poly(A) RNA in 80% formamide, 0.4 M NaCl at the theoretical 
optimum annealing temperature of 36.4 °C. A control reaction 
was also set up. The primer extension reaction was performed 
at the same time as an RNA sequencing experiment using the 
same primer and mRNA. The reaction products were fractionated 
on a sequencing gel next to radioactive size markers. The gel 
was autoradiographed for three days, after which only faint 
bands could be made out in the test lanes. An
autoradiographic exposure of six weeks was carried out, 
following which a faint but readable sequencing ladder could 
be made out in the lower part of the gel (Fig. 55). 
Unfortunately, the primer extension lane had been 
contaminated by overspill from the size marker lane on 
loading , with the result that any primer extension data was
obscured. This experiment was not repeated as there was only
enough poly(A)+RNA left for the S1 nuclease protection
analysis. The sequencing ladder is shown in Figure 55 next 
to the shorter exposure of the size markers: these were used
to identify the positions of bands in the sequencing tracks 
and thereby to interpolate the sequence where it was 
difficult to read. The sequence is shown for reference on the 
left hand side of the autoradiograph in Figure 55.
Relatively intense bands in all four lanes of the sequencing 
ladder represent primer extension terminations. Two major 
terminations occurred in this sequence, corresponding to 
nt3152 and nt3093; the sequence confirmed that no splice 
junctions were involved. Very faint bands were observed above
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the latter terminus and a further, very faint primer 
extension termination mapping to nt3069, although splicing 
could not be ruled out in this case. The faintness of these 
bands may also have been as much due to their position above 
the sequencing limit of the technique as to the relative 
abundance of the transcript. The positions of these 
terminations are shown on the genomic sequence in Figure 56,
and relative to the encoded orf's of this region and their
ATG codons in Figure 59.
Examination of the genomic sequence in the region of these 
sites revealed no known promoter/enhancer sequences; however, 
this is also the case for transcripts of BPV1 initiating at 
nt2440 and nt3080 in the same region (Ahola et al., 1987),
and for the putative late promoter of BPV4 mapped in the 
previous subsection. The protracted exposure time required 
for the autoradiograph of this RNA sequence showed that the 
transcripts represented by cDNA Q are extremely low in 
abundance in vivo. In BPV1, the abundance of transcripts 
initiating in the E2 region was at least 100 times lower than 
those from the late promoter; therefore the unspliced 
transcripts initiating from P2440 were 1000 times less
abundant.
The RNA sequencing data on the BPV4 transcripts was
complemented by a S1 nuclease protection experiment.
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3*7.3* Sl-Duclease protection analysis of sequences upstream 
of cDNA Q.
3.7.3.(i). Isolation of the probe.
On the basis of RNA sequencing data, a suitable subgenomic 
restriction fragment was chosen for S1 nuclease protection 
analysis which contained sequences from cDNA Q 5* to the 
acceptor splice site and extended upstream of the mapped 
primer extension terminations. A 406 bp Hinfl-SspI fragment 
from nt2838 to nt3244 was separated from pBV4 DNA using the 
strategy outlined in Figure 57. pBV4 was digested with Hinfl 
and SspI and the fragments fractionated on a 1.5% LMP gel. 
Unfortunately, a 396 bp Hinfl-SspI fragment of the pAT153 
vector comigrated with the 406 bp BPV4 fragment. It was 
decided to separate these out on the strand separating gel. 
THe upper half of the appropriate double band was excised 
from the agarose gel to reduce the level of contaminating
plasmid DNA (Fig. 57(b)). The DNA was extracted and 1 pg was
32phosphatased, 5' P labelled and run on a strand separating 
gel. Four single strand bands appeared as two doublets in an 
autoradiograph of the gel, labelled probes 1 to 4 (Fig. 
57(c)). The two ds DNA bands below them showed that less 
plasmid DNA was present than BPV4 probe; this variation in 
intensity was also seen in the two single strand doublets. It 
was therefore assumed that the doublet having lower mobility 
contained viral DNA, but all of the single stranded probes 
were isolated from the gel and hybridised to poly(A)+RNA,
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with appropriate controls. Probes 1 and 2 were hybridised to 
the remaining AOP A mRNA, while probes 3 and 4 were 
hybridised to AOP 298oes poly(A)+RNA, of which an estimated 
10 pg had been isolated from total RNA. The base composition 
of the first 175 nucleotides of the antisense probe (nt3244 
to nt3069) was used to calculate the optimum annealing 
temperature of the probe to RNA’s with 5’ termini at nt3069. 
This was 36.4°C, the low temperature reflecting the high A+T 
content of the probe (64.8%; Table 3.6).
Since inappropriate S1 nuclease digestion could have taken 
place in the A+T rich regions of the probe, the S1 reaction 
mixes of each annealed probe was divided into two aliquots 
and one was digested at 37°C, while the other was digested at 
the lower incubation temperature of 18°C in an attempt to 
reduce possible ’’breathing” of the weaker A-T bonds (Pelham, 
1982). Products of S1 nuclease digestion were run out on a 
sequencing gel next to radioactive size markers. An 
autoradiograph at 6 weeks’ exposure is shown in Figure 58.
No protected fragments were found for probes 3 and 4 (not 
shown), or for any of the control reactions, which were 
carried out at 18°C. A faint band representing full length 
probe was seen in the probe 2 test lane of the 18°C reaction 
(Fig. 58, lane 2(c)). This was thought to represent 
contamination by probe 1 DNA: probe 1 was protected along its 
entire length in both test reactions (lane 1(b) and (c)). The 
duration of autoradiographic exposure required to obtain this 
band intensity showed that the represented transcript was 
rare. Very faint bands of lower molecular weight occurred in
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the two test lanes of probe 1. These bands were difficult to
reproduce in a photograph but were quite apparent on the
autoradiograph. In most cases, these did not coincide between 
the 37°C and 18°C reactions (lanes 1(b) and (c), 
respectively), and therefore may have been produced by 
non-specific S1 nuclease attack. However, bands of identical 
mobility in both lanes were found which mapped to nt3071, 
nt3094 and nt3151. These corresponded almost exactly to the 
RNA sequence termini. The faint band of about 191 nucleotides 
in lane 2(c) is due to a fold in the dried down gel and does 
not represent a protected fragment.
The results of RNA sequencing and S1 nuclease protection
mapping of the 5’ ends of the transcripts represented by cDNA 
Q are shown together on the genomic sequence in Figure 56, 
and relative to the E2 orf and its ATG codons in Figure 59.
3.7.4. Discussion: cDNA Q represents novel BPV4 transcripts.
The results of RNA sequencing and S1 nuclease protection
analysis correlate at three positions: nt3069, nt3093 and
nt3151. The positions mapped by RNA sequencing are used as 
the map position could be identified using the genomic 
sequence in the latter two cases. The agreement between the 
two experiments indicates that these are genuine 5’ termini 
of extremely rare transcripts.
The other sites mapped by S1 nuclease analysis are not 
confirmed by the RNA sequencing data. The fact that S1 
nuclease reactions performed at different temperatures
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produced different sizes of protected fragments in this 
region indicated that these did not represent RNA 5' termini 
but inappropriately digested DNA:RNA hybrids. Examination of 
the genomic DNA sequence between nt3093 and nt3151 (Fig. 56) 
revealed that it is highly A+T rich (62.7/6), with an almost 
unbroken stretch of A and T residues between nt3092 and 
nt3111. The bands occurring in this region were therefore 
probably due to digestion of the DNA at the weakly bonded A-U 
and T-A hybrids. It might also be suggested that the terminus 
at nt3093 was artifactual for the same reason; however, this 
appeared also to be a major termination site in the RNA 
sequencing reaction.
No known promoter/enhancer sites are found in this region of 
the BPVM genome; however, transcriptional initiation from 
nt2440 of BPV1 occurs in the absence of an upstream TATA box 
which, as has been explained previously, is not required for 
this process (Benoist and Chambon, 1981; Mathis and Chambon, 
1981). This may explain the apparent multiple initiation site 
found in the present study. The coding potential of 
transcripts initiating at nt3069 and nt3093 in BPV4 is the 
same: each is within the E2 orf and upstream of the ATG codon 
at nt31^9, which is in a favourable sequence context for 
translational initiation (Kozak, 1986). The RNA start site at 
nt3151 is 7 nucleotides upstream of the ATG codon at nt3lS8 
which is, however, in a weak translational context. It is 
therefore possible that the latter type of transcript is 
translated predominantly from the ATG codon of the full E4 
orf at nt3300. This may represent the BPV4 homologue of the
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larger E4 protein of HPV1a (Doorbar et al., 1987). If its
expression parallels that found in HPV1a-infected papillomas, 
this will be confined to the basal layers of the epithelium, 
perhaps explaining the low abundance of this transcript in 
papilloma tissue as a whole.
S1 nuclease analysis showed that the most abundant transcript 
containing the probe sequences extended 5’ to nt2842, the 
limit of the probe. It might be expected from the Northern 
hybridisation data that sequences upstream of nt3000 could 
not be encoded in a transcript of only 1kb; however, the 
mapping experiments described above do not rule out the 
possibility of splicing at sites downstream of nt3253. 90% of 
the BPV1 transcripts initiating at are sPlicecl within
the early region (Baker and Howley, 1987). Such a splice 
junction in a BPV4 transcript could bring about the 
expression of the E5b orf. Failure to obtain an RNA 
sequencing ladder at this distance from the primer may have 
been due to the limitations of the technique: the intensity
of RNA sequencing bands falls off sharply around 200 
nucleotides upstream of the position of the primer.
Further mapping experiments will have to be carried out to 
identify possible splice junctions in transcripts initiating 
in this region.
Thus the transcripts represented by cDNA Q may express a 
protein corresponding to the E2 repressor of BPV1, and the 
full length E4 orf. Unmapped transcripts initiating upstream 
of nt2842 were also discovered by this method, and 
hybridisation of cDNA Q only to 1 kb transcripts suggests
297
that these are spliced within the early region.
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Figure 54* Northern blot hybridisation using cDNA Q as probe.
5 \ig of AOP A poly(A)+RNA was run on a 16 cm 2*2 M formaldehyde, 1.5% agarose 
gel and transferred to nylon membrane. This was prehybridised to unlabelled 
cDNA 7E11 OJA and then hybridised to radiolabelled pQ DNA.
M: RNA size markers (BRL).
(a): AOP A poly(A)+RNA vs. pQ, DNA.
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Figure 55. RNA sequencing using primer 156.
BPV4 transcripts in AOP A poly (A) RNA were sequenced 
using primer 156 (Table 3*6.) The faint sequence in 
this 6 week autoradiographic exposure was interpolated 
using the size markers to calculate the positions of 
hands on the genomic sequence, and is shown here for 
reference.
M ; radioactive size markers ( Sau961—digested 
pAT153 ENA; Hhal-digested pAT153 DNA).
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Figure 56* mRNA 5* ends mapped in the region upstream of cBNA Q by 
RNA sequencing and S1 nuclease protection.
2979 2989 2999 3009 3019
AACAAAAGGC TAAGGATGCA ATCAAGATGT ACTTATGTTT GGAAAGCCTG
3029 3039 3049 3059 3069 3079
CAGAAATCAG AGTTTGCCAA TCAAAGATGG TCACTTGTGG ACACTAGCAT AGAGACATT1
t tt
3089 3099 3109 3119 3129 3139
AAGGCGCCAC CTGAAAACAC TTTAAAAAAA AGGGGCCAGC ATGTGACTGT CATTTATGAI
tt 1' T t t t
3149 3159 3169 3179 3189 3199
CAGAATGCAA TGAATTCAAT GGTATACACT TTGTGGAAAG AAGTGTATTA TGTTGATGAA
T t
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Figure 58* S1 nuclease protection analysis of S1 -probe Q,
Probes 1 and 2 (Fig* 57) were each annealed to 5 Ug 
AOP A poly(A)+ENA at a precalculated temperature of
36*5°Cf with tKNA controls. The test reactions were
divided in half: one half was digested with S1
nuclease at 37°C for 30 min,, and the other at 18 C
for 30 min. Controls were digested at 18°C.
The reaction products were fractionated on a 
sequencing gel, which was autoradiographed for 
6 weeks.
Lanes M: radioactive size markers (Sau96l—digested 
pAT153 DNA; Hhal-digested pAT153 DNA),
1: probe 1
2: probe 2
Lanes (a): undigested probe
(b): test reaction, 37°C
(c): test reaction, 18°C
(d): control reaction.
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Figure 60.
The amended genomic organisation of BFV4 is shown with alterations to 
the previously described E5a, E5b and E4 orf's (Patel at al., 1987).
In addition, the two novel transcripts, both of the 1 kb size class, 
are included in the transcriptional map, shown here beneath the genome. 
The principal cINA's analysed in this project are also shown.
(a) Genomic organisation of BFV4
(b) Transcriptional organisation of BFV4
(c) cMA^s of BFV4 mKNA isolated from papillomas, showing positions 
of the splice junction of the major transcript and of the early 
polyadenylation site.
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3-8. SUMMARY AND CONCLUSIONS.
The initial objective of this project was to study the in 
vivo transcripts of BPV4 through the synthesis and analysis 
of cDNA’s. This objective was fulfilled in the case of two 
previously unmapped mRNA's. Sequence analysis of cDNA’s and 
of mRNA from papillomas also confirmed the differential 
utilisation of two consensus RNA splicing signals, mapped the 
nucleotide position of the early polyadenylation site and 
brought to light an error in the genomic sequence, the 
correction of which altered the genomic organisation of BPV4 
in the region of the E4 and E5 orf’s.
The results of this study will be brought together in this 
summary and discussed as a whole; finally, suggestions will 
be made for future investigations.
3.8.1. Amendment to the genomic sequence.
The sequences of two cDNA’s from independent cDNA libraries, 
and of polyadenylated BPV4 RNA isolated from papillomas, 
differed from the published genomic sequence (Patel et al., 
1987) between nt3412 and nt3460. The agreement between the 
cDNA and RNA sequences argued that they represented the 
original viral sequence. The changes to the previous genomic 
sequence involved a frameshift at nt3413, which was reversed 
at nt3459; the abolition of the translation termination codon 
between what were previously the E5a and E5b orf’s; and the 
alteration of a methionine in what had been the E2 orf to a
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termination codon in the E4 orf. Effectively, the E2 orf 
remained open in this region while the E5 orf was now 
continuous and the E4 orf divided by the new termination 
codon.
3*8.2. The ma.ior transcript of BPV4 is homologous to the E4- 
encoding major transcripts of other papillomaviruses.
cDNA 7E11 was shown by Northern hybridisation analysis to 
represent the 1 kb major transcript of BPV4. It contained two 
exons, representing nt943 to nt10l6 in the region of the E6 
orf, joined to sequences from nt3376 to the early
polyadenylation site. Primer extension and S1 nuclease 
protection analysis showed that this cDNA was near
full-length in terms of coding potential. The first
translatable orf encoded by this cDNA was a fusion orf of the 
now continuous E5 orf with four codons in the upstream exon, 
including an A7G.
The transcript represented by cDNA 7E11 was similar in every 
respect to the major transcripts of BPV1 (Baker and Hcwley, 
1987), HPV11 (Nasseri et al., 1987), HPV6b and HPV1a (Chow et 
al.f 1987a,b) in benign tumours. Those of BPV1 and HPV11 had 
been shown by cDNA analysis to encode fusions of the
respective E4 orf with small, 2- or 4-codon orf’s in the
distal 5’ exon, and the exon coordinates of the major 
transcripts of HPV6b and 1a suggested a similar arrangement 
in thes viruses. It was therefore considered that the 
continuous E5 orf specified by the BPV4 cDNA's might
307
represent the E4 homologue of BPV4.
3.8.3. Reassignment of the E4 and E5 orffs of BPV4.
The continuous E5 and the interrupted E4 orf's defined by
BPY4 cDNA and RNA sequences were compared to the E4 and E5
orf’s of other papillomaviruses by homology and alignment of
their putative translation products. Homology was low, as
expected for this divergent region of the papillomavirus 
genome (Danos et al., 1984), but it was found that the
continuous E5 orf of BPV4 generally shared greater homology
with the E4 orf’s of other papillomaviruses than with their 
E5 orf’s, particularly with the mucosa-specific HPV’s 16, 18
and 33. The alignment plot also demonstrated isolated regions 
of conservation of amino acids of potential functional or
structural importance.
On the basis of these homology analyses and the similarities 
of the major transcripts encoding these orf’s, it was decided 
to change the designation of the BPV4 E5 orf to E4.
The interrupted orf, previously designated E4, contains no 
potential translational initiator codons, and according to 
the current transcriptional map may not be expressed. These 
small orf’s are, for the present, renamed E5a and E5b,
although they exhibit little homology to the E5 orf's of
other papillomaviruses.
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3.8.4. The functional significance of the E4 orf.
The E4 orf of HPV1 is translated into a number of proteins 
which are differentially expressed in papillomas (Breitburd 
et al., 1987). The abundance of these proteins and certain of 
their properties, such as their acidity and ability to 
aggregate in intracellular inclusions, and the absence in 
virus-propagating keratinocytes of cellular keratins normally 
associated with terminal differentiation, suggested that they 
were involved in subverting the differential metabolism of 
keratinocytes to favour viral reproduction. In mucosa, a 
different regime of keratin expression is associated with 
keratinocyte differentiation (Broker and Botchan, 1986), so 
it is perhaps not surprising that greater homology is found 
between the E4 orf’s of mucosa-specific HPV’s and the 
redesignated E4 orf of BPV4, which infects the same type of 
cell, albeit in a different host species. Relatively high 
homology also exists with the E4 orf of HPV11, which affects 
both skin and mucosa, but the highest homology (26%) is with 
the E4 orf of HPV8, which, although it does not infect 
mucosal cells, is in common with HPV’s 16, 18 and 33, and
BPV4, a cancer-associated papillomavirus. Although this is a 
long-range speculation, these data may correlate 
carcinogenicity as well as cell type specificity in the 
papillomaviruses, and since the E4 proteins are thought to be 
involved at a very early stage in the alteration of cell 
metabolism (Breitburd et al., 1987), this points to a further 
avenue of oncogenic research on papillomaviruses.
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3*8.5. Mapping of the 1 kb major transcript.
Sequence analysis of cDNA's 7E11, G and J mapped the early 
polyadenylation site of BPV4 to nt4034, showing that it is 
homologous to the canonical eukaryotic polyadenylation signal 
(Fitzgerald and Shenk, 1981).
The 5’ end of the major transcript of BPV4 was mapped by
primer extension, RNA sequencing and S1 nuclease protection 
analysis, and found to be at a heterogeneous site between 
nt776 and nt902, with the major transcriptional initiation 
site at nt870. No known promoter sites were found near these 
positions, but a minor RNA start site at nt722 appeared to be 
controlled by the TATA box at nt691. The multiple
transcriptional initiation site, with an upstream,
TATA-controlled minor start site is very similar to the 
arrangement of the late promoters, P^  and Pyi85J op 
(Baker and Howley, 1987), except that the SV40 late promoter 
homology of BPV4 is not found in this region. The similarity 
of the major transcript of BPV4 to that of BPV1, and the
discovery of a conserved sequence motif, TTGPyPuNTGPyG, in 
the heterogeneous RNA start sites of both viruses, suggested 
that this is the late promoter of BPV4. In addition, failure 
to observe the 5’ end of the 4.2 kb late transcript at nt654 
in S1 nuclease analysis of this region suggested that this 
late transcript may instead start downstream of this position 
in the heterogeneous transcriptional initiation site.
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3-8.6. Mapping of novel transcripts in the E2 region.
cDNA Q represents previously unmapped 1 kb transcripts which 
do not utilise the splice site at nt3376. Northern blot 
hybridisation, RNA sequencing and S1 nuclease protection 
analysis defined minor RNA start sites at nt3069 and nt3093. 
These extremely rare transcripts potentially express a 5' 
truncated E2 orf similar to the E2 repressor of BPV1 (Lambert 
et al., 1987). A further rare transcript initiating at nt3151 
may also express the full-length E4 orf, which in HPV1a is 
thought to encode the larger E4 proteins expressed early in 
the infective cycle (Doorbar et al., 1986; Breitburd et al..
1987). The S1 nuclease analyses also showed that a minor 1 kb 
transcript, slightly more abundant than the above mRNA's, 
initiated upstream of nt2842 and contained sequences 
represented by cDNA Q up to nt3244. The existence of splice 
junctions in these transcripts at positions downstream of 
nt3244 was not precluded by these analyses.
3.8 .7 . The revised genomic and transcriptional organisation 
of BPV4.
The main results described in this thesis are presented in 
the revised genomic and transcriptional map of BPV4 in Figure 
60. The E4, E5a and E5b orf’s have been redesignated, and 
their sequence alterations are shown in Figure 38.
The 1 kb transcript size class now has three members: the
major, E4-encoding transcript initiating at the heterogeneous
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start site in the E6 region; the family of transcripts 
represented by cDNA Q, initiating both within the E2 orf and 
upstream of it; and the original 1 kb transcript defined by 
Smith et al. (1986). However, it has yet to be shown 
conclusively that the latter is not simply an exon of the 
major transcript.
It is also possible that the 5T end of the 4.2 kb late 
transcript is in the heterogeneous transcriptional start 
site.
In addition, three new promoters have been defined: the
heterogeneous start site around nt870, thought to be the late 
promoter of BPV4 , may be under the control of a conserved 
papillomavirus promoter sequence; a TATA sequence at nt691 
may direct the minor transcriptional start site at nt722; and 
the rare transcripts represented by cDNA Q may initiate at a 
multiple start site controlled by a single promoter. These 
promoters may be analogous to P^ , pyi85 anc* ^3080 *n 
(Baker and Hcwley, 1987). It thus appears that the 
transcriptional organisation of BPV4 is more similar to those 
of other papillomaviruses than was previously thought (Smith 
et al., 1986).
3.9. Future work.
Further progress has been made in the transcriptional 
analysis of BPV4 by the work carried out in this project, and 
the continuation of this experimental approach would finalise 
some of the mapping which was left incomplete. The transcript
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extending 51 to nt2842 could be mapped using an S1 probe
covering this region, and perhaps sequenced using an
oligonucleotide probe. Since cDNA Q hybridises to the 1 kb
size class of BPV4 mRNA’s, this transcript is probably 
spliced in the E2 region; this could be checked using a 3* 
end labelled S1 probe.
The 5* end of the 4.2 kb RNA could be mapped by RNA 
sequencing using a primer located in the second exon of this 
transcript. A further cDNA library would have to be 
synthesised to obtain late transcript cDNA's to confirm their 
splicing organisation.
Functional studies in cultured cells could be carried out 
using cDNA’s already available. It would be interesting to 
test the effects of expressing cDNA 7E11 in cultured cells, 
if possible primary bovine keratinocytes. BPV4 DNA has now 
been recloned in a pUC vector so that the early region and 
ncrl are intact and contiguous. This plasmid could be used 
for functional studies. In particular, cDNA 10-1 could be
expressed under the control of a constitutive promoter and 
cotransfected with the new BPV4 plasmid to test for a 
replication modulatory function. cDNA Q could be "completed” 
as a full-length cDNA by ligation to suitable subgenomic 
fragments, and used in complementation tests for the E2 
repressor function.
Difficulties have been experienced in cloning the E6 orf into 
bacterial expression vectors. cDNA N could be used instead to 
produce an E6 peptide for the production of antisera.
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